>P19084; 20 11S GLOBULIN SEED STORAGE PROTEIN G3 PRECURSOR (HELIANTH
MASKATLLLAFTLLFATCIARHQQRQQQQNQCQLQNIEALEPIEVIQAEAGVTEIWDAYD
QQFQCAWSILFDTGFNLVAFSCLPTSTPLFWPSSREGVILPGCRRTYEYSQEQQFSGEGG
RRGGGEGTFRTVIRKLENLKEGDVVAIPTGTAHWLHNDGNTELVVVFLDTQNHENQLDEN
QRRFFLAGNPQAQAQSQQQQQRQPRQQSPQRQRQRQRQGQGQNAGNIFNGFTPELIAQSF
NVDQETAQKLQGQNDQRGHIVNVGQDLQIVRPPQDRRSPRQQQEQATSPRQQQEQQQGRR
GGWSNGVEETICSMKFKVNIDNPSQADFVNPQAGSIANLNSFKFPILEHLRLSVERGELR
PNAIQSPHWTINAHNLLYVTEGALRVQIVDNQGNSVFDNELREGQVVVIPQNFAVIKRAN
EQGSRWVSFKTNDNAMIANLAGRVSASAASPLTLWANRYQLSREEAQQLKFSQRETVLFA
PSFSRGQGIRASR
>P15458; 21 2S SEED STORAGE PROTEIN 2 PRECURSOR (2S ALBUMIN STORAGE 
MANKLFLVCATFALCFLLTNASIYRTVVEFDEDDASNPMGPRQKCQKEFQQSQHLRACQK
LMRMQMRQGRGGGPSLDDEFDLEDDIENPQGPQQGHQILQQCCSELRQEEPVCVCPTLRQ
AARAVSLQGQHGPFQSRKIYKTAKYLPNICKIQQVGECPFQTTIPFFPPY
>P04403; 22 2S SULPHUR-RICH SEED STORAGE PROTEIN PRECURSOR.
MAKISVAAAALLVLMALGHATAFRATVTTTVVEEENQEECREQMQRQQMLSHCRMYMRQQ
MEESPYQTMPRRGMEPHMSECCEQLEGMDESCRCEGLRMMMMRMQQEEMQPRGEQMRRMM
RLAENIPSRCNLSPMRCPMGGSIAGF
>P33487; 33 AUXIN-BINDING PROTEIN 1 PRECURSOR (ABP).
MIVLSVGSASSSPIVVVFSVALLLFYFSETSLGAPCPINGLPIVRNISDLPQDNYGRPGL
SHMTVAGSVLHGMKEVEIWLQTFAPGSETPIHRHSCEEVFVVLKGSGTLYLAETHGNFPG
KPIEFPIFANSTIHIPINDAHQVKNTGHEDLQVLVIISRPPIKIFIYEDWFMPHTAARLK
FPYYWDEQCIQESQKDEL
>P13689; 38 AUXIN-BINDING PROTEIN 1 PRECURSOR (ABP) (ERABP1).
MAPDLSELAAAAAARGAYLAGVGVAVLLAASFLPVAESSCVRDNSLVRDISQMPQSSYGI
EGLSHITVAGALNHGMKEVEVWLQTISPGQRTPIHRHSCEEVFTVLKGKGTLLMGSSSLK
YPGQPQEIPFFQNTTFSIPVNDPHQVWNSDEHEDLQVLVIISRPPAKIFLYDDWSMPHTA
AVLKFPFVWDEDCFEAAKDEL
>Q42656; 15 ALPHA-GALACTOSIDASE PRECURSOR (EC 3.2.1.22) (MELIBIASE) 
MVKSPGTEDYTRRSLLANGLGLTPPMGWNSWNHFRCNLDEKLIRETADAMVSKGLAALGY
KYINLDDCWAELNRDSQGNLVPKGSTFPSGIKALADYVHSKGLKLGIYSDAGTQTCSKTM
PGSLGHEEQDAKTFASWGVDYLKYDNCNNNNISPKERYPIMSKALLNSGRSIFFSLCEWG
EEDPATWAKEVGNSWRTTGDIDDSWSSMTSRADMNDKWASYAGPGGWNDPDMLEVGNGGM
TTTEYRSHFSIWALAKAPLLIGCDIRSMDGATFQLLSNAEVIAVNQDKLGVQGNKVKTYG
DLEVWAGPLSGKRVAVALWNRGSSTATITAYWSDVGLPSTAVVNARDLWAHSTEKSVKGQ
ISAAVDAHDSKMYVLTPQ
>P10968; 26 AGGLUTININ ISOLECTIN 1 PRECURSOR (WGA1) (ISOLECTIN A).
MKMMSTRALALGAAAVLAFAAATAQAQRCGEQGSNMECPNNLCCSQYGYCGMGGDYCGKG
CQNGACWTSKRCGSQAGGATCTNNQCCSQYGYCGFGAEYCGAGCQGGPCRADIKCGSQAG
GKLCPNNLCCSQWGFCGLGSEFCGGGCQSGACSTDKPCGKDAGGRVCTNNYCCSKWGSCG
IGPGYCGAGCQSGGCDGVFAEAITANSTLLQE
>P11219; 28 LECTIN PRECURSOR (AGGLUTININ).
MTMTSTTTKAMAMAAAVLAAAAVAATNAQTCGKQNDGMICPHNLCCSQFGYCGLGRDYCG
TGCQSGACCSSQRCGSQGGGATCSNNQCCSQYGYCGFGSEYCGSGCQNGPCRADIKCGRN
ANGELCPNNMCCSQWGYCGLGSEFCGNGCQSGACCPEKRCGKQAGGDKCPNNFCCSAGGY
CGLGGNYCGSGCQSGGCYKGGDGMAAILANNQSVSFEGIIESVAELV
>P11218; 23 LECTIN/ENDOCHITINASE PRECURSOR (EC 3.2.1.14) (AGGLUTININ
MMMRFLSAVVIMSSAMAVGLVSAQRCGSQGGGGTCPALWCCSIWGWCGDSEPYCGRTCEN
KCWSGERSDHRCGAAVGNPPCGQDRCCSVHGWCGGGNDYCSGSKCQYRCSSSVRGPRVAL
SGNSTANSIGNVVVTEPLFDQMFSHRKDCPSQGFYSYHSFLVAAESFPAFGTIGDVATRK
REVAAFLAHISQATSGERSDVENPHAWGLCHINTTTVTENDFCTSSDWPCAAGKKYSPRG
PIQLTHNFNYGLAGQAIGEDLIQNPDLVEKDPIISFKTALWFWMSQHDNKPSCHDIVLNA
NSAANRIPNKGVIGNIISRAFGHDDFAVRSSSIGFYKRYCDMLGVSYGHDLKYWFDNTPS
SEFQRIQMRVAA
>P25404; 27 ANTIMICROBIAL PEPTIDE 2 PRECURSOR (AMP2).
MAKVPIAFLKFVIVLILFIAMSGMIEACIGNGGRCNENVGPPYCCSGFCLRQPNQGYGVC
RNR
>P27275; 25 ANTIMICROBIAL PEPTIDE PRECURSOR (AMP) (AMP2 AND AMP1).
MVNMKCVALIVIVMMAFMMVDPSMGVGECVRGRCPSGMCCSQFGYCGKGPKYCGRASTTV
DHQADVAATKTAKNPTDAKLAGAGSP
>P04750; 24 ALPHA-AMYLASE TYPE B ISOZYME PRECURSOR (EC 3.2.1.1) (1,4
MANKHMSLSLFIVLLGLSCSLASGQVLFQGFNWESWKHNGGWYNFLMGKVDDIAAAGVTH
VWLPPASQSVAEQGYMPGRLYDLDASKYGNKAQLKSLIGALHGKAVKAIADIVINHRTAE
RKDGRGIYCIFEGGTPDARLDWGPHMICRDDRPYPDGTGNRPTRTRADFGAAPDIDHLNP
RVQKELVEWLNWLRTDDGFDGWRFDFAKGYSADVAKIYVDRSEPSFAVAEIWTSLAYGGD
GKPNLNQDPHRQELVNWVNKVGGSGPATTFDFTTKGILNVAVEGELWRLRGTDGKAPGMI
GWWPAKAVTFVDNHDTGSTQHMWPFPSDRVMQGYAYILTHPGNPCIFYDHFFDWGLKEEI
DRLVSIRTRQGIHSESKLQIMEADADLYLAEIEGKVIVKLGPRYDVGHLIPEGFKVVAHG
NDYAVWEKV
>Q10723; 22 ARYLSULFATASE PRECURSOR (EC 3.1.6.1) (ARYL-SULPHATE SULP
MLQRLVVALCLLGFAALTAAAAHQRPNFVVIFTDDQDGIQNSTHPRYQPKLHEHIRYPGI
ELKNYFVTTPVCCPSRTNLWRGQFSHNTNFTDVLGPHGGYAKWKSLGIDKSYLPVWLQNL
GYNTYYVGKFLVDYSVSNYQNVPAGWTDIDALVTPYTFDYNNPGFSRNGATPNIYPGFYS
TDVIADKAVAQIKTAVAAGKPFYAQISPIAPHTSTQIYFDPVANATKTFFYPPIPAPRHW
ELFSDATLPEGTSHKNLYEADVSDKPAWIRALPLAQQNNRTYLEEVYRLRLRSLASVDEL
IDRVVATLQEAGVLDNTYLIYSADNGYHVGTHRFGAGKVTAYDEDLRVPFLIRGPGIRAS
HSDKPANSKVGLHVDFAPTILTLAGAGDQVGDKALDGTPLGLYANDDGNLLADYPRPANH
RNQFQGEFWGGWSDEVLHHIPRYTNNSWKAVRVYDEDNQQAWKLIVSCTNERELYDLKTD
PGELCNIYNKTRAAVRTRLEALLAVLVVCKGESCTNPWKILHPEGSVNSWNQSLDRKYDK
YYANVAPFQYRTCLPYQDHNNEVSAFRSTVAAAAAAAAAAAAQQPGRRRMYTWTSAGRQL
SATASAIATSPQPRSEPFVAEVERHSVPVPAEVLQSDVAKWFDNPLALA
>P22184; 21 ANTHER-SPECIFIC PROTEIN SF2 PRECURSOR.
MANNSVSYLVLLLLVFVLAISESAPVQYCDRVTNLYHEKCDEKQCTEHCKTNEKAESGYC
LVVEKQQLSICSFDCSKYKPSTPAPPPPPPKLFYSGSWLQAKVENVMLPGQKNMNCTQCP
K
>P24792; 30 L-ASCORBATE OXIDASE PRECURSOR (EC 1.10.3.3) (ASCORBASE).
MLQMGKAREPNFLILFFFGLILAFGISSEGSQIRHYKWEVEYMFWAPDCNENIVMGINGQ
FPGPTIRANAGDTVVVELINKLHTEGVVIHWHGILQRGTPWADGTASISQCAINPGETFF
YNFTVDNPGTFFYHGHLGMQRSAGLYGSLIVDPPQGKKEPFHYDGEINLLLSDWWHQSIH
KQEVGLSSKPIRWIGEPQTILLNGRGQFDCSIAAKYDSNLEPCKLKGSEPCAPYIFHVMP
KKTYRIRIASTTALAALNFAIGNHPLLVVEADGNYVQPFYTSDIDIYSGESYSVLITTDQ
NPSENYWVSVGTRGRHPNTPPGLTLLNYLPNSVSKLPTSPPPETPAWDDFDRSKNFTYRI
TAAMGSPKPPVKSNRRIFLLNTQNVINGYVKWAINDVSLALPPTPYLGAMKFNLLHAFDQ
NPPPEVFPEDYDIDTPPTNEKTKIGNGVYQFKIGEIVDVILQNANMMKENLSEIHPWHLH
GHDFWVLGYGDGKFTAEEESSLNLKNPPLRNTVVIFPYGWTAIRFVADNPGVWAFHCHIE
PHLHMGMGVVFAEGVEKVGRIPTKALACGGTAKSLINNP
>P14133; 33 L-ASCORBATE OXIDASE PRECURSOR (EC 1.10.3.3) (ASCORBASE) 
MAKVADKPFFPKPFLSFLVLSIIFGFGITLSEAGFPKIKHYKWDVEYMFWSPDCVENIVM
GINGEFPGPTIRANAGDIVVVELTNKLHTEGVVIHWHGILQRGTPWADGTASISQCAINP
GETFTYRFVVDKAGTYFYHGHLGMQRSAGLYGSLIVDPPEGRSEPFHYDEEINLLLSDWW
HQSVHKQEVGLSSKPMRWIGEPQSILINGKGQFDCSIAAKYNQGLKQCELSGKEKCAPFI
LHVQPKKTYRIRIASTTALASLNFAIGNHELLVVEADGNYVQPFVTSDIDIYSGESYSVL
ITTDQNPLENYWVSIGVRARLPKTPPGLTLLNYLPNSASKLPISPPPETPHWEDFDRSKN
FTFRIFAAMGSPKPPVRYNRRLFLLNTQNRINGFMKWAINNVSLALPPTPYLAAMKMRLN
TAFNQNPPPETFPLNYDINNPPPNPETTTGNGVYKFNMGETVDVILQNANMLNPNMSEIH
PWHLHGHDFWVLGYGEGKFYAPEDEKKLNLKNPPLRNTVVIFPYGWTAIRFVADNPGVWA
FHCHIEPHLHMGMGVVFAEGVHMVGMIPPKALACGSTALVKNYPRLP
>P06451; 18 ATP SYNTHASE A CHAIN PRECURSOR (EC 3.6.1.34) (SUBUNIT IV
MNVLSYSINPLKGLYAISGVEVGQHFYWQIGGFQIHGQVLITSWVVIAILLGSAAIAVRS
PQTIPTGGQNFFEYVLEFIRDVSKTQIGEEYRPWVPFIGTMFLFIFVSNWSGALLPWKII
QLPHGELAAPTNDINTTVALALLTSVAYFYAGLTKKGLGYFGKYIQPTPILLPINILEDF
TKPLSLSFRLFGNILADELVVVVLVSLVPLVVPIPVMFLGLFTSGIQALIFATLAAAYIG
ESLEGHH
>Q09117; 24 BARK STORAGE PROTEIN B PRECURSOR.
MPQQSMQASLRDPIAEIERSNCKIAHLRLGLVFTSDNNERALQDSGLYSPDSEDSSVDIA
GRRFHSGTLNGSSIVYVKTGSHSVNMATTLQILLARFSIHGVIYFGNAGSLDKKTMVPGD
VSVPQAVAFTGVCNWKKFRSEKGKLVFGDFNYPENGENLLGTVEYEKIKMFSPSEAPKEV
FWLPITKSWYNAATEALKDMKLRKCYSDECLPGEPKVVFGSKSSTSDFYVRNKAYGDFLN
DNFDAKTADTTSASVALTSLSNEKLFVVFQGVSNVAGETSSNSRVSYLASYNAFLAATKF
INSIPTPRLACE
>P24258; 20 CARBONIC ANHYDRASE 2 PRECURSOR (EC 4.2.1.1) (CARBONATE D
MARTGALLLAALALAGCAQACIYKFGTSPDSKATHTGDHWDHSLNGENWEGKDGAGNPWV
CKTGRKQSPINVPQYHVLDGKGSKIATGLQTQWSYPDLMSNGSSVQVINNGHTIQVQWTY
DYAGHATIAIPAMRNQSNRIVDVLEMRPNDASDRVTAVPTQFHFHSTSEHLLAGKIFPLE
LHIVHKVTDKLEACKGGCFSVTGILFQLDNGPDNELLEPIFANMPTREGTFTNLPAGTTI
KLGELLPSDRDYVTYEGSLTTPPCSEGLLWHVMTQPQRISFGQWNRYRLAVGEKECNSTE
TDAAHADAGHHHHHHRRLLHNHAHLEEVPAATSEPKHYFRRVMEETENPDAYTCTTVAFG
QNFRNAQYANGRTIKLARYE
>P10562; 26 CANAVALIN PRECURSOR.
MAFSARFPLWLLLGVVLLASVSASFAHSGHSGGEAEDESEESRAQNNPYLFRSNKFLTLF
KNQHGSLRLLQRFNEDTEKLENLRDYRVLEYCSKPNTLLLPHHSDSDLLVLVLEGQAILV
LVNPDGRDTYKLDQGDAIKIQAGTPFYLINPDNNQNLRILNFAITFRRPGTVEDFFLSST
KRLPSYLSAFSKNFLEASYDSPYDEIEQTLLQEEQEGVIVKMPKDQIQEISKHAQSSSRK
TLSSQDKPFNLRSRDPIYSNNYGKLYEITPEKNSQLRDLDILLNCLQMNEGALFVPHYNS
RATVILVANEGRAEVELVGLEQQQQQGLESMQLRRYAATLSEGDILVIPSSFPVALKAAS
DLNMVGIGVNAENNERNFLAGNKENVIRQIPRQVSDLTFPGSGEEVEELLENQKESYFVD
GQPRHIDAGGKARRAHLPNLFRTFY
>P23951; 23 26 KD ENDOCHITINASE 2 PRECURSOR (EC 3.2.1.14) (CHI-26).
MRSLAVVVAVVATVAMAIGTARGSVSSIVSRAQFDRMLLHRNDGACQAKGFYTYDAFVAA
AAAFPGFGTTGSADAQKREVAAFLAQTSHETTGGWATAPDGAFAWGYCFKQERGASSDYC
TPSAQWPCAPGKRYYGRGPIQLSHNYNYGPAGRAIGVDLLANPDLVATDATVGFKTAIWF
WMTAQPPKPSSHAVIAGQWSPSGADRAAGRVPGFGVITNIINGGIECGHGQDSRVADRIG
FYKRYCDILGVGYGNNLDCYSQRPFA
>P21226; 20 ENDOCHITINASE A2 PRECURSOR (EC 3.2.1.14).
MSKLRIPILLVLFIVSCCSAEQCGTQAGGALCPGGLCCSKFGWCGSTSEYCGDGCQSQCS
GSSGGGTLSSLISGDTFNNMLKHRNDNACQGKPFYTYDAFLSAAKAFPNFANKGDTATKK
REIAAFLGQTSHETTGGWPTAPDGPYAWGYCFLREQNPSTYCQASSEFPCASGKQYYGRG
PIQISWNYNYGQCGRAIGVDLLNNPDLVATDPVISFKTALWFWMTPQSPKPSCHDVITGG
WTPSSADRAAGRLPGYGTVTNIINGGLECGRGQDSRVQDRIGFYKRYCDIFGIGYGDNLD
CYSQRPFGSSLPLSSILLDTVAAA
>P24091; 23 ENDOCHITINASE B PRECURSOR (EC 3.2.1.14) (CHN-B).
MRLREFTALSSLLFSLLLLSASAEQCGSQAGGARCASGLCCSKFGWCGNTNDYCGPGNCQ
SQCPGGPTPPGGGDLGSIISSSMFDQMLKHRNDNACQGKGFYSYNAFINAARSFPGFGTS
GDTTARKREIAAFFAQTSHETTGGWATAPDGPYAWGYCWLREQGSPGDYCTPSGQWPCAP
GRKYFGRGPIQISHNYNYGPCGRAIGVDLLNNPDLVATDPVISFKSALWFWMTPQSPKPS
CHDVIIGRWQPSSADRAANRLPGFGVITNIINGGLECGRGTDSRVQDRIGFYRRYCSILG
VSPGDNLDCGNQRSFGNGLLVDTM
>P19172; 30 ACIDIC ENDOCHITINASE PRECURSOR (EC 3.2.1.14).
MTNMTLRKHVIYFLFFISCSLSKPSDASRGGIAIYWGQNGNEGNLSATCATGRYAYVNVA
FLVKFGNGQTPELNLAGHCNPAANTCTHFGSQVKDCQSRGIKVMLSLGGGIGNYSIGSRE
DAKVIADYLWNNFLGGKSSSRPLGDAVLDGIDFNIELGSPQHWDDLARTLSKFSHRGRKI
YLTGAPQCPFPDRLMGSALNTKRFDYVWIQFYNNPPCSYSSGNTQNLFDSWNKWTTSIAA
QKFFLGLPAAPEAADSGYIPPDVLTSQILPTLKKSRKYGGVMLWSKFWDDKNGYSSSILA
SV
>P17541; 25 ACIDIC ENDOCHITINASE PRECURSOR (EC 3.2.1.14).
MAAHKITTTLSIFFLLSSIFRSSDAAGIAIYWGQNGNEGSLASTCATGNYEFVNIAFLSS
FGSGQAPVLNLAGHCNPDNNGCAFLSDEINSCKSQNVKVLLSIGGGAGSYSLSSADDAKQ
VANFIWNSYLGGQSDSRPLGAAVLDGVDFDIESGSGQFWDVLAQELKNFGQVILSAAPQC
PIPDAHLDAAIKTGLFDSVWVQFYNNPPCMFADNADNLLSSWNQWTAFPTSKLYMGLPAA
REAAPSGGFIPADVLISQVLPTIKASSNYGGVMLWSKAFDNGYSDSIKGSIG
>P29060; 22 ACIDIC ENDOCHITINASE PRECURSOR (EC 3.2.1.14).
MIKYSFLLTALVLFLRALKLEAGDIVIYWGQNGNEGSLADTCATNNYAIVNIAFLVVFGN
GQNPVLNLAGHCDPNAGACTGLSNDIRACQNQGIKVMLSLGGGAGSYFLSSADDARNVAN
YLWNNYLGGQSNTRPLGDAVLDGIDFDIEGGTTQHWDELAKTLSQFSQQRKVYLTAAPQC
PFPDTWLNGALSTGLFDYVWVQFYNNPPCQYSGGSADNLKNYWNQWNAIQAGKIFLGLPA
AQGAAGSGFIPSDVLVSQVLPLINGSPKYGGVMLWSKFYDNGYSSAIKANV
>P36910; 25 ACIDIC ENDOCHITINASE SE2 PRECURSOR (EC 3.2.1.14).
MAAKIVSVLFLISLLIFASFESSHGSQIVIYWGQNGDEGSLADTCNSGNYGTVILAFVAT
FGNGQTPALNLAGHCDPATNCNSLSSDIKTCQQAGIKVLLSIGGGAGGYSLSSTDDANTF
ADYLWNTYLGGQSSTRPLGDAVLDGIDFDIESGDGRFWDDLARALAGHNNGQKTVYLSAA
PQCPLPDASLSTAIATGLFDYVWVQFYNNPPCQYDTSADNLLSSWNQWTTVQANQIFLGL
PASTDAAGSGFIPADALTSQVLPTIKGSAKYGGVMLWSKAYDSGYSSAIKSSV
>P42820; 27 ACIDIC ENDOCHITINASE SP2 PRECURSOR (EC 3.2.1.14).
MTLLLKNTLYLALIISVISSFPTSLFAQNCGCAPNLCCSNFGFCGTGTPYCGVGNCQSGP
CEGGTPTTPTTPTTPTTPGTGGGGSSVSDIVSQAFFDGIIGQAAASCPGKNFYTRAAFLS
AVDPKFGNEGSSDDNKREIAAFFAHISHETTNLCHIEERDGDVGDAYCDQDKAAQYPCAA
GKKYYGRGPLQLSWNYNYALAGQAIGFDGLGNPEKVATDVNTSFKAAMWFWMTNVHSVMN
QGFGATTKAINGALECNGQNQDQANDRIQFYKKYCADFGVAPGDNLTC
>P17513; 24 ACIDIC ENDOCHITINASE P PRECURSOR (EC 3.2.1.14) (PATHOGEN
MEFSGSPLTLFCCVFFLFLTGSLAQGIGSIVTNDLFNEMLKNRNDGRCPANGFYTYDAFI
AAANSFPGFGTSGDDTARRKEIAAFFGQTSHETTGGSLSAEPFTGGYCFVRQNDQSDRYY
GRGPIQLTNQNNYEKAGNAIRQDLVNNPDLVATDATISFKTAIWFWMTPQDNKPSSHDVI
IGSWTPSAADQSANRAPGCGVITNIINGGIECGVGPNAAVEDRIGYYRRYCGMLNVAPGD
NLDCYNQRNFAQG
>P02866; 29 CONCANAVALIN A PRECURSOR (CON A).
MAISKKSSLFLPIFTFITMFLMVVNKVSSSTHETNALHFMFNQFSKDQKDLILQGDATTG
TEGNLRLTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVASFEATFTFLIKSPDSHPADG
IAFFISNIDSSIPSGSTGRLLGLFPDANVIRNSTTIDFNAAYNADTIVAVELDTYPNTDI
GDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVDKRLSAVVSYPNADSATVSY
DVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKSNEIPDIATVV
>P49347; 25 CONCANAVALIN B PRECURSOR (CON B).
MGCERKALILMVVIWIMSFWTLSLADISSTEIAVYWGQREDGLLRDTCKTNNYKIVFISF
LDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQRMGVKVFLALGGPKGTYSACSA
DYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVDELNWDNLLEELYQIKDVYQS
TFLLSAAPGCLSPDEYLDNAIQTRHFDYIFVRFYNDRSCQYSTGNIQRIRNAWLSWTKSV
YPRDKNLFLELPASQATAPGGGYIPPSALIGQVLPYLPDLQTRYAGIALWNRQADKETGY
STNIIRYLNATAMPFTSNLLKYPS
>P11090; 23 CRUCIFERIN PRECURSOR (11S GLOBULIN) (12S STORAGE PROTEIN
MARLSSLLSFSLALLTFLHGSTAQQFPNECQLDQLNALEPSHVLKAEAGRIEVWDHHAPQ
LRCSGVSFVRYIIESKGLYLPSFFSTARLSFVAKGEGLMGRVVLCAETFQDSSVFQPSGG
SPFGEGQGQGQQGQGQGHQGQGQGQQGQQGQQGQQSQGQGFRDMHQKVEHIRTGDTIATH
PGVAQWFYNDGNQPLVIVSVLDLASHQNQLDRNPRPFYLAGNNPQGQVWIEGREQQPQKN
ILNGFTPEVLAKAFKIDVRTAQQLQNQQDNRGNIIRVQGPFSVIRPPLRSQRPQEEVNGL
EETICSARCTDNLDDPSNADVYKPQLGYISTLNSYDLPILRFLRLSALRGSIRQNAMVLP
QWNANANAVLYVTDGEAHVQVVNDNGDRVFDGQVSQGQLLSIPQGFSVVKRATSEQFRWI
EFKTNANAQINTLAGRTSVLRGLPLEVISNGYQISLEEARRVKFNTIETTLTHSSGPASY
GGPRKADA
>P19667; 22 CURCULIN PRECURSOR.
MAAKFLLTILVTFAAVASLGMADNVLLSGQTLHADHSLQAGAYTLTIQNKCNLVKYQNGR
QIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG
PVLWSLGPNGCRRVNGGITVAKDSTEPQHEDIKMVINN
>P15797; 33 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE, BASIC VACUOLAR ISOFORM
MSTSSHKHNTPQMAAITLLGLLLVASSIDIAGAQSIGVCYGMLGNNLPNHWEVIQLYKSR
NIGRLRLYDPNHGALQALKGSNIEVMLGLPNSDVKHIASGMEHARWWVQKNVKDFWPDVK
IKYIAVGNEISPVTGTSYLTSFLTPAMVNIYKAIGEAGLGNNIKVSTSVDMTLIGNSYPP
SQGSFRNDARWFTDPIVGFLRDTRAPLLVNIYPYFSYSGNPGQISLPYSLFTAPNVVVQD
GSRQYRNLFDAMLDSVYAALERSGGASVGIVVSESGWPSAGAFGATYDNAATYLRNLIQH
AKEGSPRKPGPIETYIFAMFDENNKNPELEKHFGLFSPNKQPKYNINFGVSGGVWDSSVE
TNATASLVSEM
>Q02126; 25 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE GIII PRECURSOR (EC 3.2.
MARKGVDVAVALVLVALAAFPAVHSIGVCNGVLGNNLPAPSDVVTLYRSKRIDAMRIYEP
ESKVLTALSGTGIAVLMDVGPALPSLASSPSAAAAWVKANVSSFPGVSFRYIAVRNEVMD
SAGQSTILPAMRNVQRALAAAGSPIKVSTSVRFDVFNNTSPPSNGVLADKSGFLRPILNF
LARPARPLLANVYPYFAYKGNPRDIQLTFATFVPGSTTVNDNGLTYTNLFDAMVDSIYAA
LEKAGTPGVKVVISESGWPSDQGFGATAQNARAYNQGLINHVGNGSPKKAGALESYIFAM
FNENLKDGDELEKNFGLFKPNMSPAYAITF
>P23432; 32 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE PRECURSOR (EC 3.2.1.39)
MALWYLFNKRSLGAAVLILVGLLMCNIQMTGAQSNIGVCYGKIANNLPSEQDVINLYKAN
GIRKMRIYNSDTNIFKSLNGSNIEIILDVPNQDLEALANSSIANGWVQDNIRSHFPYVKF
KYISIGNEVSPSNNGQYSQFLLHAMENVYNALAAAGLQDKIKVTTATYSGLLANTYPPKD
SIFREEFKSFINPIIEFLARNNLPLLANIYPYFGHIYNTVDVPLSYALFNQQGTNSTGYQ
NLFDALLDSIYFAVEKAGGPNVEIIVSESGWPSEGNSAATIENAQTYYRNLVNHVKGGAG
TPKKPGRIVETYLFAMFDENEKNGEVTEKHFGLFYPNRTAKYQLNFMYSDT
>Q03211; 23 PISTIL-SPECIFIC EXTENSIN-LIKE PROTEIN PRECURSOR (PELP).
MAVIISSKVLLIQLFVLVLGSFSKLSHGELWLELPLPFDWPPAEIPLPDIPSPFDGPTFV
LPPPSPLPSPPPPSPSPPPPSPSPPPPSTIPLIPPFTGGFLPPLPGSKLPDFAGLLPLIP
NLPDVPPIGGGPPVNQPKPSSPSPLVKPPPPPPSPCKPSPPDQSAKQPPQPPPAKQPSPP
PPPPPVKAPSPSPAKQPPPPPPPVKAPSPSPATQPPTKQPPPPPRAKKSPLLPPPPPVAY
PPVMTPSPSPAAEPPIIAPFPSPPANPPLIPRRPAPPVVKPLPPLGKPPIVSGLVYCKSC
NSYGVPTLLNASLLQGAVVKLICYGKKTMVQWATTDNKGEFRIMPKSLTTADVGKCKVYL
VKSPNPNCNVPTNFNGGKSGGLLKPLLPPKQPITPAVVPVQPPMSDLYGVGPFIFEASSK
MPCDKN
>P06599; 32 EXTENSIN PRECURSOR.
MGRIARGSKMSSLIVSLLVVLVSLNLASETTAKYTYSSPPPPEHSPPPPEHSPPPPYHYE
SPPPPKHSPPPPTPVYKYKSPPPPMHSPPPPYHFESPPPPKHSPPPPTPVYKYKSPPPPK
HSPAPVHHYKYKSPPPPTPVYKYKSPPPPKHSPAPEHHYKYKSPPPPKHFPAPEHHYKYK
YKSPPPPTPVYKYKSPPPPTPVYKYKSPPPPKHSPAPVHHYKYKSPPPPTPVYKSPPPPE
HSPPPPTPVYKYKSPPPPMHSPPPPTPVYKYKSPPPPMHSPPPPVYSPPPPKHHYSYTSP
PPPHHY
>P04722; 20 ALPHA/BETA-GLIADIN PRECURSOR (PROLAMIN) (CLASS A-II).
MKTFPILALLAIVATTATTAVRVPVPQLQLQNPSQQQPQEQVPLVQEQQFQGQQQPFPPQ
QPYPQPQPFPSQQPYLQLQPFPQPQLPYPQPQPFRPQQPYPQPQPQYSQPQQPISQQQQQ
QQQQQQQQQQILQQILQQQLIPCRDVVLQQHNIAHGSSQVLQESTYQLVQQLCCQQLWQI
PEQSRCQAIHNVVHAIILHQQHHHHQQQQQQQQQQPLSQVSFQQPQQQYPSGQGFFQPSQ
QNPQAQGSFQPQQLPQFEEIRNLALQTLPAMCNVYIPPYCTIAPFGIFGTN
>P06659; 19 GAMMA-GLIADIN B PRECURSOR.
MKTLLILTILAMAITIATANMQADPSGQVQWPQQQPFLQPHQPFSQQPQQIFPQPQQTFP
HQPQQQFPQPQQPQQQFLQPRQPFPQQPQQPYPQQPQQPFPQTQQPQQPFPQSKQPQQPF
PQPQQPQQSFPQQQPSLIQQSLQQQLNPCKNFLLQQCKPVSLVSSLWSIILPPSDCQVMR
QQCCQQLAQIPQQLQCAAIHSVVHSIIMQQEQQEQLQGVQILVPLSQQQQVGQGILVQGQ
GIIQPQQPAQLEVIRSLVLQTLPTMCNVYVPPYCSTIRAPFASIVASIGGQ
>P08489; 21 GLUTENIN, HIGH MOLECULAR WEIGHT SUBUNIT PW212 PRECURSOR.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>P14614; 24 GLUTELIN PRECURSOR.
MATIAFSRLSIYFCVLLLCHGSMAQLFGPNVNPWHNPRQGGFRECRFDRLQAFEPLRRVR
SEAGVTEYFDEKNEQFQCTGTFVIRRVIEPQGLLVPRYSNTPGMVYIIQGRGSMGLTFPG
CPATYQQQFQQFLPEGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNEGDAPVVAL
YVFDLNNNANQLEPRQKEFLLAGNNNREQQMYGRSIEQHSGQNIFSGFNNELLSEALGVN
ALVAKRLQGQNDQRGEIIRVKNGLKLLRPAFAQQQEQAQQQEQAQAQYQVQYSEEQQPST
RCNGLDENFCTIKARLNIENPSHADTYNPRAGRITRLNSQKFPILNLVQLSATRVNLYQN
AILSPFWNVNAHSLVYIVQGHARVQVVSNLGKTVFNGVLRPGQLLIIPQHYVVLKKAEHE
GCQYISFKTNANSMVSHLAGKNSIFRAMPVDVIANAYRISREQARSLKNNRGEELGAFTP
RYQQQTYPGFSNESENEALE
>P09789; 27 GLYCINE-RICH CELL WALL STRUCTURAL PROTEIN 1 PRECURSOR.
MGSSQKWVIGLLLFSSIFFELTAITLADDKLEESRWGNDNGCGFGRRGCGGGRFGGRGPS
FGRGRGAGGGFGGGAGGGAGGGLGGGGGLGGGGGAGGGGGLGGGGGAGGGFGGGAGGGAG
GGLGGGGGLGGGGGGGAGGGGGVGGGAGSGGGFGAGGGVGGGAGAGGGVGGGGGFGGGGG
GGVGGGSGHGGGFGAGGGVGGGAGGGLGGGVGGGGGGGSGGGGGIGGGSGHGGGFGAGGG
VGGGVGGGAAGGGGGGGGGGGGGGGGLGGGSGHGGGFGAGGGVGGGAAGGVGGGGGFGGG
GGGGVGGGSGHGGGFGAGGGVGGGAGGGLGGGGGAGGGGGIGGGHGGGFGVGVGIGIGVG
VGAGAGHGVGVGSGSGSGGGGNGR
>P02877; 17 HEVEIN PRECURSOR (MAJOR HEVEIN).
MNIFIVVLLCLTGVAIAEQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD
SGEGVGGGSASNVLATYHLYNSQDHGWDLNAASAYCSTWDANKPYSWRSKYGWTAFCGPV
GAHGQSSCGKCLSVTNTGTGAKTTVRIVDQCSNGGLDLDVNVFRQLDTDGKGYERGHITV
NYQFVDCGDSFNPLFSVMKSSVIN
>P16850; 25 ALPHA-AMYLASE/TRYPSIN INHIBITOR CM1 PRECURSOR (CHLOROFOR
MASKSSISPLLLATVLVSVFAAATATGPYCYAGMGLPINPLEGCREYVAQQTCGISISGS
AVSTEPGNTPRDRCCKELYDASQHCRCEAVRYFIGRRSDPNSSVLKDLPGCPREPQRDFA
KVLVTSGHCNVMTVHNAPYCLGLDI
>P01086; 24 TRYPSIN INHIBITOR CME PRECURSOR (CHLOROFORM/METHANOL-SOL
MAFKYQLLLSAAVMLAILVATATSFGDSCAPGDALPHNPLRACRTYVVSQICHQGPRLLT
SDMKRRCCDELSAIPAYCRCEALRIIMQGVVTWQGAFEGAYFKDSPNCPRERQTSYAANL
VTPQECNLGTIHGSAYCPELQPGY
>P07596; 22 ALPHA-AMYLASE/SUBTILISIN INHIBITOR PRECURSOR (BASI).
MGSRRAGSSSSPLFWPAPPSRAADPPPVHDTDGHELRADANYYVLSANRAHGGGLTMAPG
HGRHCPLFVSQDPNGQHDGFPVRITPYGVAPSDKIIRLSTDVRISFRAYTTCLQSTEWHI
DSELAAGRRHVITGPVKDPSPSGRENAFRIEKYSGAEVHEYKLMSCGDWCQDLGVFRDLK
GGAWFLGATEPYHVVVFKKAPPA
>P16969; 21 ALPHA-AMYLASE/TRYPSIN INHIBITOR PRECURSOR.
MASDHRRFVLSGAVLLSVLAVAAATLESVKDECQLGVDFPHNPLATCHTYVIKRVCGRGP
SRPMLVKERCCRELAAVPDHCRCEALRILMDGVRTPEGRVVEGRLGDRRDCPREEQRAFA
ATLVTAAECNLSSVQAPGVRLVLLADG
>P17979; 32 CATHEPSIN D INHIBITOR PRECURSOR (NDI).
MMKCLFLLCLCLLPIVVFSSTFTSQNLIDLPSESPLPKPVLDTNGKELNPDSSYRIISIG
RGALGGDVYLGKSPNSDAPCPDGVFRYNSDVGPSGTPVRFIPLSGGIFEDQLLNIQFNIP
TVKLCVSYTIWKVGNLNAYFRTMLLETGGTIGQADSSYFKIVKLSNFGYNLLYCPITPPF
LCPFCRDDNFCAKVGVVIQNGKRRLALVNENPLDVLFQEV
>P08454; 23 WOUND-INDUCED PROTEINASE INHIBITOR I PRECURSOR (CHYMOTRY
MESKFAHIIVFFLLATSFETLLARKESDGPEVIELQKEFECNGKQRWPELIGVPTKLAKG
IIEKENSLITNVQILLNGSPVTMDYRCNRVRLFDNILGDVVQIPRVA
>P20076; 27 ETHYLENE-RESPONSIVE PROTEINASE INHIBITOR I PRECURSOR.
MEANKSMVKLVAFLIILVSSCFQSLTAQDLEIEVSDGLNVLQVHDVSQSFCPGVTKESWP
ELLGTPAKFAKQIIQKENPKLTNVETLLNGSAFTEDLRCNRVRLFVNLLDIVVQTPKVG
>P31608; 24 PROTEINASE INHIBITOR A PRECURSOR (DOUBLE-HEADED PROTEINA
MAASNALLLISGVLLISLAVLCHGDPVVDSDGDAVQLNLGGNYPLYTIQSAAIGFRGGLS
TLHKDACKSYVYEAPETDRGLPVGFSASATSQPVMQLGSRYKFSFSMPVPLICDTAWSIG
KSTEETGVYKLAACSCEFCKIACPEVGSFNVNGRTLLGIGGEHFTVRFQKFDALAMKTAP
Q
>P01070; 24 TRYPSIN INHIBITORS A AND C PRECURSOR (KUNITZ).
MKSTIFFLFLFCAFTTSYLPSAIADFVLDNEGNPLENGGTYYILSDITAFGGIRAAPTGN
ERCPLTVVQSRNELDKGIGTIISSPYRIRFIAEGHPLSLKFDSFAVIMLCVGIPTEWSVV
EDLPEGPAVKIGENKDAMDGWFRLERVSDDEFNNYKLVFCPQQAEDDKCGDIGISIDHDD
GTRRLVVSKNKPLVVQFQKLDKESLAKKNHGLSRSE
>P05119; 25 WOUND-INDUCED PROTEINASE INHIBITOR II PRECURSOR.
MAVHKEVNFVAYLLIVLGMFLYVDAKACTRECGNLGFGICPRSEGSPLNPICINCCSGYK
GCNYYNSFGKFICEGESDPKRPNACTFNCDPNIAYSRCPRSQGKSLIYPTGCTTCCTGYK
GCYYFGKDGKFVCEGESDEPKANMYPVM
>P17801; 28 PUTATIVE RECEPTOR PROTEIN KINASE ZMPK1 PRECURSOR (EC 2.7
MPRPLAALLSTACILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFY
EVYTHAFTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAA
VWRADGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTT
QSRSPGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGV
LASSDFADGQALVASDVGPGVKRRLTLDPDGNLRLYSMNDSDGSWSVSMVAMTQPCNIHG
LCGPNGICHYSPTPTCSCPPGYATRNPGNWTEGCMAIVNTTCDRYDKRSMRFVRLPNTDF
WGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDVRTIYL
KLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFIA
AFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSYRELVKATRKFKVEL
GRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGS
HRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVK
PENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYS
YGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVN
YVQARTLIKLAVSCLEEDRSKRPTMEHAVQTLLSADD
>P02872; 23 GALACTOSE-BINDING LECTIN PRECURSOR (AGGLUTININ) (PNA).
MKPFCVFLTFFLLLAASSKKVDSAETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNL
NKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIP
AGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVS
GAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQI
HLIRSWSFTSTLITTTRRSIDNNEKKIMNMASA
>P16030; 28 LECTIN PRECURSOR.
MLLYNSKSYVLQLIFITLLLTQLNKVKSTSSTLTGFTFPNFWSNTQENGTEIIFLGNATY
TPGALRLTRIGEDGIPLKSNAGQASYSRPVFLWDSTGHVASFYTSFSFIVRSIDVPHITA
DGFAFFLAPVDSSVKDYGGCLGLFRYKTATDPSKNQVVAVEFDTWPNTEWSDLRYPHIGI
NVNSTVSVATTRWDNDDAYVTKSTAHITYDATSKIITVLLTYDNGRHYQLSHVVDLPKIL
PERVRIGFSGGTGFNETQYILSWSFTSTLNSTKISALTQKLRSSASYSSM
>P02867; 30 LECTIN PRECURSOR.
MASLQTQMISFYAIFLSILLTTILFFKVNSTETTSFLITKFSPDQQNLIFQGDGYTTKEK
LTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV
DTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK
SWKLQNGEEANVVIAFNAATNVLTVSLTYPNSLEEENVTSYTLSDVVSLKDVVPEWVRIG
FSATTGAEYAAHEVLSWSFHSELSGTSSSKQAADA
>P02873; 23 LECTIN PRECURSOR (ALPHA-AMYLASE INHIBITOR).
MIMASSKLLSLALFLALLSHANSATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSY
DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESKGDT
VTVEFDTFLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGK
SNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFINLKDQKSERSNI
VLNKIL
>P05046; 32 LECTIN PRECURSOR (AGGLUTININ) (SBA).
MATSKLKTQNVVVSLSLTLTLVLVLLTSKANSAETVSFSWNKFVPKQPNMILQGDAIVTS
SGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAPDTKRLAD
GLAFFLAPIDTKPQTHAGYLGLFNENESGDQVVAVEFDTFRNSWDPPNPHIGINVNSIRS
IKTTSWDLANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGF
SAATGLDIPGESHDVLSWSFASNLPHASSNIDPLDLTSFVLHEAI
>P01076; 32 METALLOCARBOXYPEPTIDASE INHIBITOR PRECURSOR (MCPI) (CARB
MAQKFTILFTILLVVIAAQDVMAQDATLTKLFQQYDPVCHKPCSTQDDCSGGTFCQACWR
FAGTCGPYVGRAMAIGV
>P14946; 23 POLLEN ALLERGEN LOL P 1 PRECURSOR (LOL P I) (ALLERGEN R7
MASSSSVLLVVALFAVFLGSAHGIAKVPPGPNITAEYGDKWLDAKSTWYGKPTGAGPKDN
GGACGYKNVDKAPFNGMTGCGNTPIFKDGRGCGSCFEIKCTKPESCSGEAVTVTITDDNE
EPIAPYHFDLSGHAFGSMAKKGEEQNVRSAGELELQFRRVKCKYPDDTKPTFHVEKASNP
NYLAILVKYVDGDGDVVAVDIKEKGKDKWIELKESWGAVWRIDTPDKLTGPFTVRYTTEG
GTKSEFEDVIPEGWKADTSYSAK
>P29092; 20 MYROSINASE MB3 PRECURSOR (EC 3.2.3.1) (SINIGRINASE) (THI
MKLLHGLALVFLLAAASCKADEEITCEENEPFTCSNTDILSSKNFGKDFIFGVASSAYQI
EGGRGRGVNVWDGFSHRYPEKSGSDLKNGDTSCESYTRWKKDVEIMGELNATGYRFSFAW
SRIVPKGKVSRGVDQAGLDYYHNLIDALLEKNITPFVTLFHWDLPQTLQDEYEGFLDRQI
IQDFKDYADLCFKEFGGKVKNWITINQLYTVPTRGYALGTDAPGRCSPKVDTKQRCYGGN
SSTEPYIVAHNQLLAHAAIVDLYRTNYAFQNGKIGPVMITRWFLPYDESDPACIEAAERM
NQFFHGWYMEPLTKGRYPDIMRQIVGSRLPNFTEAEAELVAGSYDFLGLNYYVTQYAKPK
PNPYPSETHTALMDAGVDLTFNNSRGEYPGPVFAEDANSYYYPKGIYYVMDYFKTKYNNP
LIYITENGISTPGSESRCEAIADYKRINYLCSHLCFLRKVIREKGVNIRGYFAWALGDNY
EFCKGFTVRFGLSYVNWDDLDDRNLKESGKWYQRFINGTAKNPVKQDFLRSSLSSQSQKK
RLAC
>P07597; 26 NONSPECIFIC LIPID-TRANSFER PROTEIN 1 PRECURSOR (LTP 1) (
MARAQVLLMAAALVLMLTAAPRAAVALNCGQVDSKMKPCLTYVQGGPGPSGECCNGVRDL
HNQAQSSGDRQTVCNCLKGIARGIHNLNLNNAASIPSKCNVNVPYTISPDIDCSRIY
>P19656; 27 NONSPECIFIC LIPID-TRANSFER PROTEIN PRECURSOR (LTP) (PHOS
MARTQQLAVVATAVVALVLLAAATSEAAISCGQVASAIAPCISYARGQGSGPSAGCCSGV
RSLNNAARTTADRRAACNCLKNAAAGVSGLNAGNAASIPSKCGVSIPYTISTSTDCSRVN
>P08297; 25 EARLY NODULIN 75 PRECURSOR (N-75) (NGM-75).
MTSVLHYSLLLLLLGVVILTTPVLANLKPRFFYEPPPIEKPPTYEPPPFYKPPYYPPPVH
HPPPEYQPPHEKTPPEYLPPPHEKPPPEYLPPHEKPPPEYQPPHEKPPHENPPPEHQPPH
EKPPEHQPPHEKPPPEYEPPHEKPPPEYQPPHEKPPPEYQPPHEKPPPEYQPPHEKPPPE
HQPPHEKPPEHQPPHEKPPPEYQPPHEKPPPEYQPPQEKPPHEKPPPEYQPPHEKPPPEH
QPPHEKPPPVYPPPYEKPPPVYEPPYEKPPPVVYPPPHEKPPIYEPPPLEKPPVYNPPPY
GRYPPSKKN
>Q41350; 24 OSMOTIN-LIKE PROTEIN PRECURSOR.
MASSSAKILLPLSLLFTLLSLSQSTNPNFILTLVNNCPYTIWPAIQPNAGHPVLERGGFT
LHSLTHRSFPAPNAHWSGRIWARTGCNYQHGKFYCATGDCGGRIECDGLGGAAPATLAQF
VLHHGHADFSTYGVSLVDGFNIPLTVTPHEGKGVCPVVGCRANLLESCPAVLQFRSHGGH
GPVVGCKSACEAFKSDEFCCRNHYNSPQTCKPSSYSQFFKHACPATFTYAHDSPSLMHEC
SSPRELKVIFCH
>P07745; 23 PATATIN PRECURSOR (POTATO TUBER PROTEIN).
MATTKSFLILFFMILATTSSTCATLGEMVTVLSIDGGGIKGIIPAIILEFLEGQLQEVDN
NKDARLADYFDVIGGTSTGGLLTAMITTPNENNRPFAAAKDIVPFYFEHGPHIFNYSGSI
FGPRYDGKYLLQVLQEKLGETRVHQALTEVAISSFDIKTNKPVIFTKSNLAESPQLDAKM
YDICYSTAAAPIYFPPHHFVTHTSNGATYEFNLVDGAVATVGDPALLSLSVATRLAQDDP
AFSSIKSLDYKQMLLLSLGTGTNSEFDKTYTAEEAAKWGPLRWMLAIQQMTNAASSYMTD
YYISTVFQARHSQNNYLRVQENALTGTTTEMDDASEANMELLVQVGETLLKKPVSKDSPE
TYEEALKRFAKLLSDRKKLRANKASH
>P17179; 24 PEROXIDASE C2 PRECURSOR (EC 1.11.1.7).
MHSSSSLIKLGFLLLLLNVSLSHAQLSPSFYDKTCPQVFDIATNTIKTALRSDPRIAASI
LRLHFHDCFVNGCDASILLDNTTSFRTEKDAFGNARSARGFDVIDTMKAAVEKACPKTVS
CADLLAIAAQKSVVLAGGPSWKVPSGRRDSLRGFMDLANDNLPGPSSTLQVLKDKFRNVG
LDRPSDLVALSGGHTFGKNQCQFIMDRLYNFSNSGKPDPTLDKSYLSTLRKQCPRNGNLS
VLVDFDLRTPTIFDNKYYVNLKENKGLIQSDQELFSSPDASDTIPLVRAYADGQGKFFDA
FVEAMIRMGNLSPSTGKQGEIRLNCRVVNSKPKIMDVVDTNDFASSI
>P00433; 30 PEROXIDASE C1A PRECURSOR (EC 1.11.1.7).
MHFSSSSTLFTCITLIPLVCLILHASLSDAQLTPTFYDNSCPNVSNIVRDTIVNELRSDP
RIAASILRLHFHDCFVNGCDASILLDNTTSFRTEKDAFGNANSARGFPVIDRMKAAVESA
CPRTVSCADLLTIAAQQSVTLAGGPSWRVPLGRRDSLQAFLDLANANLPAPFFTLPQLKD
SFRNVGLNRSSDLVALSGGHTFGKNQCRFIMDRLYNFSNTGLPDPTLNTTYLQTLRGLCP
LNGNLSALVDFDLRTPTIFDNKYYVNLEEQKGLIQSDQELFSSPNATDTIPLVRSFANST
QTFFNAFVEAMDRMGNITPLTGTQGQIRLNCRVVNSNSLLHDMVEVVDFVSSM
>P24101; 21 NEUTRAL PEROXIDASE C PRECURSOR (EC 1.11.1.7).
MQFSSSSITSFTWTVLITVGCLMLCASFSDAQLTPTFYDTSCPTVTNIVRDTIVNELRSD
PRIAGSILRLHFHDCFVNGCDASILLDNTTSFRTEKDALGNANSARGFPVIDRMKAAVER
ACPRTVSCADMLTIAAQQSVTLAGGPSWKVPLGRRDSLQAFLDLANANLPAPFFTLPQLK
ANFKNVGLDRPSDLVALSGAHTFGKNQCRFIMDRLYNFSNTGLPDPTLNTTYLQTLRGQC
PRNGNQSVLVDFDLRTPLVFDNKYYVNLKEQKGLIQSDQELFSSPNATDTIPLVRAYADG
TQTFFNAFVEAMNRMGNITPTTGTQGQIRLNCRVVNSNSLLHDVVDIVDFVSSM
>P24102; 19 BASIC PEROXIDASE E PRECURSOR (EC 1.11.1.7).
MGFSPSFSCSAIGALILGCLLLQASNSNAQLRPDFYFGTCPFVFDIIGNIIVDELQTDPR
IAASLLRLHFHDCFVRGCDASILLDNSTSFRTEKDAAPNANSARGFNVIDRMKVALERAC
PGRVSCADILTIASQISVLLSGGPWWPVPKGRRDSVEAFFALANTALPSPFFNLTQLKTA
FADVGLNRTSDLVALSGGHTFGRAQCQFVTPRLYNFNGTNSPDPSLYPTYLVELRRLCPQ
NGNGTVLVNFDVVTPDAFDSQYYTNLRNGKGLIQSDQELFSTPGADTIPLVNQYSSDMSV
FFRAFIDAMIRMGNLRPLTGTQGEIRQNCRVVNPRIRVVENDDGVVSSI
>Q02200; 27 LIGNIN FORMING ANIONIC PEROXIDASE PRECURSOR (EC 1.11.1.7
MNTPTQSFRAKAAIFSLLLLSCMQCHAQLSATFYDNTCPNALNTIRTSVRQAISSERRMA
ASLIRLHFHDCFVQGCDASILLDETPSIESEKTALPNLGSARGFGIIEDAKREVEKICPG
VVSCADILTVAARDASAAVGGPSWTVKLGRRDSTTASKTLAETDLPGPFDPLNRLISSFA
SKGLSTRDMVALSGAHTIGQAQCFLFRDRIYSNGTDIDAGFASTRRRQCPQEGENGNLAP
LDLVTPNQFDNNYFKNLIQKKGLLQSDQVLFNGGSTDNIVSEYSNSARAFSSDFAAAMIK
MGDISPLSGQNGIIRKVCGSVN
>P35334; 29 POLYGALACTURONASE INHIBITOR PRECURSOR (POLYGALACTURONASE
MTQFNIPVTMSSSLSIILVILVSLRTALSELCNPQDKQALLQIKKDLGNPTTLSSWLPTT
DCCNRTWLGVLCDTDTQTYRVNNLDLSGHNLPKPYPIPSSLANLPYLNFLYIGGINNLVG
PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL
GGITFDGNRISGAIPDSYGSFSKLFTAMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG
DASVLFGSDKNTKKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLQ
SLNVSFNNLCGEIPQGGNLKRFDVSSYANNKCLCGSPLPSCT
>P26216; 22 EXOPOLYGALACTURONASE PRECURSOR (EC 3.2.1.67) (EXOPG) (PE
MACTNNAMRALFLLVLFCIVHGEKEESKGIDAKASGPGGSFDITKLGASGNGKTDSTKAV
QEAWASACGGTGKQTILIPKGDFLVGQLNFTGPCKGDVTIQVDGNLLATTDLSQYKDHGN
WIEILRVDNLVITGKGNLDGQGPAVWSKNSCTKKYDCKILPNSLVMDFVNNGEVSGVTLL
NSKFFHMNMYRCKDMLIKDVTVTAPGDSPNTDGIHMGDSSGITITNTVIGVGDDCISIGP
GTSKVNITGVTCGPGHGISIGSLGRYKDEKDVTDINVKDCTLKKTMFGVRIKAYEDAASV
LTVSKIHYENIKMEDSANPIFIDMKYCPNKLCTANGASKVTVKDVTFKNITGTSSTPEAV
SLLCTAKVPCTGVTMDDVNVEYSGTNNKTMAICTNAKGSTKGCLKELACF
>P04284; 24 PATHOGENESIS-RELATED LEAF PROTEIN 6 PRECURSOR (P6) (ETHY
MGLFNISLLLTCLMVLAIFHSCEAQNSPQDYLAVHNDARAQVGVGPMSWDANLASRAQNY
ANSRAGDCNLIHSGAGENLAKGGGDFTGRAAVQLWVSERPSYNYATNQCVGGKKCRHYTQ
VVWRNSVRLGCGRARCNNGWWFISCNYDPVGNWIGQRPY
>P07053; 30 PATHOGENESIS-RELATED PROTEIN 1B PRECURSOR (PR-1B).
MGFFLFSQMPSFFLVSTLLLFLIISHSSHAQNSQQDYLDAHNTARADVGVEPLTWDNGVA
AYAQNYVSQLAADCNLVHSHGQYGENLAQGSGDFMTAAKAVEMWVDEKQYYDHDSNTCAQ
GQVCGHYTQVVWRNSVRVGCARVKCNNGGYVVSCNYDPPGNVIGQSPY
>P28493; 23 PATHOGENESIS-RELATED PROTEIN 5 PRECURSOR (PR-5).
MANISSIHILFLVFITSGIAVMATDFTLRNNCPTTVWAGTLAGQGPKLGDGGFELTPGAS
RQLTAPAGWSGRFWARTGCNFDASGNGRCVTGDCGGLRCNGGGVPPVTLAEFTLVGDGGK
DFYDVSLVDGYNVKLGIRPSGGSGDCKYAGCVSDLNAACPDMLKVMDQNNVVACKSACER
FNTDQYCCRGANDKPETCPPTDYSRIFKNACPDAYSYAYDDETSTFTCTGANYEITFCP
>P19085; 14 PROLAMIN PRECURSOR (CLONE PPROL 7).
MKIIFVFALLAIAACRPLPSLMFLGQSYRQYQLQSPVLLQQQVLSPYNEFVRQQYGIAAS
PFLQSAAFQLRNNQVWQHQAGGQQSRYQDINIVQAIAYELQLQQFGDLYFDRNQAQAQAL
LAFNVPSRYGIYPRYYGAPSTITTLGGVL
>P13046; 25 PATHOGENESIS-RELATED PROTEIN R MAJOR FORM PRECURSOR (THA
MNFLKSFPFFAFLYFGQYFVAVTHAATFDIVNKCTYTVWAAASPGGGRRLDSGQSWSINV
NPGTVQARIWGRTNCNFDGSGRGNCETGDCNGMLECQGYGKAPNTLAEFALNQPNQDFVD
ISLVDGFNIPMEFSPTNGGCRNLRCTAPINEQCPAQLKTQGGCNNPCTVIKTNEYCCTNG
PGSCGPTDLSRFFKERCPDAYSYPQDDPTSLFTCPSGTNYRVVFCP
>P12164; 24 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MLNTFSLIGICLNSTLFSSSFFFGKLPEAYAFLNPIVDIMPVIPLFFFLLAFVWQAAVSF
R
>P50272; 22 PUTATIVE POLYSACCHARIDE BINDING PROTEIN PRECURSOR.
MGFLKGTAAALTLLSAAAAASACGVLYEQCGGIGFDGVTCCSEGLMCMKMGPYYSQCRAM
PGMMGQVKPYGQCGGMNYSGKTMCSPGFKCVELNEFFSQCDLANKSPVATPKVSPTSPPG
PAQVCGKEYAACGGEMFMGAKCCKFGLVCYETSGKWQSQCRAPPPKMGEVGRYAQCGGMG
YMGSTMCVGGYKCMAISEGSMYKQCLPMHP
>P30986; 23 RETICULINE OXIDASE PRECURSOR (EC 1.5.3.9) (BERBERINE-BRI
MENKTPIFFSLSIFLSLLNCALGGNDLLSCLTFNGVRNHTVFSADSDSDFNRFLHLSIQN
PLFQNSLISKPSAIILPGSKEELSNTIRCIRKGSWTIRLRSGGHSYEGLSYTSDTPFILI
DLMNLNRVSIDLESETAWVESGSTLGELYYAITESSSKLGFTAGWCPTVGTGGHISGGGF
GMMSRKYGLAADNVVDAILIDANGAILDRQAMGEDVFWAIRGGGGGVWGAIYAWKIKLLP
VPEKVTVFRVTKNVAIDEATSLLHKWQFVAEELEEDFTLSVLGGADEKQVWLTMLGFHFG
LKTVAKSTFDLLFPELGLVEEDYLEMSWGESFAYLAGLETVSQLNNRFLKFDERAFKTKV
DLTKEPLPSKAFYGLLERLSKEPNGFIALNGFGGQMSKISSDFTPFPHRSGTRLMVEYIV
AWNQSEQKKKTEFLDWLEKVYEFMKPFVSKNPRLGYVNHIDLDLGGIDWGNKTVVNNAIE
ISRSWGESYFLSNYERLIRAKTLIDPNNVFNHPQSIPPMANFDYLEKTLGSDGGEVVI
>P24476; 23 ANTIVIRAL PROTEIN DAP-30 PRECURSOR (RIBOSOME-INACTIVATIN
MKIYLVAAIAWILFQSSSWTTDAATAYTLNLANPSASQYSSFLDQIRNNVRDTSLIYGGT
DVAVIGAPSTTDKFLRLNFQGPRGTVSLGLRRENLYVVAYLAMDNANVNRAYYFKNQITS
AELTALFPEVVVANQKQLEYGEDYQAIEKNAKITTGDQSRKELGLGINLLITMIDGVNKK
VRVVKDEARFLLIAIQMTAEAARFRYIQNLVTKNFPNKFDSENKVIQFQVSWSKISTAIF
GDCKNGVFNKDYDFGFGKVRQAKDLQMGLLKYLGRPKSSSIEANSTDDTADVL
>P29339; 23 RIBOSOME-INACTIVATING PROTEIN MOMORDIN II PRECURSOR (RRN
MVKCLLLSFLIIAIFIGVPTAKGDVNFDLSTATAKTYTKFIEDFRATLPFSHKVYDIPLL
YSTISDSRRFILLDLTSYAYETISVAIDVTNVYVVAYRTRDVSYFFKESPPEAYNILFKG
TRKITLPYTGNYENLQTAAHKIRENIDLGLPALSSAITTLFYYNAQSAPSALLVLIQTTA
EAARFKYIERHVAKYVATNFKPNLAIISLENQWSALSKQIFLAQNQGGKFRNPVDLIKPT
GERFQVTNVDSDVVKGNIKLLLNSRASTADENFITTMTLLGESVVN
>Q00465; 19 RIBOSOME-INACTIVATING PROTEIN LUFFIN-ALPHA PRECURSOR (RR
MKRFTVLILAIFVAASTVEADVRFSLSGSSSTSYSKFIGDLRKALPSNGTVYNITLLLSS
ASGASRYTLMTLSNYDGKAITVAVDVTNVYIMGYLVNSTSYFFNESDAKLASQYVFKGST
IVTLPYSGNYEKLQTAAGKIREKIPLGFPALDSAITTLFHYDSTAAAAAFLVIIQTTAEA
SRFKYIEGQIIERISKNQVPSLATISLENEWSALSKQIQLAQTNNGTFKTPVVITDDKGQ
RVEITNVTSKVVTKNIQLLLNYKQNVAAFDEDVSAKH
>P21326; 28 ANTIVIRAL PROTEIN MAP PRECURSOR (RIBOSOME-INACTIVATING P
MLTTTKVFFLLLTTWITWYAIVNPQSRAAPTLETIASLDLNNPTTYLSFITNIRTKVADK
TEQCTIQKISKTFTQRYSYIDLIVSSTQKITLAIDMADLYVLGYSDIANNKGRAFFFKDV
TEAVANNFFPGATGTNRIKLTFTGSYGDLEKNGGLRKDNPLGIFRLENSIVNIYGKAGDV
KKQAKFFLLAIQMVSEAARFKYISDKIPSEKYEEVTVDEYMTALENNWAKLSTAVYNSKP
STTTATKCQLATSPVTISPWIFKTVEEIKLVMGLLKSS
>P18632; 21 SUGI BASIC PROTEIN PRECURSOR (SBP) (MAJOR ALLERGEN CRY J
MDSPCLVALLVLSFVIGSCFSDNPIDSCWRGDSNWAQNRMKLADCAVGFGSSTMGGKGGD
LYTVTNSDDDPVNPAPGTLRYGATRDRPLWIIFSGNMNIKLKMPMYIAGYKTFDGRGAQV
YIGNGGPCVFIKRVSNVIIHGLHLYGCSTSVLGNVLINESFGVEPVHPQDGDALTLRTAT
NIWIDHNSFSNSSDGLVDVTLSSTGVTISNNLFFNHHKVMLLGHDDAYSDDKSMKVTVAF
NQFGPNCGQRMPRARYGLVHVANNNYDPWTIYAIGGSSNPTILSEGNSFTAPNESYKKQV
TIRIGCKTSSSCSNWVWQSTQDVFYNGAYFVSSGKYEGGNIYTKKEAFNVENGNATPQLT
KNAGVLTCSLSKRC
>P08471; 11 SEXUAL INDUCER GLYCOPROTEIN PRECURSOR.
MAVVVVNSATASLLAVCLVFMAVGLCTGQIVDVKFPSCRCERELTPFAIKSAATQLTSRN
PGVVNLYCFEIGIVNSGSGACYTEPASQNLSKVSVYAQAAQRDRLSAFGVLLAGAPVSNM
TYLTPRWDSLNMTTISNLNFSKTQANGTRICLELFKPTTINEFCEREGASGSFCWVALFN
DNNCVPPNSTVVISKRLCCPRFQSFLSP
>P01545; 18 ALPHA-HORDOTHIONIN PRECURSOR (PUROTHIONIN II).
MVCLLILGLVLEQVQVEGKSCCRSTLGRNCYNLCRVRGAQKLCAGVCRCKLTSSGKCPTG
FPKLALVSNSDEPDTVKYCNLGCRASMCDYMVNAAADDEEMKLYLENCGDACVNFCNGDA
GLTSLTA
>P09801; 25 VICILIN PRECURSOR (ALPHA-GLOBULIN B) (CLONE C72).
MVRNKSACVVLLFSLFLSFGLLCSAKDFPGRRGDDDPPKRYEDCRRRCEWDTRGQKEQQQ
CEESCKSQYGEKDQQQRHRPEDPQRRYEECQQECRQQEERQRPQCQQRCLKRFEQEQQQS
QRQFQECQQHCHQQEQRPERKQQCVRECRERYQENPWRREREEEAEEEETEEGEQEQSHN
PFHFHRRSFQSRFREEHGNFRVLQRFASRHPILRGINEFRLSILEANPNTFVLPHHCDAE
KIYLVTNGRGTLTFLTHENKESYNVVPGVVVRVPAGSTVYLANQDNKEKLIIAVLHRPVN
NPRQFEEFFPAGSQRPQSYLRAFSREILEPAFNTRSEQLDELFGGRQSHRRQQGQGMFRK
ASQEQIRALSQEATSPREKSGERFAFNLLYRTPRYSNQNGRFYEACPREFRQLSDINVTV
SALQLNQGSIFVPHYNSKATFVVLVNEGNGYVEMVSPHLPRQSSFEEEEEQQQEQEQEEE
RRSGQYRKIRSQLSRGDIFVVPANFPVTFVASQNQNLRMTGFGLYNQNINPDHNQRIFVA
GKINHVRQWDSQAKELAFGVSSRLVDEIFNNNPQESYFVSRQRQRASE
>P02854; 15 PROVICILIN PRECURSOR (TYPE B) (FRAGMENT).
MLLAIAFLASVCVSSRSDQENPFIFKSNRFQTLYENENGHIRLLQKFDKRSKIFENLQNY
RLLEYKSKPHTLFLPQYTDADFILVVLSGKATLTVLKSNDRNSFNLERGDAIKLPAGSIA
YFANRDDNEEPRVLDLAIPVNKPGQLQSFLLSGTQNQKSSLSGFSKNILEAAFNTNYEEI
EKVLLEQQEQEPQHRRSLKDRRQEINEENVIVKVSRDQIEELSKNAKSSSKKSVSSESGP
FNLRSRNPIYSNKFGKFFEITPEKNQQLQDLDIFVNSVDIKVGSLLLPNYNSRAIVIVTV
TEGKGDFELVGQRNENQGKENDKEEEQEEETSKQVQLYRAKLSPGDVFVIPAGHPVAINA
SSDLNLIGLGINAENNERNFLAGEEDNVISQVERPVKELAFPGSSHEVDR
>P09761; 25 WOUND-INDUCED PROTEIN WIN1 PRECURSOR.
MVKLISNSTILLSLFLFSIAAIANAQQCGRQKGGALCSGNLCCSQFGWCGSTPEFCSPSQ
GCQSRCTGTGGSTPTPSGSAQNVRATYHIYNPQNVGWDLNAVSAYCSTWDANKPLSWRKK
YGWTAFCGPVGPRGRDSCGKCLRVTNTRTGAQTTVRIVDQCSNGGLDLDVNVFRQIDTDG
NGNHQGHLIVNYQFVDCGDN
>P09762; 25 WOUND-INDUCED PROTEIN WIN2 PRECURSOR.
MVKLSCGPILLALVLCISLTSVANAQQCGRQRGGALCGNNLCCSQFGWCGSTPEYCSPSQ
GCQSQCTGSGPDPGQGGSAQNVRATYHIYNPQNVGWDLNAVSAYCSTWDANKPYAWRSKY
GWTAFCGPVGPRGRDSCGKCLRVTNTRTGAQTTVRIVDQCSNGGLDLDINVFQQIDTDGV
GNQQGHLIVNYQFVNCGDNVNVPLLSVVDKE
>P16335; 24 WOUND RESPONSIVE GWIN3 PROTEIN PRECURSOR.
MKITKFLGLSFLLFAFAATSFPDGVHAEDPAAVLDFYGREVQAGASYLIDQEDFRVVNAT
INPICNSDVILSTGIEGLPVTFSPVINSTDGVIREGTLITVSFDASTCGMAGVTPMWKIG
FNSTAKGYIVTTGGVDRLNLFKITKFESDSSFYQLSYCPNSEPFCECPCVPVGANSDKYL
APNVSYADFRFKPDARIEST
>P33679; 20 ZEAMATIN PRECURSOR.
MAGSVAIVGIFVALLAVAGEAAVFTVVNQCPFTVWAASVPVGGGRQLNRGESWRITAPAG
TTAARIWARTGCKFDASGRGSCRTGDCGGVLQCTGYGRAPNTLAEYALKQFNNLDFFDIS
LIDGFNVPMSFLPDGGSGCSRGPRCAVDVNARCPAELRQDGVCNNACPVFKKDEYCCVGS
AANDCHPTNYSRYFKGQCPDAYSYPKDDATSTFTCPAGTNYKVVFCP
>P04699; 21 ZEIN-ALPHA PRECURSOR (22 KD) (CLONE ZA1 OR M1).
MATKILALLALLALFVSATNAFIIPQCSLAPSAIIPQFLPPVTSMGFEHLAVQAYRLQQA
LAASVLQQPINQLQQQSLAHLTIQTIATQQQQQFLPALSQLDVVNPVAYLQQQLLASNPL
ALANVAAYQQQQQLQQFLPALSQLAMVNPAAYLQQQQLLSSSPLAVGNAPTYLQQQLLQQ
IVPALTQLAVANPAAYLQQLLPFNQLTVSNSAAYLQQRQQLLNPLEVPNPLVAAFLQQQQ
LLPYSQFSLMNPALSWQQPIVGGAIF
>P08031; 19 ZEIN-BETA PRECURSOR (ZEIN 2) (16 KD) (ZEIN ZC1).
MKVLIVALALLALAASAASSTSGGCGCQTPPFHLPPPFYMPPPFYLPPQQQPQPWQYPTQ
PPQLSPCQQFGSCGVGSVGSPFLGQCVEFLRHQCSPAATPYGSPQCQALQQQCCHQIRQV
EPLHRYQATYGVVLQSFLQQQPQGELAALMAAQVAQQLTAMCGLQLQQPGPCPCNAAAGG
VYY
>P33489; 41 AUXIN-BINDING PROTEIN 5 PRECURSOR (ABP) (ERABP5) (FRAGME
MVRRRPATGAAQRPQLAAVGRGLLLASVLAAAASSLPVAESSCPRDNSLVRDISRMQQSN
YGREGFSHITVTGALAHGTKEVEVWLQTFGPGQRTPIHRHSCEEVFIVLKGKGTLLLGSS
SLKYPGQPQEVPVFQNTTFSIPVNDPHQVW
>P28590; 34 ABRIN-C PRECURSOR (RRNA N-GLYCOSIDASE) (EC 3.2.2.22).
MDKTLKLLILCLAWTCSFSALRCAARTYPPVATNQDQVIKFTTEGATSQSYKQFIEALRQ
RLTGGLIHDIPVLPDPTTVEERNRYITVELSNSERESIEVGIDVTNAYVVAYRAGSQSYF
LRDAPASASTYLFPGTQRYSLRFDGSYGDLERWAHQTREEISLGLQALTHAISFLRSGAS
NDEEKARTLIVIIQMASEAARYRYISNRVGVSIRTGTAFQPDPAMLSLENNWDNLSGGVQ
QSVQDTFPNNVILSSINRQPVVVDSLSHPTVAVLALMLFVCNPPNANQSPLLIRSIVEES
KICSSRYEPTVRIGGRDGMCVDVYDDGYHNGNRIIAWKCKDRLEENQLWTLKSDKTIRSN
GKCLTTEGYAPGNYVMIYDCTSAVAEATYWEIWDNGTIINPKSALVLSAESSSMGGTLTV
QTNEYLMRQGWRTGNNTSPFVTSISGYSDLCMQAQGSNVWLADCDNNKKEQQWALYTDGS
IRSVQNTNNCLTSKDHKQGSPIVLMACSNGWASQRWLFKNDGSIYNLHDDMVMDVKRSDP
SLKEIILHPYHGKPNQIWLTLF
>P06289; 18 ATP SYNTHASE A CHAIN PRECURSOR (EC 3.6.1.34) (SUBUNIT IV
MSHTAKMASTFNNFYEISNVEVGQHFYWQLGSFQVHAQVLITSWIVIAILLSLAVLATRN
LQTIPMGGQNFVEYVLEFIRDLTRTQIGEEEYRPWVPFIGTMFLFIFVSNWSGALFPWRV
FELPNGELAAPTNDINTTVALALLTSVAYFYAGLHKKGLSYFGKYIQPTPVLLPINILED
FTKPLSLSFRLFGNILADELVVAVLISLVPLVVPIPMMFLGLFTSAIQALIFATLAAAYI
GESMEGHH
>P06452; 18 ATP SYNTHASE A CHAIN PRECURSOR (EC 3.6.1.34) (SUBUNIT IV
MNVLLCYINTLNRFYDISAVEVGQHFYWQIGDFQVHAQVLITSWVVIAILLISTILVVRN
PQTIPTSGQNFFEYVLEFIRDVSKTQIGEEYGPWVPFIGTLFLFIFVSNWSGALLPWKII
KLPHGELAAPTNDINTTVALALLTSVAYFYAGISKKGLAYFGKYIQPTPILLPINILEDF
TKPLSLSFRLFGNILADELVVVVLVSLVPLVVPIPVMFLGLFTSGIQALIFATLAAAYIG
ESMEGHH
>P36361; 26 ENDOCHITINASE CH5B PRECURSOR (EC 3.2.1.14).
MKKNRMMIMICSVGVVWMLLVGGSYGEQCGRQAGGALCPGGNCCSQFGWCGSTTDYCGKD
CQSQCGGPSPAPTDLSALISRSTFDQVLKHRNDGACPAKGFYTYDAFIAAAKAYPSFGNT
GDTATRKREIAAFLGQTSHETTGGWATAPDGPYAWGYCFVRERNPSAYCSATPQFPCAPG
QQYYGRGPIQISWNYNYGQCGRAIGVDLLNKPDLVATDSVISFKSALWFWMTAQSPKPSS
HDVITSRWTPSSADVAARRLPGYGTVTNIINGGLECGRGQDSRVQDRIGFFKRYCDLLGV
GYGNNLDCYSQTPFGNSLFLSDLVTSQ
>P16579; 22 ACIDIC ENDOCHITINASE WIN6 PRECURSOR (EC 3.2.1.14).
MSVWALFAFFSLFLSLSVRGSAEQCGRQAGDALCPGGLCCSSYGWCGTTVDYCGIGCQSQ
CDGGGGGDGGDDGCDGGDDGGGDGDDGYLSDIIPKSKFDALLKFRNDARCPAAGFYTYNA
FISAAKEFPDFGNTGDDLMRKREIAAFLGQTSHETTGGWPDAPCGPYAWGYCYLKEINCQ
PYCDPSSNYQCVAGKQYCGRGPIQLSWNYNYGLCGDDLKLPLLQEPELVETDPVISFKTA
IWFWMKPQSPKPSCHAVITGNWTPSAADLEAGRVPGYGVITNIINGGIECGQGGPNAANE
DRIGFYKKYCDSLGTTYGSNLDCYQQRPFGYGLSGLKDTM
>P36907; 23 ENDOCHITINASE PRECURSOR (EC 3.2.1.14).
MKRTLKVSFFILCLLPLFLGSKAEQCGSQAGGAVCPNGLCCSKFGFCGSTDPYCGDGCQS
QCKSSPTPTIPTPSTGGGDVGRLVPSSLFDQMLKYRNDGRCAGHGFYTYDAFIAAARSFN
GFGTTGDDNTKKKELAAFLAQTSHETTGGWPTAPDGPYAWGYCFVSEQNTQEVYCSPKDW
PCAPGKKYYGRGPIQLTHNYNYGLAGQAIKEDLINNPDLLSTNPTVSFKTAIWFWMTPQA
NKPSSHDVITGRWTPSAADSSAGRVPGYGVITNIINGGIECGHGQDNRVDDRVGFYKRYC
QIFGVDPGGNLDCNNQRSFA
>P33525; 23 CRUCIFERIN CRU1 PRECURSOR (11S GLOBULIN) (12S STORAGE PR
MVKVPHLLVATFGVLLVLNGCLARQSLGVPPQLGNACNLDNLDVLQPTETIKSEAGRVEY
WDHNNPQIRCAGVSVSRVIIEQGGLYLPTFFSSPKISYVVQGMGISGRVVPGCAETFMDS
QPMQGQQQGQPWQGQQGQQGQQGQQGQQGQQGQQGQQGQQGQQGQQGQQQQGFRDMHQKV
EHVRHGDIIAITAGSSHWIYNTGDQPLVIICLLDIANYQNQLDRNPRTFRLAGNNPQGGS
QQQQQQQQNMLSGFDPQVLAQALKIDVRLAQELQNQQDSRGNIVRVKGPFQVVRPPLRQP
YESEQWRHPRGPPQSPQDNGLEETICSMRTHENIDDPARADVYKPNLGRVTSVNSYTLPI
LQYIRLSATRGILQGNAMVLPKYNMNANEILYCTQGQARIQVVNDNGQNVLDQQVQKGQL
VVIPQGFAYVVQSHQNNFEWISFKTNANAMVSTLAGRTSALRALPLEVITNAFQISLEEA
RRIKFNTLETTLTRARGGQPQLIEEIVEA
>P51200; 25 CYTOCHROME C6 PRECURSOR (SOLUBLE CYTOCHROME F) (CYTOCHRO
MKKTLSVLFTAFSFCVIGFTQVAFAADLDNGEKVFSANCAACHAGGNNAIMPDKTLKKDV
LEANSMNGIDAITYQVTNGKNAMPAFGGRLVDEDIEDAANYVLSQSEKGW
>P49237; 29 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE, ACIDIC ISOFORM PRECURS
MARQGVIASMHALALLLGAFAAIPTGVQSIGVCYGVNGDNLPPASDVVQLYQSNGINLLR
IYFPDANPLNALSGTSIGLIMDVPNTDLASLASDPSAAAAWVQSNVQASRRSACRYIAVG
NEVSGGDTGSILPAMQNLNAALANAGLGGSIKVSTAVQSDVTQGFPPSQGTFSQGYMAPS
RQYLQSTGAPLLSNVYPYFSYVGNPAQIDLKYALFTSPGTVVQDGSNAYQNLFDALVDTF
VSALEENAGAGNVPVVVSESGWPSAGGDAATAANAQTYNQNLINHVGQGTPKRPGPIETY
IFAMFNEDQKTGAESERHFGLFNPDKSPVYPINFS
>P52409; 23 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE PRECURSOR (EC 3.2.1.39)
MPLLILLMLLAAGAAGAESATPSLHIGVNYGANADNLPSPTSVATFLATKTTIDRVKLFD
ANPTFISAFAGTPISLAVSLPNSALPALADKATGLDAARSWIRANLSPYVPATNVTLLLA
GNEILLSTDTNLILSLLPAMRRLAQALKAEGLTGVRVTTPHYLGILAPSDGIPSNASFRA
GYNTKLFPAMLQFHRDTGSPFMVNPYPYFSYRPETLNYALFRPNSGIYDPATKLNYTSML
DAQMDAIYTAMKKLGYGDVDIAVGEAGWPTQAEPGQIGVGVQEARDFNEGMIRVCSSGKG
TPLMPNRTFETYLFSLFDENQKPGPIAERHFGLFNPDFTPVYDLGLLRDGASVAPTPSPN
PSPNPSPKPAPSGGGKWCVAKDGANGTDLQNNINYACGFVDCKPIQSGGACFSPNSLQAH
ASYVMNAYYQANGHTDLACDFKGTGIVTSSDPSYGGCKYVS
>P20145; 35 PROBABLE NONSPECIFIC LIPID-TRANSFER PROTEIN PRECURSOR (L
MAMAMGMAMRKEAAVAVMMVMVVTLAAGADAGAGAACEPAQLAVCASAILGGTKPSGECC
GNLRAQQGCLCQYVKDPNYGHYVSSPHARDTLNLCGIPVPHC
>P52589; 25 PROTEIN DISULFIDE ISOMERASE PRECURSOR (PDI) (EC 5.3.4.1)
MAISKVWISLLLALAVVLSAPAARAEEAAAAEEAAAAPEAVLTLHADNFDDAIAKHPFIL
VEFYAPWCGHCKSLAPEYEKAAQLLSKHDPAIVLAKVDANDEKNKPLAGKYEVQGFPTLK
IFRSGGKNIQEYKGPREAEGIVEYLKKQVGPASKEIKAPEDATYLEDGKIHIVGVFTEFS
GTEFTNFLELAEKLRSDYDFGHTVHANHLPRGDAAVERPLVRLFKPFDELVVDSKDFDVS
ALEKFIDASSTPKVVTFDKNPDNHPYLLKYFQSNAPKAMLFLNFSTGPFESFKSAYYGAV
EEFSGKDVKFLIGDIEASQGAFQYNGLKEDQAPLILIQDSDSKKFLKEQVEAGQIVAWLK
DYFDGKLTPFRKSEPIPEANNEPVKVVVADNIHDVVFKSAKNVLIEFYAPWCGHCKKLAP
ILDEAAATLQSEEDVVIAKIDATANDVPGEFDVQGYPTLYFVTPSGKKVSYEGGRTADEI
VDYIKKNKETAGQAAAAATEKAAEPAATEPLKDEL
>P35793; 24 PATHOGENESIS-RELATED PROTEIN PRB1-3 PRECURSOR (PR-1B) (H
MQTPKLVILLALAMSAAMVNLSQAQNSPQDYVSPHNAARAAVGVGAVSWSTKLQAFAQNY
ANQRINDCKLQHSGGPYGENIFWGSAGADWKASDAVNSWVSEKKDYDYGSNTCAAGKVCG
HYTQVVWRASTSIGCARVVCNNNRGVFITCNYEPRGNIVGQKPY
>P11670; 23 BASIC FORM OF PATHOGENESIS-RELATED PROTEIN 1 PRECURSOR (
MGFLTTIVACFITFAILIHSSKAQNSPQDYLNPHNAARRQVGVGPMTWDNRLAAYAQNYA
NQRIGDCGMIHSHGPYGENLAAAFPQLNAAGAVKMWVDEKRFYDYNSNSCVGGVCGHYTQ
VVWRNSVRLGCARVRSNNGWFFITCNYDPPGNFIGQRPFGDLEEQPFDSKLELPTDV
>P92976; 22 STRICTOSIDINE SYNTHASE 3 PRECURSOR (EC 4.3.3.2).
MRSFVSLISLLLLLSFSSSVLSTKKSSFQKLPVPGNRTGPEAFAFDSTGKGFLPGVTGGK
ILKYLPKKGYVDFAQITNSSKSSLCDGALGTTNVEKCGRPAGIAFNTKTGDLYVADAALG
LHVIPRRGGLAKKIADSVGGKPFLFLDGLDVDPNTGVVYFTSFSSTFGPRDVLKAVATKD
STGKFFKYDPSKKVVTVLMDGLSGSAGCAVSSDGSFVLVGQFTKSNIKRYWIKGSKAGTS
EDFTNSVSNPDNIKRIGSTGNFWVASVVNSATGPTNPSAVKVSSAGKVLQTIPLKDKFGD
TLVSEVNDQRTALYRSSFWAFRRNSLSFKVNMVLVWVRIKVIESK
>P15324; 22 STRICTOSIDINE SYNTHASE PRECURSOR (EC 4.3.3.2).
MAKLSDSQTMALFTVFLLFLSSSLALSSPILKEILIEAPSYAPNSFTFDSTNKGFYTSVQ
DGRVIKYEGPNSGFVDFAYASPYWNKAFCENSTDAEKRPLCGRTYDISYNLQNNQLYIVD
CYYHLSVVGSEGGHATQLATSVDGVPFKWLYAVTVDQRTGIVYFTDVSTLYDDRGVQQIM
DTSDKTGRLIKYDPSTKETTLLLKELHVPGGAEVSADSSFVLVAEFLSHQIVKYWLEGPK
KGTAEVLVKIPNPGNIKRNADGHFWVSSSEELDGNMHGRVDPKGIKFDEFGNILEVIPLP
PPFAGEHFEQIQEHDGLLYIGTLFHGSVGILVYDKKGNSFVSSH
>P15461; 20 2S SEED STORAGE PROTEIN PRECURSOR (2S ALBUMIN STORAGE PR
MAKQIVLALAFAALVAFATAHTTIITTTIEDENPISGQRQVSQRIQGQRLNQCRMFLQQG
QNIPREFDNPQMGRQQEQQLQQCCQELQNIEGQCQCEAVKQVFREAQQQVQQQQGRQLVP
FRGSQQTQQLKQKAQILPNVCNLQSRRCEIGTITTTVTESNIDIPFRDRPFGTGSQQCRE
TEIQRPVGECQRFVEQQMQQSPRSTRPYQQRPGQQQQQQRGLQQQCCNELQNVKRECHCE
AIQEVARRVMRQPQQQQQQRRGQFGGQEMETARRVIQNLPNQCDLEVQQCTTCTG
>P24396; 20 STYLE DEVELOPMENT-SPECIFIC PROTEIN 9612 PRECURSOR.
MSTLFFTFSLLLLAPLLVISSIQDPELVVQDVHRSINASLTRRNLGYLSCGSGNPIDRLL
AMQPQLGKKSPAFSYCAIGFGKNAIGGKNGRIYVVTDSGNDDPVNPKPGTLRHAVIQDEP
LWIIFKRDMVIQLKQELVMNSYKTIDGRGASVHISGGPCITIHHTSNIIIHGINIHDCKQ
SGNGNIRDSPNHSGWWDVSDGDGISIFGGKNIWVDHCSLSNCHDGLIDAIHGSTAITISN
NYFTHHDKVMLLGHSDSFTQDKGMQVTVAFNHFGEGLVQRMPRCRHGYFHVVNNDYTHWE
MYAIGGSAAPTINSQGNRFLAPNEKYRKEVTKHEDAPESQWRSWNWRSEGDLMLNGAYFR
QTGAGASSSSTYARASSLSARPSSLVGSITTNAGPVNCKKGSRC
>Q00762; 24 TAPETUM-SPECIFIC PROTEIN A9 PRECURSOR.
MVSLKSLAAILVAMFLATGPTVLAQQCRDELSNVQVCAPLLLPGAVNPAANSNCCAALQA
TNKDCLCNRLRAATTLTSLCNLPSFDCGKMIHRLKPFLLDFYKLFHQ
>P33491; 20 AUXIN-BINDING PROTEIN T92 PRECURSOR (ABP).
MARHIIILVAVFWFATAEASHCSINGLPLVRNISELPQENYGRSGLSHTTIAGSVLHGMK
EIEVWLQTFAPGFRTPIHRHSCEEIFIVLKGQGTLYLTPSSHSKYPGNPQEFHIFPNSTF
HIPVNDVHQVWNTGEQEDLQVLDVISRPPVKVFMYDDWSMPHTAAKLKFPYYWDEECYQT
TSRKDEL
>P06750; 24 AGGLUTININ PRECURSOR (RRNA N-GLYCOSIDASE) (EC 3.2.2.22) 
MYAVATWLCFGSTSGWSFTLEDNNIFPKQYPIINFTTADATVESYTNFIRAVRSHLTTGA
DVRHEIPVLPNRVGLPISQRFILVELSNHAELSVTLALDVTNAYVVGCRAGNSAYFFHPD
NQEDAEAITHLFTDVQNSFTFAFGGNYDRLEQLGGLRENIELGTGPLEDAISALYYYSTC
GTQIPTLARSFMVCIQMISEAARFQYIEGEMRTRIRYNRRSAPDPSVITLENSWGRLSTA
IQESNQGAFASPIQLQRRNGSKFNVYDVSILIPIIALMVYRCAPPPSSQFSLLIRPVVPN
FNADVCMDPEPIVRIVGRNGLCVDVTGEEFFDGNPIQLWPCKSNTDWNQLWTLRKDSTIR
SNGKCLTISKSSPRQQVVIYNCSTATVGATRWQIWDNRTIINPRSGLVLAATSGNSGTKL
TVQTNIYAVSQGWLPTNNTQPFVTTIVGLYGMCLQANSGKVWLEDCTSEKAEQQWALYAD
GSIRPQQNRDNCLTTDANIKGTVVKILSCGPASSGQRWMFKNDGTILNLYNGLVLDVRRS
DPSLKQIIVHPFHGNLNQIWLPLF
>O04931; 28 ALPHA-GLUCOSIDASE PRECURSOR (EC 3.2.1.20) (MALTASE).
MERSKLPRYICPTLAVVLPLVLCMVVEGATTSKNDNQGEAIGYGYQVKNAKVDNSTGKSL
TALLQLIRNSPVYGPDIHFLSFTASFEEDDTLRIRFTDANNRRWEIPNEVLPRPPPPPSP
PPLSSLQHLPKPIPQNQPTTTVLSHPHSDLAFTLFHTTPFGFTIYRKSTHDVLFDATPIP
SNPTTFLIYKDQYLQLSSSLPAQQAHLYGLGEHTKPTFQLAHNQILTLWNADIASFNRDL
NLYGSHPFYMDVRSSPMVGSTHGVFLLNSNGMDVEYTGDRITYKVIGGIIDLYIFAGRTP
EMVLDQYTKLIGRPAPMPYWAFGFHQCRWGYRDVNEIETVVDKYAEARIPLEVMWTDIDY
MDAFKDFTLDPVHFPLDKMQQFVTKLHRNGQRYVPILDPGINTNKSYGTFIRGMQSNVFI
KRNGNPYLGSVWPGPVYYPDFLDPAARSFWVDEIKRFRDILPIDGIWIDMNEASNFITSA
PTPGSTLDNPPYKINNSGGRVPINSKTIPATAMHYGNVTEYNAHNLYGFLESQATREALV
RPATRGPFLLSRSTFAGSGKYTAHWTGDNAARWDDLQYSIPTMLNFGLFGMPMIGADICG
FAESTTEELCCRWIQLGAFYPFSRDHSARDTTHQELYLWESVAASARTVLGLRYELLPYY
YTLMYDANLRGSPIARPLSFTFPDDVATYGISSQFLIGRGIMVSPVLQPGSSIVNAYSPR
GNWVSLSNYTSSVSVSAGTYVSLSAPPDHINVHIHEGNIVAMQGEAMTTQAARSTPFHLL
VVMSDHVASTGELFLDNGIEMDIGGPGGKWTLVRFFAESGINNLTISSEVVNRGYAMSQR
WVMDKITILGLKRRVKIKEYTVQKDAGAIKVKGLGRRTSSHNQGGFFVSVISDLRQLVGQ
AFKLELEFEGATR
>P08687; 26 ALBUMIN 1 PRECURSOR (PA1).
MASVKLASLIVLFATLGMFLTKNVGAASCNGVCSPFEMPPCGTSACRCIPVGLVVGYCRN
PSGVFLRTNDEHPNLCESDADCRKKGSGNFCGHYPNPDIEYGWCFASKSEAEDFFSKITP
KDLLKSVSTA
>P31757; 25 ALLIIN LYASE PRECURSOR (EC 4.4.1.4) (ALLIINASE) (CYSTEIN
MESYDKVGSNKVPCLLILTCIIMSSFVNNNIVQAKVSWSLKAAEEAEAVANINCSGHGRA
FLDGILSDGSPKCECNTCYTGADCSEKITGCSADVASGDGLFLEEYWQQHKENSAVLVSG
WHRMSYFFNPVSNFISFELEKTIKELHEIVGNAAAKDRYIVFGVGVTQLIHGLVISLSPN
MTATPCAPQSKVVAHAPYYPVFREQTKYFDKKGYEWKGNAADYVNTSTPEQFIEMVTSPN
NPEGLLRHEVIKGCKSIYYMVYYWPHYTPIKYKADEDIMLFTMSKYTGHSGSRFGWALIK
DETVYNKLLNYMTKNTEGTSRETQLRSLKILKEVIAMVKTQNGTMRDLNTFGFQKLRERW
VNITALLDKSDRFSYQKLPQSEYCNYFRRMRPPSPSYAWVKCEWEEDKDCYQTFQNGRIN
TQSGEGFEAGSRYVRLSLIKTKDDFDQLMYYLKIMVEAKRKTPLIKQLSNDQISRRPFI
>P27932; 26 ALPHA-AMYLASE ISOZYME 3A PRECURSOR (EC 3.2.1.1) (1,4-ALP
MGKQMAALCGFLLVALLWLTPDVAHAQTQILFQGFNWDSWKKQGGWYNMLKDQVGDIASA
GVTHVWLPPPTHSVSPQGYMPGRLYDLNASKYGTKAELKSLIAAFHAKGIKCVADIVVNH
RCADDKDGRGVYCIFKGGGPRGCLDWGPSMICCDDTQYSDGTGHRDTGADFAAAPDIDHL
NPLVQRELSDWLRWLRRDVGFDGWRLDFAKGYSAAVARTYVQNARPSFVVAEIWNSLSYD
GDGKPAANQDGQRQELVNWVKQVGGPATAFDFTTKGILQSAVQGELWRMRDKDGKAPGMI
GWYPEKAVTFVDNHDTGSTQRMWPFPSDKVILGYAYILTHPGVPCIFYDQVFDWNLKQEI
NALAATRKRNGINAGSKLRVLAAESDMYVAMVDERVITKIGPRIEVGNIIPSDFHIVAHG
NDYCVWEKSGLRVPEPEGRR
>P27934; 25 ALPHA-AMYLASE ISOZYME 3E PRECURSOR (EC 3.2.1.1) (1,4-ALP
MGKHHVTLCCVVFAVLCLASSLAQAQVLFQGFNWESWRKQGGWYNFLHEKVEEIASTGAT
HVWLPPPSHSVSPQGYMPGRLYDLDASKYGTEAELKSLIEAFHDKNVECLADIVINHRCA
DYKDSRGVYCVFEGGTPDGRLDWGPDMICSDDTQYSNGRGHRDTGAGFGAAPDIDHLNPR
VQRELTDWLNWLRTDLGFDGWRLDFAKGYSAPLARIYVDNTNPTFVVGEIWSSLIYNGDG
KPSTNQDADRQELVNWVEGVGKPATAFDFTTKGILQAAVQGELWRLHDGNGKAPGLMGWM
PDQAVTFVDNHDTGSTQSLWPFPSDKVMQGYAYILTHPGIPCIFYDHVFDWNLQHEIATL
AEIRSRNGIHAESTLDILKAEGDIYVAMIDGKVITKLGPRYDAGGIIPSDFHVVAHGNDY
CVWEKEGLRVPAGRKHY
>Q43077; 25 AMINE OXIDASE PRECURSOR [COPPER-CONTAINING] (EC 1.4.3.6)
MASTTTMRLALFSVLTLLSFHAVVSVTPLHVQHPLDPLTKEEFLAVQTIVQNKYPISNNR
LAFHYIGLDDPEKDHVLRYETHPTLVSIPRKIFVVAIINSQTHEILINLRIRSIVSDNIH
NGYGFPILSVDEQSLAIKLPLKYPPFIDSVKKRGLNLSEIVCSSFTMGWFGEEKNVRTVR
LDCFMKESTVNIYVRPITGITIVADLDLMKIVEYHDRDIEAVPTAENTEYQVSKQSPPFG
PKQHSLTSHQPQGPGFQINGHSVSWANWKFHIGFDVRAGIVISLASIYDLEKHKSRRVLY
KGYISELFVPYQDPTEEFYFKTFFDSGEFGFGLSTVSLIPNRDCPPHAQFIDTYVHSANG
TPILLKNAICVFEQYGNIMWRHTENGIPNESIEESRTEVNLIVRTIVTVGNYDNVIDWEF
KASGSIKPSIALSGILEIKGTNIKHKDEIKEDLHGKLVSANSIGIYHDHFYIYYLDFDID
GTHNSFEKTSLKTVRIKDGSSKRKSYWTTETQTAKTESDAKITIGLAPAELVVVNPNIKT
AVGNEVGYRLIPAIPAHPLLTEDDYPQIRGAFTNYNVWVTAYNRTEKWAGGLYVDHSRGD
DTLAVWTKQNREIVNKDIVMWHVVGIHHVPAQEDFPIMPLLSTSFELRPTNFFERNPVLK
TLSPRDVAWPGCSN
>Q41258; 27 ANTIMICROBIAL PROTEIN ACE-AMP1 PRECURSOR.
MVRVVSLLAASTFILLIMIISSPYANSQNICPRVNRIVTPCVAYGLGRAPIAPCCRALND
LRFVNTRNLRRAACRCLVGVVNRNPGLRRNPRFQNIPRDCRNTFVRPFWWRPRIQCGRIN
LTDKLIYLDAEE
>O24006; 23 ANITBACTERIAL PEPTIDES PRECURSOR (IB-AMP1-4) [CONTAINS: 
MVQKGVVFGVLLILFICSTLTSADSKPNPTKEEEPAKKPDEVSVKSGGPEVSEDQYRHRC
CAWGPGRKYCKRWCANAEEAAAAIPEASEELAQEEAPVYSEDQWGRRCCGWGPGRRYCVR
WCQNAEEAAAAIPEATEKAQEAPVYSEDQWGRRCCGWGPGRRYCVRWCQNAEEAAAAVAI
PEASEKAQEGPVYSEDQWGRRCCGWGPGRRYCVRWCSNAADEVATPEDVEPGQYGRRCCN
WGPGRRYCKRWCHNAAEEATLKAFEEEAAREQPVYSEDQWGRRCCGWGPGRRYCRRWCQS
AEEAAAFQAGEVTASLMLIMFKACPCMGPVPSV
>P40602; 35 ANTER-SPECIFIC PROLINE-RICH PROTEIN APG PRECURSOR.
MKRSSLVDSCSYSRIFRSIFCLLSFCIFFLTTTNAQVMHRRLWPWPLWPRPYPQPWPMNP
PTPDPSPKPVAPPGPSPKPVAPPGPSPCPSPPPKPQPKPPPAPSPSPCPSPPPKPQPKPV
PPPACPPTPPKPQPKPAPPPAPKPAPPPAPKPVPCPSPPKPPAPTPKPVPPHGPPPKPAP
APTPAPSPKPAPSPPKPENKTIPAVFFFGDSVFDTGNNNNLETKIKSNYRPYGMDFKFRV
ATGRFSNGMVASDYLAKYMGVKEIVPAYLDPKIQPNDLLTGVSFASGGAGYNPTTSEAAN
AIPMLDQLTYFQDYIEKVNRLVRQHKSQYKLAGLEKTNQLISKGVAIVVGGSNDLIITYF
GSGAQRLKNDIDSYTTIIADSAASFVLQLYGYGARRIGVIGTPPLGCVPSQRLKKKKICN
EELNYASQLFNSKLLLILGQLSKTLPNSTFVYMDIYTIISQMLETPAAYGFEETKKPCCK
TGLLSAGALCKKSTSKICPNTSSYLFWDGVHPTQRAYKTINKVLIKEYLHVLSK
>P80595; 30 APYRASE PRECURSOR (EC 3.6.1.5) (ATP-DIPHOSPHATASE) (ADEN
MLNQNSHFIFIILAIFLVLPLSLLSKNVNAQIPLRRHLLSHESEHYAVIFDAGSTGSRVH
VFRFDEKLGLLPIGNNIEYFMATEPGLSSYAEDPKAAANSLEPLLDGAEGVVPQELQSET
PLELGATAGLRMLKGDAAEKILQAVRNLVKNQSTFHSKDQWVTILDGTQEGSYMWAAINY
LLGNLGKDYKSTTATIDLGGGSVQMAYAISNEQFAKAPQNEDGEPYVQQKHLMSKDYNLY
VHSYLNYGQLAGRAEIFKASRNESNPCALEGCDGYYSYGGVDYKVKAPKKGSSWKRCRRL
TRHALKINAKCNIEECTFNGVWNGGGGDGQKNIHASSFFYDIGAQVGIVDTKFPSALAKP
IQYLNAAKVACQTNVADIKSIFPKTQDRNIPYLCMDLIYEYTLLVDGFGLNPHKEITVIH
DVQYKNYLVGAAWPLGCAIDLVSSTTNKIRVASS
>O04057; 25 ASPARTIC PROTEINASE PRECURSOR (EC 3.4.23.-).
MASYHSKAAFLCLFLLVSFNIVSSASNDGLLRVGLKKIKLDPENRLAARVESKDAEILKA
AFRKYNPKGNLGESSDTDIVALKNYLDAQYYGEIAIGTPPQKFTVIFDTGSSNLWVLCEC
LFSVACHFHARYKSSRSSSYKKNGTSASIRYGTGAVSGFFSYDNVKVGDLVVKEQVFIEA
TREPSLTFLVAKFDGLLGLGFQEIAVGNAVPVWYNMVEQGLVKEPVFSFWLNRNVEEEEG
GEIVFGGVDPKHYRGKHTYVPVTQKGYWQFDMGDVLIDGEPTGFCDGGCSAIADSGTSLL
AGPTPVITMINHAIGAKGVVSQQCKAVVAQYGQTIMDLLLSEADPKKICSQINLCTFDGT
RGVSMGIESVVDENAGKSSDSLHDGMCSVCEMTVVWMQNQLRQNQTKERIINYINELCDR
MPSPMGQSAVDCGQLSSMPTVSFTIGGKIFDLAPEEYILKVGEGPVAQCISGFTAFDIPP
PRGPLWILGDVFMGRYHTVFDFGKLRVGSAEAA
>P42210; 22 PHYTEPSIN PRECURSOR (EC 3.4.23.40) (ASPARTIC PROTEINASE)
MGTRGLALALLAAVLLLQTVLPAASEAEGLVRIALKKRPIDRNSRVATGLSGGEEQPLLS
GANPLRSEEEGDIVALKNYMNAQYFGEIGVGTPPQKFTVIFDTGSSNLWVPSAKCYFSIA
CYLHSRYKAGASSTYKKNGKPAAIQYGTGSIAGYFSEDSVTVGDLVVKDQEFIEATKEPG
ITFLVAKFDGILGLGFKEISVGKAVPVWYKMIEQGLVSDPVFSFWLNRHVDEGEGGEIIF
GGMDPKHYVGEHTYVPVTQKGYWQFDMGDVLVGGKSTGFCAGGCAAIADSGTSLLAGPTA
IITEINEKIGAAGVVSQECKTIVSQYGQQILDLLLAETQPKKICSQVGLCTFDGTRGVSA
GIRSVVDDEPVKSNGLRADPMCSACEMAVVWMQNQLAQNKTQDLILDYVNQLCNRLPSPM
GESAVDCGSLGSMPDIEFTIGGKKFALKPEEYILKVGEGAAAQCISGFTAMDIPPPRGPL
WILGDVFMGPYHTVFDYGKLRIGFAKAA
>P42211; 19 ASPARTIC PROTEINASE PRECURSOR (EC 3.4.23.-).
MAKRHLLLVTTCLWALSCALLLHASSDGFLRVNLNKKRLDKEDLTAAKLAQQGNRLLKTG
SSDSDPVPLVDYLNTQYYGVIGLGSPPQNFTVIFDTGSSNLWVPSAKCYFSIACYLHSRY
NSKKSSSYKADGETCKITYGSGAISGFFSKDNVLVGDQVVKNQKFIEATRETSVTFIIGK
FDGILGLGYPEISVGKAPPIWQSMQEQELLADDVFSFWLNRDPDASSGGELVFGGMDPKH
YKGDHTYVPVSRKGYWQFNMGDLLIDGHSTGFCAKGCAAIVDSGTSLLAGPTAIVAQVNH
AIGAEGIISTECKEVVSEYGEMILNLLIAQTDPQKVCSQVGLCMFDGKRSVSNGIESVVD
KENLGSDAMCSVCEMAVVWIENQLRENKTKELILNYANQLCERLPSPNGESTVSCHQISK
MPNLAFTIANKTFILTPEQYIVKLEQGGQTVCISGFMAFDIPPPRGPLWILGDVFMGAYH
TVFDFGKDRIGFAKSA
>P32765; 26 21 KD SEED PROTEIN PRECURSOR.
MKTATAVVLLLFAFTSKSYFFGVANAANSPVLDTDGDELQTGVQYYVLSSISGAGGGGLA
LGRATGQSCPEIVVQRRSDLDNGTPVIFSNADSKDDVVRVSTDVNIEFVPIRDRLCSTST
VWRLDNYDNSAGKWWVTTDGVKGEPGPNTLCSWFKIEKAGVLGYKFRFCPSVCDSCTTLC
SDIGRHSDDDGQIRLALSDNEWAWMFKKASKTIKQVVNAKH
>Q07488; 22 BLUE COPPER PROTEIN PRECURSOR.
MAGVFKTVTFLVLVFAAVVVFAEDYDVGDDTEWTRPMDPEFYTSWATGKTFRVGDELEFD
FAAGRHDVAVVSEAAFENCEKEKPISHMTVPPVKIMLNTTGPQYFICTVGDHCRFGQKLS
ITVVAAGATGGATLGAGATPALGSTPSTGGTTPPTAGGTTTPSGSSGTTTPAGNAASSLG
GATFLVAFVSAVVALF
>P45582; 25 BETA-GALACTOSIDASE PRECURSOR (EC 3.2.1.23) (LACTASE).
MALKLVLMLMVALLAAVWSPPAVTASVTYDHKSVIINGQRRILISGSIHYPRSTPEMWPD
LIQKAKDGGLDVIQTYVFWNGHEPSPGQYYFGGRYDLVRFLKLVKQAGLYAHLRIGPYVC
AEWNFGGFPVWLKYVPGIHFRTDNGPFKAAMGKFTEKIVSMMKAEGLYETQGGPIILSQI
ENEYGPVEYYDGAAGKSYTNWAAKMAVGLNTGVPWVMCKQDDAPDPVINTCNGFYCDYFS
PNKDNKPKMWTEAWTGWFTGFGGAVPQRPAEDMAFAVARFIQKGGSFINYYMYHGGTNFG
RTAGGPFISTSYDYDAPIDEYGLLRQPKWGHLRDLHKAIKLCEPALVSGEPTITSLGQNQ
ESYVYRSKSSCAAFLANFNSRYYATVTFNGMHYNLPPWSVSILPDCKTTVFNTARVGAQT
TTMKMQYLGGFSWKAYTEDTDALNDNTFTKDGLVEQLSTTWDRSDYLWYTTYVDIAKNEE
FLKTGKYPYLTVMSAGHAVHVFINGQLSGTAYGSLDNPKLTYSGSAKLWAGSNKISILSV
SVGLPNVGNHFETWNTGVLGPVTLTGLNEGKRDLSLQKWTYQIGLHGETLSLHSLTGSSN
VEWGEASQKQPLTWYKTFFNAPPGNEPLALDMNTMGKGQIWINGQSIGRYWPAYKASGSC
GSCDYRGTYNEKKCLSNCGEASQRWYHVPRSWLIPTGNFLVVLEEWGGDPTGISMVKRSV
ASVCAEVEELQPTMDNWRTKAYGRPKVHLSCDPGQKMSKIKFASFGTPQGTCGSFSEGSC
HAHKSYDAFEQEGLMQNCVGQEFCSVNVAPEVFGGDPCPGTMKKLAVEAICE
>P49676; 20 BETA-GALACTOSIDASE PRECURSOR (EC 3.2.1.23) (LACTASE).
MKMKQFNLLSLFLILITSFGSANSTIVSHDERAITIDGQRRILLSGSIHYPRSTSDMWPD
LISKAKDGGLDTIETYVFWNAHEPSRRQYDFSGNLDLVRFIKTIQSAGLYSVLRIGPYVC
AEWNYGGFPVWLHNMPDMKFRTINPGFMNEMQNFTTKIVNMMKEESLFASQGGPIILAQI
ENEYGNVISSYGAEGKAYIDWCANMANSLDIGVPWIMCQQPHAPQPMIETCNGFYCDQYK
PSNPSSPKMWTENWTGWFKNWGGKHPYRTAEDLAFSVARFFQTGGTFQNYYMYHGGTNFG
RVAGGPYITTSYDYDAPLDEYGNLNQPKWGHLKQLHTLLKSMEKPLTYGNISTIDLGNSV
TATVYSTNEKSSCFIGNVNATADALVNFKGKDYNVPAWSVSVLPDCDKEAYNTARVNTQT
SIITEDSCDEPEKLKWTWRPEFTTQKTILKGSGDLIAKGLVDQKDVTNDASDYLWYMTRV
HLDKKDPIWSRNMSLRVHSNAHVLHAYVNGKYVGNQIVRDNKFDYRFEKKVNLVHGTNHL
ALLSVSVGLQNYGPFFESGPTGINGPVKLVGYKGDETIEKDLSKHQWDYKIGLNGFNHKL
FSMKSAGHHHRKWSTEKLPADRMLSWYKANFKAPLGKDPVIVDLNGLGKGEVWINGQSIG
RYWPSFNSSDEGCTEECDYRGEYGSDKCAFMCGKPTQRWYHVPRSFLNDKGHNTITLFEE
MGGDPSMVKFKTVVTGRVCAKAHEHNKVELSCNNRPISAVKFASFGNPSGQCGSFAAGSC
EGAKDAVKVVAKECVGKLNCTMNVSSHKFGSNLDCGDSPKRLFVEVEC
>P26204; 18 NON-CYANOGENIC BETA-GLUCOSIDASE PRECURSOR (EC 3.2.1.21).
MDFIVAIFALFVISSFTITSTNAVEASTLLDIGNLSRSSFPRGFIFGAGSSAYQFEGAVN
EGGRGPSIWDTFTHKYPEKIRDGSNADITVDQYHRYKEDVGIMKDQNMDSYRFSISWPRI
LPKGKLSGGINHEGIKYYNNLINELLANGIQPFVTLFHWDLPQVLEDEYGGFLNSGVIND
FRDYTDLCFKEFGDRVRYWSTLNEPWVFSNSGYALGTNAPGRCSASNVAKPGDSGTGPYI
VTHNQILAHAEAVHVYKTKYQAYQKGKIGITLVSNWLMPLDDNSIPDIKAAERSLDFQFG
LFMEQLTTGDYSKSMRRIVKNRLPKFSKFESSLVNGSFDFIGINYYSSSYISNAPSHGNA
KPSYSTNPMTNISFEKHGIPLGPRAASIWIYVYPYMFIQEDFEIFCYILKINITILQFSI
TENGMNEFNDATLPVEEALLNTYRIDYYYRHLYYIRSAIRAGSNVKGFYAWSFLDCNEWF
AGFTVRFGLNFVD
>P33050; 27 POLLEN SPECIFIC PROTEIN C13 PRECURSOR.
MASVPAPATTTAAVILCLCVVLSCAAADDPNLPDYVIQGRVYCDTCRAGFVTNVTEYIAG
AKVRLECKHFGTGKLERAIDGVTDATGTYTIELKDSHEEDICQVVLVASPRKDCDEVQAL
RDRAGVLLTRNVGISDSLRPANPLGYFKDVPLPVCAALLKQLDSDDDDDQ
>P48263; 26 CYTOCHROME C-550 PRECURSOR (C550).
MFNKNFWTSIIIGCLFCTITYSGVNAAALDEETRTVALNSTETVVLTPEQVKRGKRLFNS
TCGICHVGGITKTNPNVGLDSEALALATPPRNNIESLVDYMKNPTSYDGSEEIYDIHPSI
RSADAFPKMRNLTEEDLYDIAGHILLSPKILPSQWGGGKIYY
>P51199; 26 CYTOCHROME C-550 PRECURSOR (C550).
MLKRSSWLATLLGLLTVASVSTIVYAIELDEATRTVPLESSGRTVVLTPEQVKRGKRLFN
NSCAICHNGGITKTNPNVGLDPESLGLATPQRDNIEALVDYMKDPTSYDGAESIAELHPS
IKSAEIFPKMRNLTDEDLFTIAGHILLQPKIVSEKWGGGKIYY
>Q39817; 25 CALNEXIN HOMOLOG PRECURSOR.
MGERKGIPMALGLLAMILFFIASSSSHLVRASDDADDAIFYESFDEDFDGRWIVSDKEDY
NGVWKHAKSDGHDDYGLLVSEQARKYAIVKELAESVSLKDGTVVLQFETRLQNGLECGGA
YIKYLRPQESGWKPKEFDNESPYSIMFGPDKCGATNKVHFIFKHKNPKSGEYVEHHLKYP
PSVPSDKLTHVYTAILKPDNELQILIDGEEKKKANFLSSEDFEPPLIPSKTIPDPDDKKP
EDWDERAKIPDPSAVKPDDWDEDAPMEILDEEAEKPEGWLDDEPEEIDDPEATKPEDWDD
EEDGEWEAPKIENPKCEAAPGCGEWKRPTKRNPAYKGKWSAPYIDNPSYKGIWKPREIPN
PEYFELAKPDFEPIAAIGIEIWTMQDGILFDNVLIANDDKVAESYRETTWKPKFTVEKDK
LKAEEEAATGSDGISGFQKKVFDLLYKIADIPFLSEHKSKIFDLIEKAEKQPNLTIGILV
AVVVVFVSIFFRLIFGGKKPAKVEKKPERTEASNNQGSGENEENKEKEKQKEEASNAARR
RPRRET
>P07519; 30 SERINE CARBOXYPEPTIDASE I PRECURSOR (EC 3.4.16.5) (CARBO
MARCRRRSGCTAGAALLLLLALALSGGGGAAPQGAEVTGLPGFDGALPSKHYAGYVTVDE
GHGRNLFYYVVESERDPGKDPVVLWLNGGPGCSSFDGFVYEHGPFNFESGGSVKSLPKLH
LNPYAWSKVSTMIYLDSPAGVGLSYSKNVSDYETGDLKTATDSHTFLLKWFQLYPEFLSN
PFYIAGESYAGVYVPTLSHEVVKGIQGGAKPTINFKGYMVGNGVCDTIFDGNALVPFAHG
MGLISDEIYQQASTSCHGNYWNATDGKCDTAISKIESLISGLNIYDILEPCYHSRSIKEV
NLQNSKLPQSFKDLGTTNKPFPVRTRMLGRAWPLRAPVKAGRVPSWQEVASGVPCMSDEV
ATAWLDNAAVRSAIHAQSVSAIGPWLLCTDKLYFVHDAGSMIAYHKNLTSQGYRAIIFSG
DHDMCVPFTGSEAWTKSLGYGVVDSWRPWITNGQVSGYTEGYEHGLTFATIKGAGHTVPE
YKPQEAFAFYSRWLAGSKL
>P37890; 25 SERINE CARBOXYPEPTIDASE I PRECURSOR (EC 3.4.16.5) (CARBO
MARRGRRSLASPAVAIALFVFLAYGGGGGGGGVCEAAPASAVVKSVPGFDGALPSKHYAG
YVTVEEQHGRNLFYYLVESERDPAKDPLVLWLNGGPGCSSFDGFVYEHGPFNFESGGSAK
SLPKLHLNPYSWSKVSSVIYLDSPAGVGLSYSKNTSDYNTGDLKTAADSHTFLLKWFQLY
PEFLSNPFYIAGESYAGVYVPTLSHEVVKGLHDGVKPTINFKGYMVGNGVCDTVFDGNAL
VPFAHGMALISDDIYQEAQTACHGNYWNTTTDKCENALYKVDTSINDLNIYDILEPCYHS
KTIKKVTPANTKLPKSFQHLGTTTKPLAVRTRMHGRAWPLRAPVRAGRVPSWQEFARGSR
PSGVPCMSDEVATAWLNNDDVRAAIHAQPVSSIGSWLICTNVLDFIHDAGSMISYHKNLT
GQGYRAFIYSGDHDMCVPYTGTEAWTRSLGYGVIDSWRPWHLNGQVSGYTQGYEHGLTFA
TIKGAGHTVPEYKPQESLAFYSRWLAGSKL
>P37891; 21 SERINE CARBOXYPEPTIDASE III PRECURSOR (EC 3.4.16.5).
MATARVSLILLVVVLAASACAEGLRLPRDAKFPAAQAERLIRSLNLLPKEAGPTGAGDVP
SVAPGELLERRVTLPGLPQGVGDLGHHAGYYRLPNTHDARMFYFLFESRGKKEDPVVIWL
TGGPGCSSELAVFYENGPFTISNNMSLAWNKFGWDTISNIIFVDQPTGTGFSYSSDDRDT
RHDETGVSNDLYSFLQVFFKKHPEFAKNDFFITGESYAGHYIPAFASRVHQGNKANEGIH
INLKGFAIGNGLTDPAIQYKAYTDYALDMNLIKKSDYDRINKFIPPCEFAIKLCGTNGKA
SCMAAYMVCNSIFSSIMKLVGTKNYYDVRKECEGKLCYDFSNLEKFFGDKAVKEAIGVGD
LEFVSCSTTVYQAMLTDWMRNLEVGIPALLEDGINVLIYAGEYDLICNWLGNSRWVHSME
WSGQKDFVSSHESPFVVDGAEAGVLKSHGPLSFLKVHNAGHMVPMDQPKASLEMLRRFTQ
GKLKEEWLAELPEQPMYAAM
>P11515; 21 SERINE CARBOXYPEPTIDASE III PRECURSOR (EC 3.4.16.5) (CP-
MATTPRLASLLLLLALCAAAAGALRLPPDASFPGAQAERLIRALNLLPGRPRRGLGAGAE
DVAPGQLLERRVTLPGLPEGVGDLGHHAGYYRLPNTHDARMFYFFFESRGKKEDPVVIWL
TGGPGCSSELAVFYENGPFTIANNMSLVWNKFGWDKISNIIFVDPATGTGFSYSSDDRDT
RHDEAGVSNDLYDFLQVFFKKHPEFVKNDFFITGESYAGHYIPAFASRVHQGNKKNEGTH
INLKGFAIGNGLTDPAIQYKAYTDYALDMNLIQKADYDRINKFIPPCEFAIKLCGTDGKA
SCMAAYMVCNSIFNSIMKLVGTKNYYDVRKECEGKLCYDFSNLEKFFGDKAVRQAIGVGD
IEFVSCSTSVYQAMLTDWMRNLEVGIPALLEDGINVLIYAGEYDLICNWLGNSRWVHSME
WSGQKDFAKTAESSFLVDDAQAGVLKSHGALSFLKVHNAGHMVPMDQPKAALEMLRRFTQ
GKLKESVPEEEPATTFYAAI
>P32826; 22 SERINE CARBOXYPEPTIDASE PRECURSOR (EC 3.4.16.-).
MEKLTFLSLLLHFVVFIASTIPSSSFLLNDRTFERSNLPSTRAEKLIRELNLFPQQDLNV
IDVADLPLTAAEGPGIVERKFVFPNILADGGPTVDDLGHHAGYYKLPKSRGASMFYFFFE
SRNKKDAPVVIWLTGGPGCSSELAVFYENGPFKITSNMSLAWNEYGWDQVSNLLYVDQPV
GTGFSYTTDKSDIRHDETGVSNDLYDFLQAFFAEHPKLAKNDFYITGESYAGHYIPAFAS
RVHKGNKANEGVHINLKGFAIGNGLTDPALQYPAYPDYALEMGLITQKEHDRLEKIVPLC
ELSIKLCGTDGTTSCLASYLVCNSLFSGVMSHAGGVNYYDIRKKCVGSLCYDFSNMEKFL
NLQSVRKSLGVGDIDFVSCSTSVYQAMLVDWMRNLEVGIPTLLEDGISLLVYAGEYDLIC
NWLGNSRWVNAMEWSGKTNFGAAKEVPFIVDGKEAGLLKTYEQLSFLKVRDAGHMVPMDQ
PKAALKMLKRWMENSLIEDATVTVAAQGGEELVAADVITSSFALHENKRQQIIKQCVSN
>P11955; 19 26 KD ENDOCHITINASE 1 PRECURSOR (EC 3.2.1.14).
MRAFVLFAVVAMAATMAVAEQCGSQAGGATCPNCLCCSRFGWCGSTPYCGDGCQSQCSGC
GGGSTPVTPTPSGGGGVSSIVSRALFDRMLLHRNDGACQAKGFYTYDAFVAAASAFRGFG
TTGGTDTRKREVAAFLAQTSHETTGGWATAPDGAFAWGYCFKQERGATSNYCTPSAQWPC
APGKSYYGRGPIQLSHNYNYGPAGRAIGVDLLRNPDLVATDPTVSFKTAMWFWMTAQAPK
PSSHAVITGQWSPSGTDRAAGRVPGFGVITNIVNGGIECGHGQDSRVADRIGFYKRYCDI
LGVGYGNNLDCYSQRPFA
>P24626; 18 BASIC ENDOCHITINASE 1 PRECURSOR (EC 3.2.1.14).
MRALALAVVAMAVVAVRGEQCGSQAGGALCPNCLCCSQYGWCGSTSDYCGAGCQSQCSGG
CGGGPTPPSSGGGSGVASIISPSLFDQMLLHRNDQACRAKGFYTYDAFVAAANAYPDFAT
TRDADTCKREVAAFLAQTSHETTGGWPTAPDGPYSWGYCFKEENNGNAPTYCEPKPEWPC
AAAKKYYGRGPIQITYNYNYGRGAGIGSDLLNNPDLVASDAVSFKTAFWFWMTPQSPKPS
CHAVITGQWTPSADDQAAGRVPGYGEITNIINGGVECGHGADDKVADRIGFYKRYCDMLG
VSYGDNLDCYNQRPYPPS
>P25765; 21 BASIC ENDOCHITINASE 2 PRECURSOR (EC 3.2.1.14).
MRALAVVAMVARPFLAAAVHAEQCGSQAGGAVCPNCLCCSQFGWCGSTSDYCGAGCQSQC
SRLRRRRPDASGGGGSGVASIVSRSLFDLMLLHRNDAACPASNFYTYDAFVAAASAFPGF
AAAGDADTNKREVAAFLAQTSHETTGGWATAPDGPYTWGYCFKEENGGAGPDYCQQSAQW
PCAAGKKYYGRGPIQLSYNFNYGPAGQAIGADLLGDPDLVASDATVSFDTAFWFWMTPQS
PKPSCNAVATGQWTPSADDQRAGRVPGYGVITNIINGGLECGHGEDDRIADRIGFYKRYC
DILGVSYGANLDCYSQRPSAPPKLRLPSFHTVINNH
>P27054; 23 ENDOCHITINASE PR4 PRECURSOR (EC 3.2.1.14).
MGNKLVLVLVAVALVMGPKNVSAQNCGCAEGLCCSQYGYCGTGEDYCGTGCQQGPCTTAS
PPPSNNVNADILTADFLNGIIDQADSGCAGKNFYTRDAFLSALNSYTDFGRVGSEDDSKR
EIAAAFAHFTHETGHFCYIEEIDGASKDYCDEESIAQYPCSSSKGYHGRGPIQLSWNFNY
GPAGSANNFDGLGAPETVSNDVVVSFKTALWYWMQHVRPVINQGFGATIRAINGALECDG
ANPTTVQARVNYYTEYCRQLGVATGDNLTC
>P36908; 22 ACIDIC ENDOCHITINASE PRECURSOR (EC 3.2.1.14).
MEKCFNIIPSLLLISLLIKSSNAAGIAVYWGQNGNEGSLQDACNTNNYQFVNIAFLSTFG
NGQNPQINLAGHCDPSTNGCTKFSPEIQACQAKGIKVLLSLGGGAGSYSLNSAEEATTLA
NYLWNNFLGGTSTSRPLGDAVLDGIDFDIESGGQHYDELAKALNGFSQQKVYLSAAPQCP
YPDAHLDSAIQTGLFDYVWVQFYNNPQCQYSNGNINNLVNAWNQWTSSQAKQVFLGVPAS
DAAAPSGGLIPADVLTSQVLPAIKTSPKYGGVMIWDRFNDAQSGYSNAIKGSV
>P51614; 25 ACIDIC CHITINASE PRECURSOR (EC 3.2.1.14).
MARTPQSTPLLISLSVLALLQTSYAGGIAIYWGQNGNEGTLTQTCNTGKYSYVNIAFLNK
FGNGQTPEINLAGHCNPASNGCTSVSTGIRNCQNRGIKVMLSIGGGAGSYSLSSSNDAQN
VANYLWNNFLGGQSSSRPLGDAVLDGIDFDIELGSTLHWDDLARALSRIEFQQERGRKVY
LTAAPQCPFPDKVPGTALNTGLFDYVWVQFYNNPPCQYSSGNTNNLLNSWNRWTSSINST
GSFMGLPASSAAAGRGFIPANVLTSQILPVIKRSPKYGGVMLWSKYYDDQSGYSSSIKSS
V
>P52711; 20 SERINE CARBOXYPEPTIDASE II-3 PRECURSOR (EC 3.4.16.6) (CP
MKCTVVALVLLVAVQCLVLGAGPAAAAKARRTRQGDYLNRLRGSPSSRASWESLAAVEEQ
TTTKAAGRPAPVAAAVEAGRKEADRVEALPGHPRGVDFAQYAGYVTVDAAAGRALFYYLA
EAVGGNGDKTKPLLLWLNGGPGCSSLGYGAMEELGPFRVMSDGKTLYSNPYSWNHAANVL
FLESPAGVGYSYSNTTADYGRSGDNGTAEDAYQFLDNWLERFPEYKGREFYITGESYAGH
YVPQLAHAILRHASPDINLKGIMIGNAVINDWTDSKGMYDFFWTHALISDETADGISKNC
NFTAYGAGVASNALCDAASDEVGESLADIDIYNIYAPNCQSEKLVTPPIAPSIDNFDPCT
DYYVEAYLNRPDVQKALHANVTRLDHPWSACSDVLTRWVDSAKTVLPIIQELMKNSIRVW
VYSGDTDGRVPVTSSRLSVNQLQLPVAAKWRPWFSSTKGAGEVGGYIVQYKGDLSLVTVR
GAGHEVPSYQPRRALVLVQNFLAGKALPDCKECEQD
>P47925; 21 PUTATIVE CELL WALL PROTEIN PRECURSOR.
MASSLITSAVIVVVLSLVLGSVEQVSGLRHVPKSPKITDVKHPDFLVTIEPKPTILIPGV
GRFLLPPKCKKPFYPYNPVTGAPLTGGGIPSYNGGQGAGPHTQLPGGDDTLVPNPGFEEP
TPTIGAGTGSNGQVPPVPLP
>Q10716; 18 CYSTEINE PROTEINASE 1 PRECURSOR (EC 3.4.22.-).
MAHRVLLLLSLASAAAVAAAVDAEDPLIRQVVPGGDDNDLELNAESHFLSFVQRFGKSYK
DADEHAYRLSVFKDNLRRARRHQLLDPSAEHGVTKFSDLTPAEFRRTYLGLRKSRRALLR
ELGESAHEAPVLPTDGLPDDFDWRDHGAVGPVKNQGSCGSCWSFSASGALEGAHYLATGK
LEVLSEQQFVDCDHECDSSEPDSCDSGCNGGLMTTAFSYLQKAGGLESEKDYPYTGSDGK
CKFDKSKIVASVQNFSVVSVDEAQISANLIKHGPLAIGINAAYMQTYIGGVSCPYICGRH
LDHGVLLVGYGASGFAPIRLKDKPYWIIKNSWGENWGENGYYKICRGSNVRNKCGVDSMV
STVSAVHASKE
>P25250; 28 CYSTEINE PROTEINASE EP-B 4 PRECURSOR (EC 3.4.22.-).
MGLLSKKLLVASMVAAVLAVAAVELCSAIPMEDKDLESEEALWDLYERWQSAHRVRRHHA
EKHRRFGTFKSNAHFIHSHNKRGDHPYRLHLNRFGDMDQAEFRATFVGDLRRDTPSKPPS
VPGFMYAALNVSDLPPSVDWRQKGAVTGVKDQGKCGSCWAFSTVVSVEGINAIRTGSLVS
LSEQELIDCDTADNDGCQGGLMDNAFEYIKNNGGLITEAAYPYRAARGTCNVARAAQNSP
VVVHIDGHQDVPANSEEDLARAVANQPVSVAVEASGKAFMFYSEGVFTGECGTELDHGVA
VVGYGVAEDGKAYWTVKNSWGPSWGEQGYIRVEKDSGASGGLCGIAMEASYPVKTYSKPK
PTPRRALGARESL
>Q10717; 19 CYSTEINE PROTEINASE 2 PRECURSOR (EC 3.4.22.-).
MVPRRLFVLAVVVLADTAAVVNSGFADSNPIRPVTDRAASALESTVFAALGRTRDALRFA
RFAVRYGKSYESAAEVHKRFRIFSESLQLVRSTNRKGLSYRLGINRFADMSWEEFRATRL
GAAQNCSATLTGNHRMRAAAVALPETKDWREDGIVSPVKNQGHCGSCWTFSTTGALEAAY
TQATGKPISLSEQQLVDCGFAFNNFGCNGGLPSQAFEYIKYNGGLDTEESYPYQGVNGIC
KFKNENVGVKVLDSVNITLGAEDELKDAVGLVRPVSVAFEVITGFRLYKSGVYTSDHCGT
TPMDVNHAVLAVGYGVEDGVPYWLIKNSWGADWGDEGYFKMEMGKNMCGVATCASYPIVA
>Q40143; 16 CYSTEINE PROTEINASE 3 PRECURSOR (EC 3.4.22.-).
MSRLSLVLILVAGLFATALAGPATFADKNPIRQVVFPDELENGILQVVGQTRSALSFARF
AIRHRKRYDSVEEIKQRFEIFLDNLKMIRSHNRKGLSYKLGINEFTDLTWDEFRKHKLGA
SQNCSATTKGNLKLTNVVLPETKDWRKDGIVSPVKAQGKCGSCWTFSTTGALEAAYAQAF
GKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKFNGGLDTEEAYPYTGKNGICKFSQ
ANIGVKVISSVNITLGAEYELKYAVALVRPVSVAFEVVKGFKQYKSGVYASTECGDTPMD
VNHAVLAVGYGVENGTPYWLIKNSWGADWGEDGYFKMEMGKNMCGVATCASYPIVA
>P43156; 20 THIOL PROTEASE SEN102 PRECURSOR (EC 3.4.22.-).
MAKPKFIALALVALSFLSIAQSIPFTEKDLASEDSLWNLYEKWRTHHTVARDLDEKNRRF
NVFKENVKFIHEFNQKKDAPYKLALNKFGDMTNQEFRSKYAGSKIQHHRSQRGIQKNTGS
FMYENVGSLPAASIDWRAKGAVTGVKDQGQCGSCWAFSTIASVEGINQIKTGELVSLSEQ
ELVDCDTSYNEGCNGGLMDYAFEFIQKNGITTEDSYPYAEQDGTCASNLLNSPVVSIDGH
QDVPANNENALMQAVANQPISVSIEASGYGFQFYSEGVFTGRCGTELDHGVAIVGYGATR
DGTKYWIVKNSWGEEWGESGYIRMQRGISDKRGKCGIAMEASYPIKTSANPKNSSTRDEL
>P25804; 18 CYSTEINE PROTEINASE 15A PRECURSOR (EC 3.4.22.-) (TURGOR-
MDRRFLFALFLFAAVATAVTDDTNNDDFIIRQVVDNEEDHLLNAEHHFTSFKSKFSKSYA
TKEEHDYRFGVFKSNLIKAKLHQNRDPTAEHGITKFSDLTASEFRRQFLGLKKRLRLPAH
AQKAPILPTTNLPEDFDWREKGAVTPVKDQGSCGSCWAFSTTGALEGAHYLATGKLVSLS
EQQLVDCDHVCDPEQAGSCDSGCNGGLMNNAFEYLLESGGVVQEKDYAYTGRDGSCKFDK
SKVVASVSNFSVVTLDEDQIAANLVKNGPLAVAINAAWMQTYMSGVSCPYVCAKSRLDHG
VLLVGFGKGAYAPIRLKEKPYWIIKNSWGQNWGEQGYYKICRGRNVCGVDSMVSTVAAAQ
SNH
>P25803; 20 VIGNAIN PRECURSOR (EC 3.4.22.-) (BEAN ENDOPEPTIDASE) (CY
MATKKLLWVVLSFSLVLGVANSFDFHDKDLASEESLWDLYERWRSHHTVSRSLGEKHKRF
NVFKANLMHVHNTNKMDKPYKLKLNKFADMTNHEFRSTYAGSKVNHPRMFRGTPHENGAF
MYEKVVSVPPSVDWRKKGAVTDVKDQGQCGSCWAFSTVVAVEGINQIKTNKLVALSEQEL
VDCDKEENQGCNGGLMESAFEFIKQKGGITTESNYPYKAQEGTCDASKVNDLAVSIDGHE
NVPANDEDALLKAVANQPVSVAIDAGGSDFQFYSEGVFTGDCSTDLNHGVAIVGYGTTVD
GTNYWIVRNSWGPEWGEHGYIRMQRNISKKEGLCGIAMLPSYPIKNSSDNPTGSFSSPKD
EL
>Q01783; 27 DISEASE RESISTANCE RESPONSE PROTEIN 230 PRECURSOR.
MEKKSLACLSFLLLVLFVAQEIVVSEANTCENLAGSYKGVCFGGCDRHCRTQEGAISGRC
RDDFRCWCTKNC
>P22242; 26 DESSICATION-RELATED PROTEIN CLONE PCC13-62 PRECURSOR.
MAQQPTFASAALVSFFLALICSCSYAAWHHEKDDIPKSDVSLLEFPLNLELLEAEFFAWA
AFGKGIDELEPELAKGGPSPIGVQKANLSPFIRDIIAQFAYQEFGHVRAIQSSVEGFPRP
LLDLSAKSFATVMDSAFGKTLKPPFDPYANDINYLLACYVVPYVGLTGYVGANPKLESPV
SRKLVAGLLAVEAGQDAIIRALLYERATDKVEPYGITVAEFTNKISELRNKLGDKGVKDL
GLIVEPELGAEGKISGNVLAGDKNSLAFPRTPERCLGSCTAAAMRPSPAAFIPKAPTGKS
PSLIWRIRAFSIV
>Q03773; 32 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE PRECURSOR (EC 3.2.1.39)
MAKYHSSGKSSSMTAIAFLFILLITYTGTTDAQSGVCYGRLGNNLPTPQEVVALYNQANI
RRMRIYGPSPEVLEALRGSNIELLLDIPNDNLRNLASSQDNANKWVQDNIKNYANNVRFR
YVSVGNEVKPEHSFAQFLVPALENIQRAISNAGLGNQVKVSTAIDTGALAESFPPSKGSF
KSDYRGAYLDGVIRFLVNNNAPLMVNVYSYFAYTANPKDISLDYALFRSPSVVVQDGSLG
YRNLFDASVDAVYAALEKAGGGSLNIVVSESGWPSSGGTATSLDNARTYNTNLVRNVKQG
TPKRPGAPLETYVFAMFDENQKQPEFEKFWGLFSPITKQPKYSINFN
>P52408; 39 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE PRECURSOR (EC 3.2.1.39)
MTKSNSSSVGRLLSLISIVLLLGQLVVGSLATKQHTGAPIGVCNGMVGDDLPPQAEVVAL
YKTNNIPRMRLYDPNPAALEALRGSNIKLLLGVPNENLQYIALSQANANAWVQNNVRNYA
NVKFKYIAVGNEVKPSDSFAQFLVPAMRNIQEAISLAGLAKKIKVSTAIDTGVLGETFPP
SIGSFKSEYNALLYPIIRFLVSHQSPLLVNLYPYFAYSGNTQDIRLDYALFTAPSVVVQD
GNFGYRNLFDAMLDGVYAALEKAGGGSLKVVISETGWPSAAGTATTIDNARTFISNLIQH
VKEGTPRRPGRPIETYIFAMFDENRKTPELEKHWGLFSPTKQPKYQISFN
>P36401; 24 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE, ACIDIC ISOFORM PR-Q' P
MAHLIVTLLLLSVLTLATLDFTGAQAGVCYGRQGNGLPSPADVVSLCNRNNIRRMRIYDP
DQPTLEALRGSNIELMLGVPNPDLENVAASQANADTWVQNNVRNYGNVKFRYIAVGNEVS
PLNENSKYVPVLLNAMRNIQTAISGAGLGNQIKVSTAIETGLTTDTSPPSNGRFKDDVRQ
FIEPIINFLVTNRAPLLVNLYPYFAIANNADIKLEYALFTSSEVVVNDNGRGYRNLFDAI
LDATYSALEKASGSSLEIVVSESGWPSAGAGQLTSIDNARTYNNNLISHVKGGSPKRPSG
PIETYVFALFDEDQKDPEIEKHFGLFSANMQPKYQISFN
>P52398; 26 GLUCAN ENDO-1,3-BETA-GLUCOSIDASE, ACIDIC ISOFORM PRECURS
MCSIQIIGAQSIGVCYGKAANNLPSDQDVINLYNANGIRKLRIYYPDKNIFKALNGSNIE
IILGVPNQDLEALANSSIANGWVQDNIRSHFPYVKFKYISIGNKVSPTNNDQYSEFLLQA
MKNVYNALAAAGLQDMIKVSTVTYSGVLANTYPPERSIFREEFKSFINPIIQFLARNNLP
LLANVYPYFVHVSNTADVSLSYALFTQQGTNSAGYQNLFDAILDSMYFAVEKAGGPNVEI
IVSESGWPSEGSSAATIENAQTYYRNLINHVKSGAGTPKKPGKTIETYLFAMFDENDKIG
EITEKHFGLFSPDQRAKYQLNFNYLPIYILR
>P21745; 22 EMBRYONIC ABUNDANT PROTEIN PRECURSOR (CLONE USP LAMBDA V
MEFAHLTVLSLFCLAFVGITATSSGEDYWQSIWPNTPLPKTFSDLLIPSGKTNSLPIKSE
ELKQYSTLFFEHDLHPGKNFILGNTNSVGSIIRPFTKSRQGVTDSIWLANKEKQSLEDFC
YSPTAIAEHKHCVSSLKSMIDQVISHFGSTKIKAISSNFAPYQDQYVVEDVKKVGDNAVM
CHRLNFEKVVFNCHQVRDTTAYVVSLVASDGTKTKALTVCHHDTRGMNPELLYEALEVTP
GTVPVCHFIGNKAAAWVPNHTADNLCVM
>P35016; 20 ENDOPLASMIN HOMOLOG PRECURSOR (GRP94 HOMOLOG).
MRKWTVPSVLFLLCPSLSSSCQGRKIHANAEADSDAPVDPPKVEDKIGAVPNGLSTDSDV
AKREAESMSMRNLRSDAEKFEFQAEVSRLMDIIINSLYSNKDIFLRELISNASDALDKIR
FLALTDKEILGEGDTAKLEIQIKLDKEKKILSIRDRGIGMTKEDLIKNLGTIAKSGTSAF
VEKMQTSGDLNLIGQFGVGFYSVYLVPDYVEVISKHNDDKQYIWESKADGAFAISEDVWN
EPLGRGTEIRLHLRDEAQEYLDEFKLKELVKRYSEFINFPIYLWASKEVEVEVPAEEDDS
SDDEDNKSESSSSEEGEEEETEKEEDEKKPKTKKVKETTYEWELLNDMKAIWLRNPKDVT
DDEYTKFYHSLAKDFSEEKPLAWSHFTAEGDVEFKAFTLLPPKAPQDLYESYYNSNKSNL
KLYVRRVFISDEFDELLPKYLNFLKGLVDSDTLPLNVSREMLQQHSSLKTIKKKLIRKAL
DMIRKIADEDPDEANDKDKKEVEESTDNDEKKGQYAKFWNEFGKSIKLGIIEDAANRNRL
AKLLRFESTKSEGKLTSLDQYISRMKSGQKDIFYITGTSKEQLEKSPFLERLTKKNYEVI
LFTDPVDEYLMQYLMDYEDKKFQNVSKEGLKIGKDSKDKELKESFKELTKWWKGALASEN
VDDVKISNRLANTPCVVVTSKYGWSSNMERIMQSQTLSDASKQAYMRGKRVLEINPRHPI
IKELRERVVKDAEDESVKQTARLMYQTALMESGFMLNDPKEFASSIYDSVKSSLKISPDA
TVEEEDDTEEAEAESGTTESSAAEDAGAETLDLKDEL
>P38661; 28 PROBABLE PROTEIN DISULFIDE ISOMERASE P5 PRECURSOR (EC 5.
MKMEMHQIWSRIALASFAFAILFVSVSADDVVVLTEENFEKEVGHDKGALVEFYAPWCGH
CKKLAPEYEKLPNSFKKAKSVLIAKVDCDEHKSVCSKYGVSGYPTIQWFPKGSLEPKKFE
GPRTAESLAEFVNTEGGTNVKIATAPSHVVVLTPETFNEVVLDGTKDVLVEFYAPWCGHC
KSLAPIYEKVAAVFKSEDDVVIANLDADKYRDLAEKYDVSGFPTLKFFPKGNKAGEDYGG
GRDLDDFVAFINEKSGTSRDAKGQLTSEAGIVEDLDELVKEFVAANDEEKKAVFARIEEE
VKKLEGSASRYGKIYLKVSKKYLEKGSDYAKNEIQRLERLLEKSISPAKADELTLKKNIL
STYA
>P24152; 24 EXTENSIN PRECURSOR (PROLINE-RICH GLYCOPROTEIN).
MMGGKAALLLALVAVTLAVVEIQADAGYGYGGGYPTPTPKPPAKGPKPEKPPTKGHGHKP
EKPPKEHKPTPPTYTPSPKPTPPPATPKPTPPTYTPSPKPKSPVYPPPPKASTPPTYTPS
PKPPATKPPTYPTPKPPATKPPTPPVYTPSPKPPVTKPPTPKPTPPVYTPNPKPPVTKPP
THTPSPKPPTSKPTPPVYTPSPKPPKPSPPTYTPTPKPPATKPPTSTPTHPKPTPHTPYP
QAHPPTYKPAPKPSPPAPTPPTYTPPVSHTPSSPPPPPPPPYY
>Q08355; 28 EZY-1 PROTEIN PRECURSOR.
MQLSSSLRSARSAAASSGCALASRPVVACRRVTPSVTRPGPFTIATGPLLPASRSKAGGG
IRVFSSALYEFGQQLKEDLEHDLSRARVDAITNKTRIAELEQQRRILMAVGGMADDEPEL
KAALMQLEEILGVSFNELQLMLAETLADHPAKMDNLAAMAAVVGTGSDGGGDESGDRRTA
DAADADGDGDGGERAWLRFKADVRACLADLRNRKGGITLHRAIVKDMVSASSNPGARRSS
SSVDKMAREELDRLMPFLLDDFLDNMPGLKAAFTGKAEPGAEGDDGEDEEEGEAQGVGED
AVDSSSGGSGGGGVLSCTAWQQVLGRTVPASSPTLALVLARGYLAMAPRQYRALALVRMI
LPGKTGGGVDGALTRKEGLSLLKKLRPGISGLADKDKQWLEWVIARLAAEFAVQPAGDGH
EPEPKRPELPPTAVQREPPAEEQHKPTAGARDSPNM
>P46689; 23 GIBBERELLIN-REGULATED PROTEIN 1 PRECURSOR.
MAISKALIASLLISLLVLQLVQADVESSQKKNGYAKKIDCGSACVARCRLSRRPRLCHRA
CGTCCYRCNCVPPGTYGNYDKCQCYASLTTHGGRRKCP
>P46688; 18 GIBBERELLIN-REGULATED PROTEIN 2 PRECURSOR.
MAVFRSTLVLLLIIVCLTTYELHVHAADGAKVGEGVVKIDCGGRCKDRCSKSSRTKLCLR
ACNSCCSRCNCVPPGTSGNTHLCPCYASITTHGGRLKCP
>P26759; 23 GERMIN GF-3.8 PRECURSOR.
MGYSKNIASGMFAMLLLASAVLSSNPHPLQDFCVADLDGKAVSVNGHMCKPMSEAGDDFL
FSSKLAKAGNTSTPNGSAVTDLNVAEWPGTNTLGVSMNRVDFAPGGTNPPHIHPRATEIG
IVMKGELLVGILGSLDSGNKLYSRVVRAGETFLIPRGLMHFQFNVGKTEASMVVFFNSQS
PSVVFVPLTLFGSNPPIPKPVLTKALRVEAGVVELLKSKFAGGS
>P29835; 22 19 KD GLOBULIN PRECURSOR (ALPHA-GLOBULIN).
MASKVVFFAAALMAAMVAISGAHVSESEMRFRDRQCQREVQDSPLDACRQVLDRQLTGRE
RFQPMFRRPGALGLRMQCCQQLQDVSRECRCAAIRRMVRSYEESMPMPLEQGWSSSSSEY
YGGEGSSSEQGYYGEGSSEEGYYGEQQQQPGMTRVRLTRARQYAAQLPSMCRVEPQQCSI
FAAGQY
>P31178; 28 AUTOLYSIN PRECURSOR (EC 3.4.24.38) (GAMETE LYTIC ENZYME)
MSLATRRFGAAAALLVAACVLCTAPAWAQNETTGTGMVKTKSAFRWIRPPPARPPPFRRP
PPAQTPYVHKVEYTELQILCPQTIDSVTGYPMDDPRCNVPRATVAAGEEALTIRNEFELL
NGDVLNVTLEEVDTPENPSRRRLLSIIREEQRTGRVLLATSAELPTPTFRLKSLKSILKG
SQKEIYAGKPIDLRTIVYIMDFSSCKLSGWSAPATLTPEKVTSDMLRGASAPTNNLANYY
GACSYEKTLFNPDNFLVLGPVPVPCIGGVTPPPRPPRPPRPPPRAGSTISSLSRRNDTYD
DWWDLSKYCTASEQQAWERAAEAYAQAIVAQDPNSATGKKLQGILQWRERRRNIYILPPG
VKCSWSGYADVTCTSATCSAYVRGYSDTNAMQVIMHEAMHNYGLEHAGRGTLEYGDATDV
MGDFNKAGKGLLCPNAPNMYRIGWAKPINEPGVAPFQNATGAWGNLTAANFTTDPWIRGL
VIPAQGTRDDNMIVVNVGAQSTRDGAMKATGAQAYYFSYRIKNTTAGGYDSGLTLDFHKK
VLVHAYNGIQSERVFGFKSNLLDWGPNFQSRSNTWTSPFLAYNNGLGGGVRLVVQSTSDT
QAVVDICRISENGKELSCDDGIDNDCDGLQDNEDPDCQ
>Q03684; 25 78 KD GLUCOSE REGULATED PROTEIN HOMOLOG 4 PRECURSOR (GRP
MAGGAWNRRTSLIVFGIVLFGCLFAFSIATEEATKLGTVIGIDLGTTYSCVGVYKNGHVE
IIANDQGNRITPSWVAFTDGERLIGEAAKNLAAVNPERTVFDVKRLIGRKFDDKEVQRDM
KLVPYKIVNKDGKPYIQVKIKDGETKIFSPEEISAMILTKMKETAEAYLGKKIKDAVVTV
PAYFNDAQRQATKDAGVIAGLNVARIINEPTAAAIAYGLDKKGGEKNILVFDLGGGTFDV
SILTIDNGVFEVLSTNGDTHLGGEDFDQRIMEYFIKLIKKKHGKDISKDNRALGKLRREA
ERAKRALSSQHQVRVEIESLFDGVDFSEPLTRARFEELNNDLFRKTMGPVKKAMDDAGLE
KTQIDEIVLVGGSTRIPKVQQLLKDYFDGKEPNKGVNPDEAVAYGAAVQGGILSGEGGDE
TKDILLLDVAPLTLGIETVGGVMTKLIPRNTVIPTKKSQVFTTYQDQQTTVTIQVFEGER
SLTKDCRLLGKFDLTGIAPAPRGTPQIEVTFEVDANGILNVKAEDKASGKSEKITITNDK
GRLSQEEIERMVKEAEEFAEEDKKVKERIDARNSLETYVYNMRNQINDKDKLADKLESDE
KEKIETATKEALEWLDDNQSAEKEDYEEKLKEVEAVCNPIITAVYQKSGGAPGGESGASE
DDDHDEL
>P10495; 30 GLYCINE-RICH CELL WALL STRUCTURAL PROTEIN 1.0 PRECURSOR 
MATSKVLLSNVLFVFVCFGICSAARTLLTLEDRVNLHVGTVVGGYGGGGGSGGGGGGAAV
ELGGGGYGEGAGGGEGAGAGYGAAGGGHGGGGGNGGGGGGGADGGGYGGGAGKGGGEGYG
GGGANGGGYGGGGGSGGGGGGGAGGAGSGYGGGEGSGAGGGYGGANGGGGGGNGGGGGGG
SGGAHGGGAAGGGEGAGQGAGGGYGGGAAGGGGRGSGGGGGGGYGGGGARGSGYGGGGGS
GEGGGHGGGYYP
>P37704; 25 GLYCINE-RICH PROTEIN DC7.1 PRECURSOR.
MGSKIFLLLGLSIAFALLISSEVAARDLSETTTEGASLDGGHHGGGGGGHYSGGGGHGGS
HHGGGGHGGCHHYCHGSCCSAAEAKALEAAQVKPQN
>P27483; 20 GLYCINE-RICH CELL WALL STRUCTURAL PROTEIN PRECURSOR.
MLVVVVIGVVECRRFEKETLGGGGGGGLGGGFGGGKGFGGGIGAGGGFGGGAGGGAGGGL
GGGAGGGGGIGGGAGGGAGGGLGGGAGGGLGGGHGGGIGGGAGGGAGGGLGGGHGGGIGG
GAGGGSGGGLGGGIGGGAGGGAGGGGGLGGGHGGGIGGGAGGGAGGGLGGGHGGGIGGGA
GGGSGGGLGGGIGGGAGGGAGGGGGAGGGGGLGGGHGGGFGGGAGGGLGGGAGGGTGGGF
GGGAGGGAGGGAGGGFGGGAGGGAGGGFGGGAGGGAGGGAGGGFGGGAGGGHGGGVGGGF
GGGSGGGFGGGAGGGAGGGAGGGFGGGGGAGGGFGGGF
>P22503; 23 ENDOGLUCANASE PRECURSOR (EC 3.2.1.4) (ENDO-1,4-BETA-GLUC
MGYHSVFIAVFLWSSMVCHNGLAMMDDGKLTSSSGPPNYDYADALAKAILFFEGQRSGKL
PSSQRVKWREDSALSDGKLQNVNLMGGYYDAGDNVKFGWPMAFSTSLLSWAAVEYESEIS
SVNQLGYLQSAIRWGADFMLRAHTSPTTLYTQVGDGNADHNCWERPEDMDTPRTVYKIDA
NSPGTEVAAEYAAALSAASIVFKKIDAKYSSTLLSHSKSLFDFADKNRGSYSGSCPFYCS
YSGYQDELLWAAAWLYKASGESKYLSYIISNQGWSQTVSEFSWDNKFVGAQTLLTEEFYG
GKKDLAKIKTDAESFICAVMPGSNSRQIKTTPGGLLFTRDSSNLQYTTSSTMVLFIFSRI
LNRNHINGINCGSSHFTASQIRGFAKTQVEYILGKNPMKMSYMVGFGSKYPKQLHHRGSS
IPSIKVHPAKVGCNAGLSDYYNSANPNPNTHVGAIVGGPDSNDRFNDARSDYSHAEPTTY
INAAFVASISALLAKT
>P12213; 24 POTENTIAL HEME-BINDING PROTEIN PRECURSOR (ORF 229).
MAKKKAFTPLFYLASIVFLPWWISFSVNKCLESWVTNWWNTGQSEIFLNNIQEKSLLEKF
IELEELLFLDEMIKEYSETHLEEFGIGIHKETIQLIKIQNENRIHTILHFSTNIICFIIL
SGYSILGNEKLVILNSWAQEFLYNLSDTVKAFSILLLTDLCIGFHSPHGWELMIGSIYKD
FGFVHNDQIISGLVSTFPVILDTIFKYWIFRYLNRLSPSLVVIYHSMND
>P43082; 21 HEVEIN-LIKE PROTEIN PRECURSOR.
MKIRLSITIILLSYTVATVAGQQCGRQGGGRTCPGNICCSQYGYCGTTADYCSPTNNCQS
NCWGSGPSGPGESASNVRATYHFYNPAQNNWDLRAVSAYCSTWDADKPYAWRSKYGWTAF
CGPAGPRGQASCGKCLRVKNTRTNAAVTVRIVDQCSNGGLDLDVAMFNQIDTDGFGYQQG
HLIVDYQFVDCGNELIGQPDSRNMLVSAIDRV
>P19244; 28 22.7 KD CLASS IV HEAT SHOCK PROTEIN PRECURSOR.
MSLKPLNMLLVPFLLLILAADFPLKAKASLLPFIDSPNTLLSDLWSDRFPDPFRVLEQIP
YGVEKHEPSITLSHARVDWKETPEGHVIMVDVPGLKKDDIKIEVEENRVLRVSGERKKEE
DKKGDHWHRVERSYGKFWRQFKLPQNVDLDSVKAKMENGVLTLTLHKLSHDKIKGPRMVS
IVEEDDKPSKIVNDELK
>P30236; 20 22.0 KD CLASS IV HEAT SHOCK PROTEIN PRECURSOR.
MRLQQLNLFFLLLCVAKANGSLLPFMDPPITLLADLWSDRFPDPFRVLEHIPFGVDKDEA
SMAMSPARVDWKETPEGHVIMLDVPGLKREEIKVEVEENRVLRVSGERKKEEEKKGDHWH
RVERSYGKFWRQFRLPQNVDLDSVKAKLENGVLTLTLDKLSPGKIKGPRVVSIAGEDHQQ
GNLNNDGAKQEL
>P01055; 19 BOWMAN-BIRK TYPE PROTEINASE INHIBITOR PRECURSOR (BBI).
MVVLKVCLVLLFLVGGTTSANLRLSKLGLLMKSDHQHSNDDESSKPCCDQCACTKSNPPQ
CRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCKPSEDDKEN
>P49174; 28 BETA-FRUCTOFURANOSIDASE, CELL WALL ISOZYME PRECURSOR (EC
MGTRPRGVVLAPWAVVLVLVLALRLAGASHVIHRSLEAEAAPSVPASIVSPLLRTGYHFQ
PPMNWINDPNAPLYYKGWYHLFYQYNPKGAVWGNIVWAHSVSRDLINWVALEPAIYPSIP
SDKYGCWSGSATILEDGTPAILYTGIDRADINYQVQVLALPKDASDPLLREWEKPEEYNP
VATPAAGGINATQFRDPTTAWRHAGHWRMLVGSVRGARGMALVYRSRDFRKWTKAKHPLH
SAALTGMWECPDFFPVSGPGLQAGLDTSAPGTKYVLKSSLDLTRYDYYTIGSYDGGKDRY
YPDDPAGDYHHRRRYDYGNYYASKTFYDPVERRRVLLGWANESDSVPDDKAKGWAGIHAI
PRKIWLDPTGKQLLQWPIHEVEKLRGKAVSVDAKLVKPGDHFEVTGIATYQADVEVSFEL
ELEAGTSLLEKAEAFDPAYDDDAQKLCGVKGADARGGVGPFGLWVLASADLQERTAVFFR
VFRDGHGKPKVLMCTDPTKSSLSPDLYKPTFAGFVDADISSGKITLRSLIDRSVVESFGA
GGKTCILSRVYPSIAVGKDAHLYVFNNGEVDVTVSGLTAWEMKKPLMNGA
>O22866; 27 PUTATIVE TRYPSIN INHIBITOR T01O24.26 PRECURSOR.
MAMKSVSTLAVFAILFLVIVEMPEIKAQGSKCLKEYGGNVGFSYCAPRIFPSFCYRNCRK
NKGAKGGRCRSGGAGAGSMICLCDYCSDKP
>P34950; 21 TRYPSIN INHIBITOR II PRECURSOR (TGT-II).
MASVAESSGVVEVIELISDGGNDLPRKIMSGRHGGICPRILMPCKTDDDCMLDCRCLSNG
YCG
>P31862; 15 BOWMAN-BIRK TYPE WOUND INDUCED PROTEINASE INHIBITOR WIP1
MKSSPHLVLILCLQAALVMGVFAALAKENAMVESKAIDINPGQLKCCTNCNFSFSGLYTC
DDVKKDCDPVCKKCVVAVHASYSGNNKFRCTDTFLGMCGPKC
>P13447; 17 ANTHER SPECIFIC LAT52 PROTEIN PRECURSOR.
MAKAIVLLSALCILALANFAHCRPEVFDVEGKVYCDTCRVQFETKLSENLEGATVKLQCR
NISTEAETFSVEGVTDKDGKYKLTVNGDHENDICEVTVVKSPREDCKESVSGYEKARIEC
SDNVGIHNAVRFANPLFFMKAESVQGCKEALDELGLFPLEF
>P93535; 37 SEED LECTIN PRECURSOR (LECSJASG).
MATSNSRPHLLQTHKPFSVVLAISITFFLLLLNKVNSAEILSFSFPKFASNQEDLLLQGD
ALVSSKGELQLTTVENGVPIWNSTGRALYYAPVHIWDKSTGRVASFATSFSFVVKAPVAS
KSADGIAFFLAPPNNQIQGPGGGHLGLFHSSGYNSSYQIIAVDFDTHINAWDPNTRHIGI
DVNSINSTKTVTWGWQNGEVANVLISYQAATETLTVSLTYPSSQTSYILSAAVDLKSILP
EWVRVGFTAATGLTTQYVETHDVLSWSFTSTLETGDCGAKDDNVHLVSYAFI
>P02857; 21 LEGUMIN A PRECURSOR.
MAKLLALSLSFCFLLLGGCFALREQPQQNECQLERLDALEPDNRIESEGGLIETWNPNNK
QFRCAGVALSRATLQRNALRRPYYSNAPQEIFIQQGNGYFGMVFPGCPETFEEPQESEQG
EGRRYRDRHQKVNRFREGDIIAVPTGIVFWMYNDQDTPVIAVSLTDIRSSNNQLDQMPRR
FYLAGNHEQEFLQYQHQQGGKQEQENEGNNIFSGFKRDYLEDAFNVNRHIVDRLQGRNED
EEKGAIVKVKGGLSIISPPEKQARHQRGSRQEEDEDEEKQPRHQRGSRQEEEEDEDEERQ
PRHQRRRGEEEEEDKKERGGSQKGKSRRQGDNGLEETVCTAKLRLNIGPSSSPDIYNPEA
GRIKTVTSLDLPVLRWLKLSAEHGSLHKNAMFVPHYNLNANSIIYALKGRARLQVVNCNG
NTVFDGELEAGRALTVPQNYAVAAKSLSDRFSYVAFKTNDRAGIARLAGTSSVINNLPLD
VVAATFNLQRNEARQLKSNNPFKFLVPARESENRASA
>Q03200; 21 LIGHT REGULATED PROTEIN PRECURSOR.
MQTAASSVVGLSAVLPAAVKGRSLQIQAPRRVALRVRAAAAAVAVEAAEVDYSSNISVFP
MEACDLIGGEACNVQMYPEAKLSSSAAVAVSRAAAEEVDRDYLSYDEPTTVFPEEACDDL
GGEFCKAT
>P29136; 28 METALLOENDOPROTEINASE 1 PRECURSOR (EC 3.4.24.-) (SMEP1).
MTLRNHQELLVALATLYFLATSLPSVSAHGPYAWDGEATYKFTTYHPGQNYKGLSNVKNY
FHHLGYIPNAPHFDDNFDDTLVSAIKTYQKNYNLNVTGKFDINTLKQIMTPRCGVPDIII
NTNKTTSFGMISDYTFFKDMPRWQAGTTQLTYAFSPEPRLDDTFKSAIARAFSKWTPVVN
IAFQETTSYETANIKILFASKNHGDPYPFDGPGGILGHAFAPTDGRCHFDADEYWVASGD
VTKSPVTSAFDLESVAVHEIGHLLGLGHSSDLRAIMYPSIPPRTRKVNLAQDDIDGIRKL
YGINP
>P27759; 25 POLLEN ALLERGEN AMB A 1.1 PRECURSOR (ANTIGEN E) (ANTIGEN
MGIKHCCYILYFTLALVTLLQPVRSAEDLQEILPVNETRRLTTSGAYNIIDGCWRGKADW
AENRKALADCAQGFGKGTVGGKDGDIYTVTSELDDDVANPKEGTLRFGAAQNRPLWIIFE
RDMVIRLDKEMVVNSDKTIDGRGAKVEIINAGFTLNGVKNVIIHNINMHDVKVNPGGLIK
SNDGPAAPRAGSDGDAISISGSSQIWIDHCSLSKSVDGLVDAKLGTTRLTVSNSLFTQHQ
FVLLFGAGDENIEDRGMLATVAFNTFTDNVDQRMPRCRHGFFQVVNNNYDKWGSYAIGGS
ASPTILSQGNRFCAPDERSKKNVLGRHGEAAAESMKWNWRTNKDVLENGAIFVASGVDPV
LTPEQSAGMIPAEPGESALSLTSSAGVLSCQPGAPC
>P43175; 22 POLLEN ALLERGEN AMB P 5-B PRECURSOR (AMB P V-B).
MNNEKNVSFEFIGSTNEVDEIKVMACYAAGSICGEKRGYCSSDPGRYCPWQVVCYESRKI
CAKNAAKMRMNVTKNTI
>P22284; 28 POLLEN ALLERGEN KBG 31 PRECURSOR (POLLEN ALLERGEN POA P 
MDKANGAYKTALKAASAVAPAEKFPVFQATFDKNLKEGLSGPDAVGFAKKLDAFIQTSYL
STKAAEPKEKFDLFVLSLTEVLRFMAGAVKAPPASKFPAKPAPKVAAYTPAAPAGAAPKA
TTDEQKLIEKINVGFKAAVAAAAGVPAASKYKTFVATFGAASNKAFAEALSTEPKGAAVA
SSKAVLTSKLDAAYKLAYKSAEGATPEAKYDAYVATLSEALRIIAGTLEVHGVKPAAEEV
KAIPAGELQVIDKVDAAFKVAATAANAAPANDKFTVFEAAFNDAIKASTGGAYQSYKFIP
ALEAAVKQSYAATVATAPAVKYTVFETALKKAITAMSQAQKAAKPAAAVTGTATSAVGAA
TGAATAAAGGYKV
>P22285; 23 POLLEN ALLERGEN KBG 41 PRECURSOR (POLLEN ALLERGEN POA P 
MAVHQYTVALFLAVALVAGPAASYAADVGYGAPATLATPATPAAPAAGYTPAAPAGAAPK
ATTDEQKLIEKINAGFKAAVAAAAGVPAVDKYKTFVATFGTASNKAFAEALSTEPKGAAA
ASSNAVLTSKLDAAYKLAYKSAEGATPEAKYDAYVATLSEALRIIAGTLEVHAVKPAGEE
VKAIPAGELQVIDKVDAAFKVAATAANAAPANDKFTVFEAAFNDAIKASTGGAYQSYKFI
PALEAAVKQSYAATVATAPAVKYTVFETALKKAITAMSQAQKAAKPAAAVTATATGAVGA
ATGAVGAATGAATAAAGGYKTGAATPTAGGYKV
>Q40638; 23 MAJOR POLLEN ALLERGEN ORY S 1 PRECURSOR (ORY S I).
MASSSLLLACVVVAAMVSPSPAGHPKVPPGPNITTSYGDKWLEARPPGMVRPRVLAPKDN
GGACGYKDVDKAPFLGMNSCGNDPIFKDGKGCGSCFEIKCSKPEACSDKPALIHVTDMND
EPIAAYHFDLSGLAMAKDGKDEELRKAGIIDTQFRRVKCKYPADTKITFHIEKASNPNYL
ALLVKYVAGDGDVVEVEIKEKGSEEWKALKESWGAIWRIDTPKPLKGPFSVRVTTEGARR
SSAEDAIPDPGRRQRVQVNVQAK
>P43214; 26 POLLEN ALLERGEN PHL P 2 PRECURSOR (PHL P II).
MSMASSSSSSLLAMAVLAALFAGAWCVPKVTFTVEKGSNEKHLAVLVKYEGDTMAEVELR
EHGSDEWVAMTKGEGGVWTFDSEEPLQGPFNFRFLTEKGMKNVFDDVVPEKYTIGATYAP
EE
>P43215; 22 POLLEN ALLERGEN PHL P 6 PRECURSOR (PHL P VI).
MVAMFLAVAVVLGLATSPTAEGGKATTEEQKLIEDVNASFRAAMATTANVPPADKYKTFE
AAFTVSSKRNLADAVSKAPQLVPKLDEVYNAAYNAADHAAPEDKYEAFVLHFSEALRIIA
GTPEVHAVKPGA
>Q02917; 26 EARLY NODULIN 55-2 PRECURSOR (N-55-2) (NODULIN-315).
MASCLPNASPFLVMLAMCLLISTSEAEKYVVGGSEKSWKFPLSKPDSLSHWANSHRFKIG
DTLIFKYEKRTESVHEGNETDYEGCNTVGKYHIVFNGGNTKVMLTKPGFRHFISGNQSHC
QMGLKLAVLVISSNKTKKNLLSPSPSPSPPPSSLLSPSPSPLPNNQGVTSSSGAGFIGVM
MWLMLLL
>Q43017; 26 NONSPECIFIC LIPID-TRANSFER PROTEIN 1 PRECURSOR (LTP 1).
MAYSAMTKLALVVALCMVVSVPIAQAITCGQVSSNLAPCIPYVRGGGAVPPACCNGIRNV
NNLARTTPDRQAACNCLKQLSASVPGVNPNNAAALPGKCGVNIPYQISPSTNCANVK
>Q43193; 20 NONSPECIFIC LIPID-TRANSFER PROTEIN 1 PRECURSOR (LTP 1).
MARLAVAIAVVAAVVVVLAATTSEAAISCGQVSSAIALCLSYARGQGFAPSAGCCSGVRS
LNSAARTTADRRAACNCLKNAARGISGLNAGNAASIPSKCGVSVPYTISTSTDCSRVS
>P27056; 23 NONSPECIFIC LIPID-TRANSFER PROTEIN 2 PRECURSOR (LTP 2).
MEMVSKIACFVLLCMVVVAPHAEALTCGQVTAGLAPCLPYLQGRGPLGGCCGGVKNLLGS
AKTTADRKTACTCLKSAANAIKGIDLNKAAGIPSVCKVNIPYKISPSTDCSTVQ
>Q43194; 23 NONSPECIFIC LIPID-TRANSFER PROTEIN 2 PRECURSOR (LTP 2).
MARSMKLAVAIAVVAAAAAVVLAATTSEAAVTCGQVSSAIGPCLSYARGQGSGPSAGCCS
GVRSLNSAARTTADRRAACNCLKNAARGIRGLNVGKAASIPSKCGVSIPYTISTSTDCSR
VS
>Q43019; 25 NONSPECIFIC LIPID-TRANSFER PROTEIN 3 PRECURSOR (LTP 3).
MASSGQLLKLVCLVAVMCCMAVGGPKAMAAVSCGQVVNNLTPCINYVANGGALNPSCCTG
VRSLYSLAQTTADRQSICNCLKQAVNGIPYTNANAGLAAGLPGKCGVNIPYKISPSTDCK
SIK
>Q42842; 25 NONSPECIFIC LIPID-TRANSFER PROTEIN 4.3 PRECURSOR (LTP 4.
MARAAATQLVLVAMVAAMLLVATDAAISCGQVSSALSPCISYARGNGAKPPVACCSGVKR
LAGAAQSTADKQAACKCIKSAAGGLNAGKAAGIPSMCGVSVPYAISASVDCSKIR
>P27631; 26 NONSPECIFIC LIPID-TRANSFER PROTEIN PRECURSOR (LTP) (EXTR
MGVLRSSFVAMMVMYMVLATTPNAEAVLTCGQVTGALAPCLGYLRSQVNVPVPLTCCNVV
RGLNNAARTTLDKRTACGCLKQTANAVTGLNLNAAAGLPARCGVNIPYKISPTTDCNRVV
>Q41073; 25 NONSPECIFIC LIPID-TRANSFER PROTEIN PRECURSOR (LTP).
MAVKKMVEAVFVVGLVVTMMNVWGAVPVEGAISCNQVVSAMTPCATYLIGNAATPAATCC
PSIRGLDSQVKATPDRQAVCNCLKTQAKSYGVKLGKAANLPGLCKVTDLNVPISPNVDCS
KVH
>Q40905; 36 PROBABLE NONSPECIFIC LIPID-TRANSFER PROTEIN 1 PRECURSOR 
MRTVSARSSVALVVIVAAVLVWTSSASVAPAPAPGSEETCGTVVGALMPCLPFVQGKEKE
PSKGCCSGAKRLDGETKTGPQRVHACECIQTAMKTYSDIDGKLVSEVPKHCGIVDSKLPP
IDVNMDCKTLGVLHYKGN
>P04144; 21 NODULIN 23 PRECURSOR (N-23).
MRVIVITVFLFIGAAIAEDVGIGLLSEAEAYVSPKLKKFITPCTSHVGETCSTTSSSGSE
ALMQNQGGLLFAFRFYGEMLGRPCAQLYQTSVTNLQVEPSEVFPRKNNPQGGRKSKLDDH
QVQPLSFRLPPFRLPPMPKLGPTSPIIRTIPSPPIAPRDLSLIETIQLRTALRTCTHVTA
RTCLTAPNVATSDLEACLTPSMNQCIYPRGAEYGSPPIRA
>P25226; 23 EARLY NODULIN 5 PRECURSOR (N-5).
MASSSSPIFLMIIFSMWLLFSYSESTEYLVRDSENSWKVNFPSRDALNRWVTRHQLTIHD
TIDVVDEDDCNTEIRSKLGGDFVVTKRPLVLPPLITLPLSPSPAPAPSLSGAAAGHGFIV
WLGASLPMLMFLIWL
>P25776; 21 ORYZAIN ALPHA CHAIN PRECURSOR (EC 3.4.22.-).
MRISMALAAAALLLLLSLAAADMSIVSYGERSEEEARRLYAEWKAEHGKSYNAVGEEERR
YAAFRDNLRYIDEHNAAADAGVHSFRLGLNRFADLTNEEYRDTYLGLRNKPRRERKVSDR
YLAADNEALPESVDWRTKGAVAEIKDQGGCGSCWAFSAIAAVEDINQIVTGDLISLSEQE
LVDCDTSYNEGCNGGLMDYAFDFIINNGGIDTEDDYPYKGKDERCDVNRKNAKVVTIDSY
EDVTPNSETSLQKAVRNQPVSVAIEAGGRAFQLYSSGIFTGKCGTALDHGVAAVGYGTEN
GKDYWIVRNSWGKSWGESGYVRMERNIKASSGKCGIAVEPSYPLKKGENPPNPGPTPPSP
TPPPTVCDNYYTCPDSTTCCCIYEYGKYCYAWGCCPLEGATCCDDHYSCCPHEYPICNVQ
QGTCLMAKDSPLAVKALKRTLAKPNLSFLFGNGKKSSA
>P25777; 21 ORYZAIN BETA CHAIN PRECURSOR (EC 3.4.22.-).
MAARAAAAAFLLLLIVVGHRASDMSIISYNAEHGARGLEEGPTEAEARAAYDLWLAENGG
GSPNALGGEHERRFLVFWDNLKFVDAHNARADEGGGFRLGMNRFADLTNEEFRATFLGAK
VAERSRAAGERYRHDGVEELPESVDWREKGAVAPVKNQGQCGSCWAFSAVSTVESINQLV
TGEMITLSEQELVECSTNGQNSGCNGGLMADAFDFIIKNGGIDTEDDYPYKAVDGKCDIN
RENAKVVSIDGFEDVPQNDEKSLQKAVAHQPVSVAIEAGGREFQLYHSGVFSGRCGTSLD
HGVVAVGYGTDNGKDYWIVRNSWGPKWGESGYVRMERNINVTTGKCGIAMMASYPTKSGA
NPPKPSPTPPTPPTPPPPSAPDHVCDDNFSCPAGSTCCCAFGFRNLCLVWGCCPVEGATC
CKDHASCCPPDYPVCNTRAGTCSASKNSPLSVKALKRTLAKLNTHELIDNM
>P25778; 24 ORYZAIN GAMMA CHAIN PRECURSOR (EC 3.4.22.-).
MAHRRIILLLAVAAVAATSAVAAASSGFDDSNPIRSVTDHAASALESTVIAALGRTRGAL
RFARFAVRHGKRYGDAAEVQRRFRIFSESLELVRSTNRRGLPYRLGINRFADMSWEEFQA
SRLGAAQNCSATLAGNHRMRDAPALPETKDWREDGIVSPVKDQGHCGSCWPFSTTGSLEA
RYTQATGPPVSLSEQQLADCATRYNNFGCSGGLPSQAFEYIKYNGGLDTEEAYPYTGVNG
ICHYKPENAGVKVLDSVNITLVAEDELKNAVGLVRPVSVAFQVINGFRMYKSGVYTSDHC
GTSPMDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDNGYFTMEMGKNMCGIATCASYPI
VA
>P50700; 22 OSMOTIN-LIKE PROTEIN OSM34 PRECURSOR.
MANLLVSTFIFSALLLISTATAATFEILNQCSYTVWAAASPGGGRRLDAGQSWRLDVAAG
TKMARIWGRTNCNFDSSGRGRCQTGDCSGGLQCTGWGQPPNTLAEYALNQFNNLDFYDIS
LVDGFNIPMEFSPTSSNCHRILCTADINGQCPNVLRAPGGCNNPCTVFQTNQYCCTNGQG
SCSDTVYSRFFKQRCPDAYSYPQDDPTSTFTCTNTNYRVVFCPRSRLGATGSHQLPIKMV
TEEN
>P14170; 21 OSMOTIN PRECURSOR.
MGNLRSSFVFFLLALVTYTYAATIEVRNNCPYTVWAASTPIGGGRRLDRGQTWVINAPRG
TKMARVWGRTNCNFNAAGRGTCQTGDCGGVLQCTGWGKPPNTLAEYALDQFSGLDFWDIS
LVDGFNIPMTFAPTNPSGGKCHAIHCTANINGECPRELRVPGGCNNPCTTFGGQQYCCTQ
GPCGPTFFSKFFKQRCPDAYSYPQDDPTSTFTCPGGSTNYRVIFCPNGQAHPNFPLEMPG
SDEVAK
>P22895; 23 P34 PROBABLE THIOL PROTEASE PRECURSOR (EC 3.4.22.-).
MGFLVLLLFSLLGLSSSSSISTHRSILDLDLTKFTTQKQVSSLFQLWKSEHGRVYHNHEE
EAKRLEIFKNNSNYIRDMNANRKSPHSHRLGLNKFADITPQEFSKKYLQAPKDVSQQIKM
ANKKMKKEQYSCDHPPASWDWRKKGVITQVKYQGGCGRGWAFSATGAIEAAHAIATGDLV
SLSEQELVDCVEESEGSYNGWQYQSFEWVLEHGGIATDDDYPYRAKEGRCKANKIQDKVT
IDGYETLIMSDESTESETEQAFLSAILEQPISVSIDAKDFHLYTGGIYDGENCTSPYGIN
HFVLLVGYGSADGVDYWIAKNSWGFDWGEDGYIWIQRNTGNLLGVCGMNYFASYPTKEES
ETLVSARVKGHRRVDHSPL
>P05994; 18 PAPAYA PROTEINASE IV PRECURSOR (EC 3.4.22.25) (PPIV) (PA
MAIICSFSKLLFVAICLFGHMSLSYCDFSIVGYSQDDLTSTERLIQLFNSWMLKHNKNYK
NVDEKLYRFEIFKDNLKYIDERNKMINGYWLGLNEFSDLSNDEFKEKYVGSLPEDYTNQP
YDEEFVNEDIVDLPESVDWRAKGAVTPVKHQGYCESCWAFSTVATVEGINKIKTGNLVEL
SEQELVDCDKQSYGCNRGYQSTSLQYVAQNGIHLRAKYPYIAKQQTCRANQVGGPKVKTN
GVGRVQSNNEGSLLNAIAHQPVSVVVESAGRDFQNYKGGIFEGSCGTKVDHAVTAVGYGK
SGGKGYILIKNSWGPGWGENGYIRIRRASGNSPGVCGVYRSSYYPIKN
>P15722; 22 PROBABLE PECTATE LYASE P59 PRECURSOR (EC 4.2.2.2).
MGGPKIKYSFLFLCITFATIIPSLMAHIGHYDEVWRRRAEEAKEYARNIYEPHPENVTLA
FNQKLRDTMKELKKVKGTHNNSTRRGLGTKKYTGPCMVTNPIDKCWRCDPNWADNRKKLA
DCAMGFGSKAIGGKDGEFYVVTDNSDDYNDPKPGTLRHAVIQKEPLWIIFKRGMNIRLHQ
EMIMQSDKTIDARGVNVHITKGAGITLQYIKNVIIHGLHIHDIVEGNGGMVRDAVDHIGI
RTKSDGDGISIFGASYIWIDHVSMQRCYDGLIDAVEGSTGITISNGHFTDHNEVMLFGAS
DSSSIDQVMQITLAFNHFGKRLIQRMPRCRWGYIHVVNNDYTHWNMYAIGGSMHPTIIHQ
GNRFIAPPDIFKKQVTKREYNPESVWMQWTWRSEGNLFMNGAYFTESGDPEWSSKHKDLY
DGISAAPAEDVTWMTRFAGVLGCKPGKPC
>P22195; 22 CATIONIC PEROXIDASE 1 PRECURSOR (EC 1.11.1.7).
MALPISKVDFLIFMCLIGLGSAQLSSNFYATKCPNALSTIKSAVNSCVAKEARMGASLLR
LHFHDCFVQGCDASVLLDDTSNFTGEKTAGPNANSIRGFEVIDTIKSQVESLCPGVVSCA
DILAVAARDSVVALGGASWNVLLGRRDSTTASLSSANSDLPAPFFNLSGLISAFSNKGFT
TKELVTLSGAHTIGQAQCTAFRTRIYNESNIDPTYAKSLQANCPSVGGDTNLSPFDVTTP
NKFDNAYYINLRNKKGLLHSDQQLFNGVSTDSQVTAYSNNAATFNTDFGNAMIKMGNLSP
LTGTSGQIRTNCRKTN
>P27337; 21 PEROXIDASE 1 PRECURSOR (EC 1.11.1.7).
MASSSYTSLLVLVALVTAASAQLSPTFYDTSCPRALATIKSGVMAAVTSDPRMGASLLRL
HFHDCFVQGCDASVLLSGMEQNAIPNAGSLRGFGVIDSIKTQIEAICKQTVSCADILTVA
ARDSVVALGGPSWTVPLGRRDSIDANENEANTDLPGFNSSRAELEAAFLKKGGLNTVDMV
ALSGAHTIGQAQCSTFRARIYGGDTNINAAYAASLRANCPQTVGSGDGSLANLDTTTANT
FDNAYYTNLMSQKGLLHSDQVLFNNDTTDNTVRNFASNPAAFSSSFTTAMIKMGNIAPKT
GTQGQIRLSCSRVNS
>P37834; 22 PEROXIDASE PRECURSOR (EC 1.11.1.7).
MASSRVILALLLAAAAVMASSAQLDEKFYSNSCPSVEAVVRKEMVRALGRAPSLAGPLLR
MHFHDCFVRGCDGSVLLDSAGNSTAEKDATPNQTLRGFGFVERVKAAVEKACPGTVSCAD
VLALMARDAVWLSKGPFWAVPLGRRDGRVSIANETDQLPPPTANFTELTQMFAAKNLDLK
DLVVLSAGHTIGTSHCFSFTDRLYNFTGLDNAHDIDPTLELQYMARLRSKCTSLQDNTTL
VEMDPGSFKTFDLGYFKNVAKRRGLFHSDGELLTNGFTRAYVQRHAGGGYKDEFFADFAA
SMVKMGGVEVLTGSQGEIRKKCNVVN
>P81131; 18 PERPHORIN I PRECURSOR.
MMRKALLALCVATAFAVAQAQNVAYPNFPYCQCIKSPSPYSLEPVVKSNRTGQYCFTLRV
TKPSPSATGYCATKADIKKIEINVNQVCDVFGNVVNATLNGVPTKVGPAFDTPPDGPNTS
RILRFTQLNLGLDSDGAMLCITLGQNDKGKGCTTLEDLCAPPAGAPKGTCSLALFDSKPD
CCPISRVSPPAPPPPPPPPPPEPVAVPITPPCKTCVYATITALPPLLFPFQLTPSICQSV
ADKIAGDLEMIVTSYSIGYSGATITCSGNVIKVCASFSLPPGAPYTGLQADISNALTFWL
SLLAPSTGCPAYFANHQVTVTVGGDGDPNSVTCLEGTATTTCKPGNPDFPKCECETKPAA
TRFAALPTLTQEPGRPSNRTNSTLYCFTLQVVAPLNPNGLCGNTTTLLKAELWGNDIPTQ
RRKILALAFKAAGASSPLRYLSPSWGSAGEQTLKVSGLNWDASQADGAKICMELSNDTNL
KTFCNTGQDTCWINLFSPDKQCCPLFAASLTP
>P22196; 23 CATIONIC PEROXIDASE 2 PRECURSOR (EC 1.11.1.7).
MEGVFNNKKFILVFVFMLGLCIGITTVHGQGTRVGFYSRTCPRAESIVRSTVRSHVNSDP
TLAAKILRMHFHDCFVQGCDGSILISGPATEKTAFANLGLRGYEIIDDAKTQLEAACPGV
VSCADILALAARDSVVLSGGLSWQVPTGRRDGRVSQASDVSNLPAPSDSVDVQKQKFAAK
GLNTQDLVTLVGGHTIGTSECQFFSNRLFNFNGTAAADPAIDPSFVSNLQALCPQNTGAA
NRVALDTGSQFKFDTSYFSNLRNRRGVLQSDQALWNDPSTKSFVQRYLGLRGFLGLTFNV
EFGKSMVKMSNIGVKTGTDGEIRKICSAFN
>P15004; 25 SUBERIZATION-ASSOCIATED ANIONIC PEROXIDASE 2 PRECURSOR (
MGFRLSLLSLAVSLVALALAGVAIYRNTYEAMIMNNGSLLQNISPDIDSLESGEVSILIL
NDKKKNSDKYLSQQLTQESCVFSAVKGVVDSAIDNETRMGASLIRLHFHDCFVDGCDGGI
LLDDINGTFTGEQNSPPNNNSVRGFEVIAQAKQSVVDSCPNISVSCADILAIAARDSLAK
LGGQTYTVALGRSDATTANFSGAINQLPAPSDNLTVQIQKFSDKNFTVREMVALAGAHTV
GFARCSTVCTSGNVNPAAQLQCNCSATLTDSDLQQLDTTPAVFDKVYYDNLNNNQGIMFS
DQVLTGNTTTAGFVTTYSNNVTVFLEDFAAAMIKMGNLPPSAGAQLEIRDVCSRVNPTSV
ASM
>P37835; 23 PEROXIDASE PRECURSOR (EC 1.11.1.7).
MASASSVSLMLLVAAAMASAASAQLSATFYDTSCPNALSTIKSAVTAAVNSEPRMGASLV
RLHFHDCFVQGCDASVLLSGQEQNAGPNAGSLRGFNVVDNIKTQVEAICSQTVSCADILA
VAARDSVVALGGPSWTVLLGRRDSTTANESQANTDLPAPSSSLAELIGNFSRKGLDVTDM
VALSGAHTIGQAQCQNFRDRLYNETNIDSSFATALKANCPRPTGSGDSNLAPLDTTTPNA
FDSAYYTNLLSNKGLLHSDQVLFNGGSTDNTVRNFSSNTAAFNSAFTAAMVKMGNISPLT
GTQGQIRLNCSKVN
>Q05091; 24 POLYGALACTURONASE INHIBITOR PRECURSOR (POLYGALACTURONASE
MELKFSTFLSLTLLFSSVLNPALSDLCNPDDKKVLLQIKKAFGDPYVLASWKSDTDCCDW
YCVTCDSTTNRINSLTIFAGQVSGQIPALVGDLPYLETLEFHKQPNLTGPIQPAIAKLKG
LKSLRLSWTNLSGSVPDFLSQLKNLTFLDLSFNNLTGAIPSSLSELPNLGALRLDRNKLT
GHIPISFGQFIGNVPDLYLSHNQLSGNIPTSFAQMDFTSIDLSRNKLEGDASVIFGLNKT
TQIVDLSRNLLEFNLSKVEFPTSLTSLDINHNKIYGSIPVEFTQLNFQFLNVSYNRLCGQ
IPVGGKLQSFDEYSYFHNRCLCGAPLPSCK
>P49062; 31 EXOPOLYGALACTURONASE CLONE GBGE184 PRECURSOR (EC 3.2.1.6
MANARSLVAKANNINVGSLILMALVFGSCVANGEYLGGRRGLAANSGNPTVYDITKFGAV
GDGSTNTFKAFLNTWIQVCDSPVPATLLVPKGTFLAGPVIFAGPCKSKVTVNVIGTIIAT
TSGYATPEWFLFERVDNLVLTGTGTFHGKGEAVWKADGCGKKVQCNLPPTSLKFRNMKNV
EINGISSVNAKAFHMFLVKTENVNIQNIKLTAPAESPNTDGIHLSNADNVSILDSTIATG
DDCVSVGRGSNNVTVERVICGPGHGLSVGSLGKYKNEEDVSGIHVNNCTMIETDNGLRIK
TWGGSDPSKAVDIKFENIIMQSVKNPIIIDQNYGSRGGDSQVAISDILFKNIRGTTITKD
VVQIMCSKSVPCQGVNVVDVNLDYVGKTGGEKKSSSGGLVGALCDNANVIFGGKLSFPMC
PK
>P49063; 23 EXOPOLYGALACTURONASE CLONE GBGA483 PRECURSOR (EC 3.2.1.6
MVGSHKASGVLLVLLVVMATTIANGTPVVDKAKNAATAVEDTAKNAATAVGGAAASVGAK
VSGAKPGAAVDVKASGAKGDGKTDDSAAFAAAWKEACAAGSTITVPKGEYMVESLEFKGP
CKGPVTLELNGNFKAPATVKTTKPHAGWIDFENIADFTLNGNKAIFDGQGSLAWKANDCA
KTGKCNSLPINIRFTGLTNSKINSITSTNSKLFHMNILNCKNITLSDIGIDAPPESLNTD
GIHIGRSNGVNLIGAKIKTGDDCVSIGDGTENLIVENVECGPGHGISIGSLGRYPNEQPV
KGVTVRKCLIKNTDNGVRIKTWPGSPPGIASNILFEDITMDNVSLPVLIDQEYCPYGHCK
AGVPSQVKLSDVTIKGIKGTSATKVAVKLMCSKGVPCTNIALSDINLVHNGKEGPAVSAC
SNIKPILSGKLVPAACTEVAKPGP
>Q39766; 26 POLYGALACTURONASE PRECURSOR (EC 3.2.1.15) (PG) (PECTINAS
MAPHLNIVPSMFVLLLLFISASKVQPDAFDVVAKFGAKADGKTDLSKPFLDAWKEACASV
TPSTVVIPKGTYLLSKVNLEGPCKAPIEINVQGTIQAPADPSAFKDPNWVRFYSVENFKM
FGGGIFDGQGSIAYEKNTCENREFRSKLPVNIRFDFVTNALIQDITSKDSKLFHINVFAC
KNITLERLKIEAPDESPNTDGIHMGKSEGVNIIASDIKTGDDCISIGDGTKNMVIKEITC
GPGHGISIGSLGKFQNEEPVEGIKISNCTITNTSNGARIKTWPGEHGGAVSEIHFEDITM
NNVSSPILIDQQYCPWNKCKKNEESKVKLSNISFKNIRGTSALPEAIKFICSGSSPCQNV
ELADIDIQHNGAEPATSQCLNVKPITIGKLNPIPCSGPVPKTPSATA
>P48978; 26 POLYGALACTURONASE PRECURSOR (EC 3.2.1.15) (PG) (PECTINAS
MALKTQLLWSFVVVFVVSFSTTSCSGSSFQEVNALHSYVDHVDDKESGYNSRAYPSYTDT
IEGLKVMELIRPRTQLFSSRKLNTITGGIATSSAPAKTISVDDFGAKGNGADDTQAFVKA
WKAACSSSGAMVLVVPQKNYLVRPIEFSGPCKSQLTLQIYGTIEASEDRSIYKDIDHWLI
FDNVQNLLVVGPGTINGNGNIWWKNSCKIKPQPPCGTYAPTAVTFNRCNNLVVKNLNIQD
AQQIHVIFQNCINVQASCLTVTAPEDSPNTDGIHVTNTQNITISSSVIGTGDDCISIVSG
SQRVQATDITCGPGHGISIGSLGEDGSEDHVSGVFVNGAKLSGTSNGLRIKTWKGGSGSA
TNIVFQNVQMNDVTNPIIIDQNYCDHKTKDCKQQKSAVQVKNVLYQNIRGTSASGDAITL
NCSQSVPCQGIVLQSVQLQNGRAECNNVQPAYKGVVSPRC
>Q40312; 20 POLYGALACTURONASE PRECURSOR (EC 3.2.1.15) (PG) (PECTINAS
MKFSTAIIVSFLFIADFCAAQSGVLDISKFGGKPNSDIGQALTSAWNEACASTTAAKIVI
PAGTYQLNGIELKGPCKAPIELQVDGTIQAPADPSVIKGTEQWFKFLYMDHLTLSGKGVF
DGQGATVYKKAAPASAWSGKNSNSKVFMNFGFNFVNNSIVRGVTSKDSKNFHVMVFGCKN
ITFDGFTITAPGDSPNTDGIHMGKSTDVKILNTNIGTGDDCVSIGDGSKQITVQGVNCGP
GHGLSVGSLGKFTTEENVEGITVKNCTLTATDNGVRIKTWPDAPGTITVSDIHFEDITMT
NVKNPVIIDQEYYPWNQCSKKNPSKIKLSKISFKNVKGTSGTAEGVVLICSSAVPCDGVE
LNNVDLKFNGAPTTAKCTNVKPLVTGTAPVCQAPGAPAASTTATPAASKTATPAAGKSPA
K
>P48979; 25 POLYGALACTURONASE PRECURSOR (EC 3.2.1.15) (PG) (PECTINAS
MANRRSLFSLSLIFVFMINSAIASPLTYNVASLGAKADGKTDSTKAFLSAWAKACASMNP
GVIYVPAGTFFLRDVVFSGPCKNNAITFRIAGTLVAPSDYRVIGNAANWIFFHHVNGVTI
SGGILDGQGTALWACKACHGESCPSGATTLGFSDSNNIVVSGLASLNSQMFHIVINDFQN
VQMQGVRVSRSGNSPNTDGIHVQMSSGVTILNSKIATGDDCVSIGPGTSNLWIEGVACGP
GHGISIGSLGKEQEEAGVQNVTVKTVTFSGTQNGLRIKSWGRPSTGFARNILFQHATMVN
VENPIVIDQHYCPDNKGCPGQVSGVQISDVTYEDIHGTSATEVAVKFDCSPKHPCREIKL
EDVKLTYKNQAAESSCSHADGTTEGVVQPTSCL
>Q00652; 22 PUTATIVE KUNITZ-TYPE INHIBITOR PRECURSOR.
MKSINILSFLLLSSTLSLVAFARSFSSENPIVLPSTCHDDDNLVLPEVYDQDGHPLRIGQ
RYIINNPLIGAGAVYLYNIGNLQCPNAVLQHMSIPQFLGEGTPVVFVRKSESDYGDVVRV
MTGVYIKFFVKTTKLCVDQTVWKVNHEGLVVTGGQVGNENDIFKIRKTDLVTPEGSKFVY
KLLHCPSHLQCKNIGGNFKNGYPRLVTVDDDKDFLPFVFIKA
>P41510; 22 PROBABLE PECTINESTERASE PRECURSOR (EC 3.1.1.11) (PECTIN
MAVGKIVISVASMLLVVGVAIGVVTFVNKGGGAGGDKTLNSHQKAVESLCASATDKGSCA
KTLDPVKSDDPSKLIKAFMLATKDAVTKSTNFTASTEEGMGKNINATSKAVLDYCKRVLM
YALEDLETIVEEMGEDLQQSGSKMDQLKQWLTGVFNYQTDCIDDIEESELRKVMGEGIAH
SKILSSNAIDIFHALTTAMSQMNVKVDDMKKGNLGETPAPDRDLLEDLDQKGLPKWHSDK
DRKLMAQAGRPGAPADEGIGEGGGGGGKIKPTHVVAKDGSGQFKTISEAVKACPEKNPGR
CIIYIKAGVYKEQVTIPKKVNNVFMFGDGATQTIITFDRSVGLSPGTTTSLSGTVQVESE
GFMAKWIGFQNTAGPLGHQAVAFRVNGDRAVIFNCRFDGYQDTLYVNNGRQFYRNIVVSG
TVDFIFGKSATVIQNSLILCRKGSPGQTNHVTADGNEKGKAVKIGIVLHNCRIMADKELE
ADRLTVKSYLGRPWKPFATTAVIGTEIGDLIQPTGWNEWQGEKFHLTATYVEFNNRGPGA
NTAARVPWAKMAKSAAEVERFTVANWLTPANWIQEANVPVQLGL
>P27061; 15 ACID PHOSPHATASE PRECURSOR 1 (EC 3.1.3.2).
MRIFVFLVLLTVAIGTENLNSHVFPRPLIIEYPEKQLRDELKCTTWRFVVETNNLSPWKT
IPEECADYVKEYMVGPGYKMEIDRVSDEAGEYAKSVDLGDDGRDVWIFDVDETLLSNLPY
YSDHRYGLEVFDDVEFDKWVENGTAPALGSSLKLYQEVLKLGFKVFLLTGRSERHRSVTV
ENLMNAGFHDWHKLILRGSDDHGKTATTYKSERRNAMVEEGFRIVGNSGDQWSDLLGSSM
SYRSFKLPNPMYYIL
>P32937; 20 PATHOGENESIS-RELATED PROTEIN 1A/1B PRECURSOR.
MSTSAVLFLLLAVFAAGASAATFNIKNNCGSTIWPAGIPVGGGFELGSGQTSSINVPAGT
QAGRIWARTGCSFNGGSGSCQTGDCGGQLSCSLSGQPPATLAEFTIGGGSTQDFYDISVI
DGFNLAMDFSCSTGDALQCRDPSCPPPQAYQHPNDVATHACSGNNNYQITFCP
>P33154; 26 PATHOGENESIS-RELATED PROTEIN 1 PRECURSOR (PR-1).
MNFTGYSRFLIVFVALVGALVLPSKAQDSPQDYLRVHNQARGAVGVGPMQWDERVAAYAR
SYAEQLRGNCRLIHSGGPYGENLAWGSGDLSGVSAVNMWVSEKANYNYAANTCNGVCGHY
TQVVWRKSVRLGCAKVRCNNGGTIISCNYDPRGNYVNEKPY
>Q40374; 23 PATHOGENESIS-RELATED PROTEIN PR-1 PRECURSOR.
MSFRCFSFALFLLLLTFISHVSASYIPNKKSFKSRSFKNQFLIPQNIARAAVGLRPLVWD
DKLTHYAQWYANQRRNDCALEHSNGPYGENIFWGSGVGWNPAQAVSAWVDEKQFYNYWHN
SCVDGEMCGHYTQVVWGSTTKVGCASVVCSDDKGTFMTCNYDPPGNYYGERPY
>P29063; 25 PATHOGENESIS-RELATED PROTEIN PR-4B PRECURSOR.
MERVNNYKLCVALLIMSVMMAMAAAQSATNVRSTYHLYNPQNINWDLRAASAFCATWDAD
KPLAWRQKYGWTAFCGPAGPRGQDSCGRCLRVTNTGTGTQATVRIVDQCSNGGLDLDVNV
FNQLDTNGLGYQQGHLIVNYEFVNCND
>Q00008; 27 PATHOGENESIS-RELATED PROTEIN PRMS PRECURSOR.
MEASNKLAVLLLWLVMAAATAVHPSYSENSPQDYLTPQNSARAAVGVGPVTWSTKLQQFA
EKYAAQRAGDCRLQHSGGPYGENIFWGSAGFDWKAVDAVRSWVDEKQWYNYATNSCAAGK
VCGHYTQVVWRATTSIGCARVVCRDNRGVFIICNYEPRGNIAGMKPY
>P18263; 9 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MTTLALVLAKLPEAYAPFAPIVDVLPVIPVFFILLAFVWQAAVSFR
>P14237; 8 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MLMSLFLAKLPAAYALFDPIVDILPIIPLFFLLLAFVWQAAIGFK
>P31481; 17 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MSFITLNNFFNTNTFFGLLPEQYAPFDPLIDVLPIIPVLFFLLAFVWQASVKFR
>P49513; 7 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MESLLLARLPEAYVVFSPIVDVLPIIPVFFLLLAFVWQAAIGFR
>P41598; 22 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MPVMFNIFLDDAFIHSNNPFFGKLPEAYAISDPIVDVMPIIPVLSFLLAFVWQAAVSFR
>P51317; 8 PHOTOSYSTEM II 4 KD REACTION CENTRE PROTEIN PRECURSOR.
MNSALFLAKLPEAYAVFKPIVDILPVIPVFFLLLAFVWQAAIGFR
>P33432; 19 PUROINDOLINE-A PRECURSOR.
MKALFLIGLLALVASTAFAQYSEVVGSYDVAGGGGAQQCPVETKLNSCRNYLLDRCSTMK
DFPVTWRWWKWWKGGCQELLGECCSRLGQMPPQCRCNIIQGSIQGDLGGIFGFQRDRASK
VIQEAKNLPPRCNQGPPCNIPGTIGYYW
>Q01882; 26 SEED ALLERGENIC PROTEIN RA14 PRECURSOR.
MASNKVVFSALLLIIVSVLAATTRMADHHKDQVVYSLGERCQPGMGYPMYSLPRCRAVVK
RQCVGTRSPGAVDEQLAQDCCRELAAVDDSWCRCSALNHMVGGIYRELGATDVGHPMAEV
FPGCRRGDLERAAASLPAFCNVDIPNGTGGVCYWLGYPRTPRTGH
>P43296; 23 CYSTEINE PROTEINASE RD19A PRECURSOR (EC 3.4.22.-).
MDRLKLYFSVFVLSFFIVSVSSSDVNDGDDLVIRQVVGGAEPQVLTSEDHFSLFKRKFGK
VYASNEEHDYRFSVFKANLRRARRHQKLDPSATHGVTQFSDLTRSEFRKKHLGVRSGFKL
PKDANKAPILPTENLPEDFDWRDHGAVTPVKNQGSCGSCWSFSATGALEGANFLATGKLV
SLSEQQLVDCDHECDPEEADSCDSGCNGGLMNSAFEYTLKTGGLMKEEDYPYTGKDGKTC
KLDKSKIVASVSNFSVISIDEEQIAANLVKNGPLAVAINAGYMQTYIGGVSCPYICTRRL
NHGVLLVGYGAAGYAPARFKEKPYWIIKNSWGETWGENGFYKICKGRNICGVDSMVSTVA
ATVSTTAH
>P43297; 21 CYSTEINE PROTEINASE RD21A PRECURSOR (EC 3.4.22.-).
MGFLKPTMAILFLAMVAVSSAVDMSIISYDEKHGVSTTGGRSEAEVMSIYEAWLVKHGKA
QSQNSLVEKDRRFEIFKDNLRFVDEHNEKNLSYRLGLTRFADLTNDEYRSKYLGAKMEKK
GERRTSLRYEARVGDELPESIDWRKKGAVAEVKDQGGCGSCWAFSTIGAVEGINQIVTGD
LITLSEQELVDCDTSYNEGCNGGLMDYAFEFIIKNGGIDTDKDYPYKGVDGTCDQIRKNA
KVVTIDSYEDVPTYSEESLKKAVAHQPISIAIEAGGRAFQLYDSGIFDGSCGTQLDHGVV
AVGYGTENGKDYWIVRNSWGKSWGESGYLRMARNIASSSGKCGIAIEPSYPIKNGENPPN
PGPSPPSPIKPPTQCDSYYTCPESNTCCCLFEYGKYCFAWGCCPLEAATCCDDNYSCCPH
EYPVCDLDQGTCLLSKNSPFSVKALKRKPATPFWSQGRKNIA
>Q41495; 19 STS14 PROTEIN PRECURSOR.
MFVLSTAMACLVYIYIYIYDEEKKRELKVRNKMTNLLFFQFLLLTTASSLTHISAQTVPP
PPPPPTSAATPPSRAAQEFLDAHNKARSEVGVGPLTWSPMLAKETSLLVRYQRDKQNCSF
ANLSNGKYGGNQLWASGTVVTPRMAVDSWVAEKKFYNYENNSCTGDDKCGVYTQIVWKKS
IELGCAQRTCYEGPATLTVCFYNPPGNVIGEKPY
>P32026; 25 FLOWER-SPECIFIC GAMMA-THIONIN PRECURSOR.
MARSLCFMAFAILAMMLFVAYEVQARECKTESNTFPGICITKPPCRKACISEKFTDGHCS
KLLRRCLCTKPCVFDEKMIKTGAETLVEEAKTLAAALLEEEIMDN
>P31110; 26 THAUMATIN-LIKE PROTEIN PRECURSOR.
MASPATSSAVLVVVLVATLAAGGANAATFTITNRCSFTVWPAATPVGGGVQLSPGQTWTI
NVPAGTSSGRVWGRTGCSFDGSGRGSCATGDCAGALSCTLSGQKPLTLAEFTIGGSQDFY
DLSVIDGYNVAMSFSCSSGVTVTCRDSRCPDAYLFPEDNTKTHACSGNSNYQVVFCP
>P49043; 20 VACUOLAR PROCESSING ENZYME PRECURSOR (EC 3.4.22.-) (VPE)
MTRLASGVLITLLVALAGIADGSRDIAGDILKLPSEAYRFFHNGGGGAKVNDDDDSVGTR
WAVLLAGSNGFWNYRHQADICHAYQLLRKGGLKDENIIVFMYDDIAFNEENPRPGVIINH
PHGDDVYKGVPKDYTGEDVTVEKFFAVVLGNKTALTGGSGKVVDSGPNDHIFIFYSDHGG
PGVLGMPTSRYIYADELIDVLKKKHASGNYKSLVFYLEACESGSIFEGLLLEGLNIYATT
ASNAEESSWGTYCPGEIPGPPPEYSTCLGDLYSIAWMEDSDIHNLRTETLHQQYELVKTR
TASYNSYGSHVMQYGDIGLSKNNLFTYLGTNPANDNYTFVDENSLRPASKAVNQRDADLL
HFWDKYRKAPEGTPRKAEAQKQFFEAMSHRMHVDHSIKLIGKLLFGIEKGPEILNTVRPA
GQPLVDDWGCLKSLVRTFESHCGALSQYGMKHMRSLANICNTGIGKEKMAEASAQACENI
PSGPWSSLDKGFSA
>P49044; 19 VACUOLAR PROCESSING ENZYME PRECURSOR (EC 3.4.22.-) (VPE)
MGSSQLSTLLFFTIVVTFLTVVSSGRDLPGDYLRLPSETSRFFREPKNDDDFEGTRWAIL
LAGSNGYWNYRHQSDVCHAYQLLRKGGSKEENIIVFMYDDIASNEENPRPGVIINKPDGD
DVYAGVPKDYTGAEVHADNFYAALLGNKSALTGGSGKVVDSGPNDHIFVYYTDHGGPGVL
GMPVGPYLYASDLNEVLKKKHASGTYKSLVFYLEACESGSIFEGLLPDDLNIYATTASNA
EESSWGYYCPGDKPPPPPEYSTCLGDLYSIAWMEDSEVHNLQTESLQQQYKLVKNRTISE
PYGSHVMEYGDIGLSKNDLYQYLGTNPANDNNSFVDETENSLKLRTPSAAVNQRDADLIH
FWEKFRKAPEGSSQKNEAEKQVLEAMSHRKHIDNSVKLIGQLLFGIEKGTELLDVVRPAG
SPLVDNWDCLKTMVKTFETHCGSLSQYGMKHMRSFANICNAGIPNEPMAEASAQACASIP
ANPWSSLQGGFSA
>Q04732; 20 CALCIUM-BINDING ACIDIC-REPEAT PROTEIN PRECURSOR (ARP).
MSHLWCWLFLVLCLACLVLSIEAKDSDGDGLLDVDEINVYFTDPYNADSDQDGLTDGLEV
NRHQTHPQDKDTDDDSIGDGVEVNNLGTNPKDPDSDDDGLTDGAEVNLYRTDPLDADSTT
TGCPMGGGAEVRHRPQNGDTDDDGLTDGAEVNVHRTNPQDGDSDDDGLSDGAEVNTYHSN
PKDGDSDDDGVSDGAEVNPKLKDSDGDGLTDEEEIKLYRTDPFCADSDFDGLLDGEEVKV
HKTNPLDGDSDDDGLGDGAEVTHFNTNPLDADSDNDGLDDGEEINVHGTDPEDPDSDNDG
LNDGDEVNVYNTDPEEDDSDEDGVCDGAEVNVHHTNPKDEDSDNDGIPDGAEINTHKTDP
NDEDSDDDGIADGAEVTLTDSDGDGLPDEDEVALYNTNPANADSDYDGLTDGAEVKRYQS
NPLDKDTDDDGLGDGVEVTVGTDPHDATVTTTGSRTAVEINVHGSDPNDEDTDDDGLTDG
AEVNLHRTDPEDADTDDDGLTDGAEVNTYRTNPKLADSDGDGLSDGAEVNTHKSDPNDGD
SDDDGVPDAAEAKVKDSDGDGLSDTDEVRFRTNPKLADTDFDGLTDGAEILKHKTDPRNR
DTDGDGVADGLEVNTYGSDPKDADTDDDGLTDGAEINVHDTNPTDADSDDDGLSDGAEVM
TYHTNAKDGDSDDDGKADGAEVSASTDPWRSDHSV
>P15590; 18 GLOBULIN-1 S ALLELE PRECURSOR (GLB1-S) (7S-LIKE).
MVSARIVVLLAVLLCAAAAVASSWEDDNHHHHGGHKSGRCVRRCEDRPWHQRPRCLEQCR
EEEREKRQERSRHEADDRSGEGSSEDEREREQEKEEKQKDRRPYVFDRRSFRRVVRSEQG
SLRVLRPFDEVSRLLRGIRDYRVAVLEANPRSFVVPSHTDAHCIGYVAEGEGVVTTIENG
ERRSYTIKQGHVFVAPAGAVTYLANTDGRKKLVITKILHTISVPGEFQFFFGPGGRNPES
FLSSFSKSIQRAAYKTSSDRLERLFGRHGQDKGIIVRATEEQTRELRRHASEGGHGPHWP
LPPFGESRGPYSLLDQRPSIANQHGQLYEADARSFHDLAEHDVSVSFANITAGSMSAPLY
NTRSFKIAYVPNGKGYAEIVCPHRQSQGGESERERGKGRRSEEEEESSEEQEEVGQGYHT
IRARLSPGTAFVVPAGHPFVAVASRDSNLQIVCFEVHADRNEKVFLAGADNVLQKLDRVA
KALSFASKAEEVDEVLGSRREKGFLPGPKESGGHEEREQEEEEREERHGGRGERERHGRE
EREKEEEEREGRHGRGRREEVAETLLRMVTARM
>P26792; 31 BETA-FRUCTOFURANOSIDASE, INSOLUBLE ISOENZYME 1 PRECURSOR
MGVTIRNRNYDHGSLPFLQSLLAILLVTTTTLHINGVEAFHEIHYNLQSVGAENVKQVHR
TGYHFQPKQNWINDPNGPMYYKGVYHLFYQYNPKGAVWGNIVWAHSVSTDLINWTPLEPA
IFPSKPFDKYGCRSGSATILPGNKPVILYTGIVEGPPKNVQVQNYAIPANLSDPYLRKWI
KPDNNPLVVANNGENATAFRDPTTAWLDKSGHWKMLVGSKRNRRGIAYLYRSKDFIKWTK
AKHPIHSQANTGMWECPDFFPVSLKGLNGLDTSVTGESVKHVLKVSLDLTRYEYYTVGTY
LTDKDRYIPDNTSVDGWAGLRYDYGNFYASKTFFDPSKNRRILWGWANESDSTAHDVAKG
WAGIQLIPRTLWLDPSGKQLMQWPIEELETLRGSKVKFSRKQDLSKGILVEVKGITAAQA
DVEVTFSFKSLAKREPFDPKWLEYDAEKICSLKGSTVQGGVGPFGLLTLASEKLEEYTPV
FFRVFKAQNTHKVLMCSDATRSSLKEGLYRPSFAGFVDVDLATDKKISLRSLIDNSVVES
FGAKGKTCISSRVYPTLAVYENAHLYVFNNGSETITVENLDAWSMKKPLRMN
>P16270; 21 NONSEED LECTIN PRECURSOR.
MALYRTKELVSLVSIMFVLLATNIEALSFNFPKITPGNTAITLQGNAKILANGVLALTNS
TQIPPTTTFPSTGRALYSTPVPLWDSATGNVASFVTSFSFVILNPSGRVPTDGLVFFIAP
PDTEIPNNSQSQYLGVVDSKTSINRFVGLEFDLYANSFDPYMRHIGIDINSLISTKTVRY
NFVSGSLTKVTIIYDSPSNTLTAVITYENGQISTISQNVDLKAVLPKDVSVGFSATSTIA
VSHNIHSWSFTSNLEATTGNIVSQV
>P32439; 23 MFS18 PROTEIN PRECURSOR.
MARSSKMMVAARLLALALAVSTAEARNIKTTTTEKKDDAVVQPQTFPPFDRLGGGASPAF
GGLPGGSIPGSSIPGFSMPGSGSSLPGFSLPGSGTMPLFGGGSPGFSGFGGMPGSPTAGS
VPEHANKP
>P15721; 27 PROBABLE PECTATE LYASE P56 PRECURSOR (EC 4.2.2.2).
MEYSYRTKINVLFIVLILFVFAALGTAINAPRRKLTKKYRGPCMAVNSIDKCWRCDPFWA
EDRQKMADCALGFGINAMGGKYGPYYIVTDNSDDDVVDPKPGTLRFGVIQKGPLWITFAR
SMRIRLTRELIVSSNKTIDGRGKYVHIANGAGIKIQSASNVIISNLRIHNIVPTAGGLLR
ESDDHLGLRGADEGDAISIFNSHDIWIDHISMSRATDGLIDAVAGSTNITISNCHFTDHE
KVMLFGANDHAEEDRGMKITLAYNHFGKRLDQRMPRCRFGFFHLVNNDYTHWERYAIGGS
SGATIISQGNRFIAEDKLLVKEVTYREKSTSSVEEWMKWTWITDGDDFENGATFTPSGDQ
NLLSKIDHLNLIQPEPSSKVGLLTKFSGALSCKIRRPC
>P01089; 21 2S ALBUMIN PRECURSOR.
MAKLIPTIALVSVLLFIIANASFAYRTTITTIEIDESKGEREGSSSQQCRQEVQRKDLSS
CERYLRQSSSRRSPGEEVLRMPGDENQQQESQQLQQCCNQVKQVRDECQCEAIKYIAEDQ
IQQGQLHGEESERVAQRAGEIVSSCGVRCMRQTRTNPSQQGCRGQIQEQQNLRQCQEYIK
QQVSGQGPRRSDNQERSLRGCCDHLKQMQSQCRCEGLRQAIEQQQSQGQLQGQDVFEAFR
TAANLPSMCGVSPTECRF
>P22551; 28 S-LOCUS-SPECIFIC GLYCOPROTEIN PRECURSOR.
MRGVIPNYHHSYTLFFFVILVLFPHVFSTNTLSPNEALTISSNKTLVSPGDVFELGFFKT
TTRNSPDGTDRWYLGIWYKTTSGHRTYVWVANRDNALHNSMGTLKISHASLVLLDHSNTP
VWSTNFTGVAHLPVTAELLANGNFVLRDSKTNDLDRFMWQSFDYPVDTLLPEMKLGRNLI
GSENEKILTSWKSPTDPSSGDFSFILETEGFLHEFYLLKNEFKVYRTGPWNGVRFNGIPK
MQNWSYIDNSFIDNNEEVAYSFQVNNNHNIHTRFRMSSTGYLQVITWTKTVPQRNMFWSF
PEDTCDLYKVCGPYAYCDMHTSPTCNCIKGFVPKNAGRWDLRDMSGGCVRSSKLSCGEGD
GFLRMSQMKLPETSEAVVDKRIGLKECREKCVRDCNCTGYANMDIMNGGSGCVMWTGELD
DMRKYNAGGQDLYVKVAAASLVPS